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Chronic obstructive pulmonary disease (COPD) is an important cause of morbidity 
and mortality worldwide. Some studies suggest that COPD may affect work, however 
this relationship remains poorly understood.  Various methods are used in this thesis 
to investigate the impact of COPD on employment and work productivity. 
Findings from the systematic review showed that patients with COPD had lower 
employment and higher sickness absence rates compared to those without COPD. 
From the cross-sectional analyses, breathlessness and occupational exposures to 
vapours, gases, dusts and fumes (VGDF) were identified as the main modifiable 
factors associated with unemployment and poor work productivity in COPD patients. 
Finally, few patients agreed to take part in the occupational intervention. Although 
most participating patients received a range of recommendations, these were not 
taken up by all. Potential benefits and suggestions for future occupational 
interventions were identified. 
This work confirms that having COPD adversely affects patients’ rates of employment 
and work productivity. Future interventions should focus on managing breathlessness 
and reducing occupational exposures to VGDF to improve work ability and work 
productivity among patients with COPD. The development of novel interventions 
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1.  INTRODUCTION 
 
1.1 The importance of work on health and wellbeing 
There is increasing evidence that being in work is good for physical and mental 
health and wellbeing.1 Being in work provides a feeling of self-worth1 but also has 
economic advantages for both the individual and society. Evidence suggests that 
being out of work may be harmful for individuals.2  
Those not in work are more likely to have higher mortality rates with a government 
commissioned review reporting 37% excess mortality in those who were unemployed 
(and not ill) compared to those in employment.2 Unemployed people are also more 
likely to have poorer mental health (suicidal thoughts in unemployed vs. employed 
men: 21.7% vs. 13.8%),3 and there is evidence to suggest that those who become 
unemployed are approximately twice as likely to experience a negative impact on 
their mental health (men: OR=2.05 (95% CI: 1.71-2.47); women: OR=1.72 (95% CI 
1.39-2.12).4 There is also evidence of increased health service utilisation in those 
unemployed (increased visits to the GP among men: adjusted OR=1.83 (95% CI 
1.61-2.09).5  
Conversely, work may also be associated with negative health outcomes. Within the 
UK, workplace exposures contribute to approximately 13000 deaths annually due to 
lung disease and cancer.6 There is also evidence of the association between other 
occupational factors and poor health. For example, those in unstable employment 
(fixed term contract or temporary employment) are more likely to have higher levels 
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of fatigue, back and muscular pains compared to those with a permanent job.7 
Furthermore, a recent labour force survey found approximately 1.2 million workers 
felt that their health condition was either caused or worsened by their work.8  
Although sickness and disability still account for many of those who are not in work,9 
there is an agreement across a number of groups (e.g. all political parties, employers 
and disability groups) that those who are unwell or disabled should aim to remain in 
work or return to work as it is therapeutic; promotes recovery and rehabilitation and 
there are better health outcomes for patients.2;10 It is therefore recognised that being 
in work outweighs the risks associated with working and the beneficial effects of 
being in work are greater than the negative of long-term sickness absence or 
unemployment,1 with the proviso that the individual has a ‘good job’. Such 
characteristics may include: fair pay; job security; personal development; job 
satisfaction; greater control/autonomy and non-discriminatory.2 
1.2 Working with a chronic condition 
Among those of working age, an estimated 15% are affected by a chronic condition 
or disability in the UK.11 With the state pension age increasing, the UK workforce will 
be working longer to an older age12; which also increases the chance of developing a 
chronic condition. This, in addition to the current trajectory, therefore suggests  that 
more people will be working with a chronic health condition in the future.1 
Whilst there is a beneficial impact of working on the health and wellbeing of an 
individual, having a chronic illness is often associated with poor work ability. 
Employment rates in the UK are lower in those with a chronic condition (60.4%) 
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compared to the general population (73.5%).13 Previous research has focused on the 
burden of common health conditions, such as musculoskeletal disorders and mental 
health conditions, on work productivity losses.14-18 Consequently, there has been 
increasing attention to work-based interventions to help people stay in work for 
longer and prevent those with common health conditions progressing from short-term 
sickness absence to incapacity benefits and job loss.15;19-21  
Of the main long-term health conditions, there is a growing interest in the impact of 
chronic obstructive pulmonary disease (COPD) on the ability to work. As COPD 
progresses patients are increasingly faced with a number of functional limitations, 
and as a result, can experience effects on their personal, social and work life.22;23 
Little is understood about the relationship between COPD and work, which may also 
explain the paucity of evidence assessing work-based interventions in patients with 
COPD as well as the lack of health interventions assessing working outcomes in 
COPD patients. 
1.3 Definition and description of COPD  
COPD is a progressive lung disease, characterised by airflow limitation. The most 
commonly used definition of COPD is by the Global Initiative for Chronic Obstructive 
Lung Disease (GOLD): 
“Chronic Obstructive Pulmonary Disease (COPD), a common preventable and 
treatable disease, is characterized by persistent airflow limitation that is usually 
progressive and associated with an enhanced chronic inflammatory response in the 
airways and the lung to noxious particles or gases. Exacerbations and comorbidities 
contribute to the overall severity in individual patients.” 24 
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The airflow limitation is initially caused by chronic lung inflammation, leading to 
obstructive bronchiolitis (small airways disease) and emphysema (destruction of the 
lung parenchymal tissue).24 The role and contribution of both conditions varies for 
each individual.24 COPD is associated with a number of symptoms, disability and 
poorer quality of life.25 
Although known to primarily impact on lung function, there is increasing evidence of 
the systemic consequences of COPD (particularly systemic inflammation),26 which 
includes the frequently occurring co-existing illnesses (or co-morbidities) in patients 
with COPD.27 However, it is unclear whether the associations between certain co-
morbidities and COPD are due to the shared risk factors, such as smoking and poor 
physical activity, or caused by COPD itself.28 Nevertheless, it is well recognised that 
the associated systemic consequences lead to poorer health outcomes, for example 
reduced quality of life and increased mortality.27 Some of the most common 
comorbidities include: cardiovascular disease, cancer, diabetes, osteoporosis, 
depression/anxiety, muscle loss or dysfunction, anaemia and gastroesophageal 
reflux.26;27 
1.4 The burden of COPD 
COPD is one of the leading causes of morbidity and mortality worldwide29;30; affecting 
approximately 6-10% of the population worldwide.31 Furthermore, both COPD 
prevalence and mortality are increasing24;32;33; much of which is due to the ageing 
global population as well as the continued use of tobacco worldwide.34 The 
prevalence of diagnosed COPD in the UK is 1.8%,35 however due to the known large 
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under diagnosis of the condition,36;37 the actual prevalence of COPD may be as much 
as twice as high.25;37;38 Healthcare utilisation among COPD patients is high. It is 
estimated that 94000 of annual hospital admissions in the UK are due to COPD39; 
with COPD exacerbations as the second most common cause of accident and 
emergency visits.40 In addition, those with more severe disease are more likely to 
experience increased risks of hospitalisation, with more than one third being 
readmitted into hospital within 30 days.41 Consequently, COPD has a significant 
impact; costing the NHS in excess of £800m annually,41 with costs associated with 
inpatient stays accounting for more than £240m alone.42 However, these costs alone 
do not reflect the true burden of COPD; there are also significant indirect costs 
(largely due to lost productivity) to society. Indirect costs account for 27% to 61% of 
the total costs attributable to COPD.43 In the US, it is estimated that COPD accounts 
for 16.4 million lost working days each year44; costing approximately $3.9bn in the 
US annually.44 In the UK, the estimated societal cost of sickness absence due to 
COPD is £1.1bn.45 With increasing morbidity among those with COPD, it is likely that 
these costs will increase too. 
1.5 COPD symptoms, diagnosis, severity, COPD 
prognosis and exacerbations 
COPD is associated with a number of respiratory symptoms: breathlessness 
(dyspnoea), chronic cough, sputum production and wheezing25; COPD patients may 
present with one or more of these symptoms. Chronic cough is often one of the first 
symptoms of COPD, and although to begin with it may be irregular, as the disease 
progresses patients experience daily coughing.24 Breathlessness is an important 
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COPD symptom; associated with disability and anxiety.24 Other symptoms patients 
may experience include fatigue, weight loss, waking at night and ankle swelling.25 
The presentation of COPD is associated with considerable clinical heterogeneity, and 
therefore a number of indicators are used to make a clinical diagnosis. Currently, a 
COPD diagnosis is considered among patients who have a history of exposure to the 
risk factors associated with COPD (e.g. smoking) and those who present with one of 
the following respiratory symptoms: breathlessness, chronic cough or regular sputum 
production.25 To confirm a diagnosis of COPD, patients are also required to meet the 
spirometry (lung function test) criteria for airflow limitation: post-bronchodilator FEV1 
(forced expiratory volume in one second)/FVC (forced vital capacity) <0.70.25 The 
Global Initiative for Chronic Obstructive Lung Disease (GOLD) have also categorised 
the spirometric values using various cut-off points to indicate the categories of 
disease severity (Table 1-1), and this is currently used as the standard in 
categorising COPD according to the NICE (National Institute for Health and Care 
Excellence) guidelines.24;25  
Disease severity GOLD staging Spirometry criteria 
Mild GOLD 1 FEV1/FVC < 0.70 FEV1 > 80% predicted 
Moderate GOLD 2 FEV1/FVC < 0.70 50% < FEV1 < 80% predicted 
Severe GOLD 3 FEV1/FVC < 0.70 30% < FEV1 < 50% predicted 




Table 1-1 Global Initiative for Chronic Obstructive Lung Disease (GOLD) 
classification disease severity staging 
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Although airflow obstruction is used to define disease severity, it is now increasingly 
recognised that FEV1 alone does not fully describe the impact of COPD on patients’ 
lives. Evidence demonstrates that dyspnoea (an important COPD symptom) better 
measures disease severity as well as gauging the level of impact.46;47 In fact, GOLD 
advocates that in addition to evaluating the level of airflow obstruction, a formal 
symptomatic assessment should be conducted.24 This has encouraged the 
development of a variety of multi-dimensional indices, incorporating different facets of 
disease severity, for example the BODE index48 and the ADO index.49 GOLD have 
also developed a composite measure, using a range of prognostic markers, to help 
better understand, describe and define the impact of COPD on the individual as well 
as guide management. It includes symptom impact (the CAT score), breathlessness, 
degree of airflow obstruction and risk of exacerbations.24  There are a range of 
prognostic indices available, but there is insufficient evidence for the implementation 
of a particular prognostic index.50 
Life expectancy decreases with increasing disease severity and among continuing 
smokers in patients with COPD. Among men, life expectancy for those with GOLD 
stage 2 and 3 or 4 is 1.2 years and 4.7 years lower than those without COPD.51 
Among male smokers with GOLD stage 2 and 3 or 4, a reduction in life expectancy of 
2.2 years and 5.8 years was found when compared to those without COPD.51  
COPD patients also experience exacerbations of their condition. A COPD 
exacerbation can be described as a “sustained worsening of the patient’s condition 
from the usual stable state, which is beyond normal day-to-day variations that is 
acute in onset and may warrant additional treatment”.52 Symptoms include worsening 
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cough, breathlessness, increased sputum production and change in sputum colour.25 
Annual exacerbation rates have been shown to vary from 0.5 to 3.5 per patient53; 
with 31% of reported exacerbations requiring hospitalisation.54 COPD exacerbations 
contribute towards a worsening prognosis (increased risk of morbidity and 
mortality),55;56 and an increased exacerbation frequency is associated with poorer 
quality of life.57 Thus COPD exacerbations are considered as important events,58 and 
therefore are often used as a marker of disease severity. 
Co-morbidities also play an important role in the worsening prognosis of COPD; 
evidence suggests that mortality is largely due to non-respiratory related diseases for 
example coronary heart disease, cancer and stroke; with respiratory related cause of 
death only accounting for 8-9% of all deaths in patients with COPD over a 25 year 
follow-up.59  
Due to the multi-dimensional nature of COPD, the GOLD committee encourages an 
independent assessment of the following in determining the patient’s disease 
severity, health status and future risk of events: patient’s symptoms, severity of 
airflow obstruction, exacerbation risk and the presence of co-morbidities.24 
1.6 The treatment and management of COPD 
Due to the progressive nature of the chronic condition, COPD cannot be cured; 
however the condition can be managed to delay the progression of the disease, for 
example preventing exacerbations and easing symptoms. The most effective advice 
to manage and alter the course of COPD is smoking cessation.24;60;61 Correct 
pharmacological therapy (including correct inhaler technique) is advised to help with 
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symptom management, exacerbation frequency and severity and improve general 
overall health.24 Patients are also recommended annual influenza vaccinations and a 
single pneumococcal vaccination to reduce the risk of infections,25 which lead to 
exacerbations.62  
NICE advise that patients with more severe COPD (those with a recent 
hospitalisation due to COPD or MRC score>3) should be referred to pulmonary 
rehabilitation.25 Pulmonary rehabilitation is a multi-faceted programme involving 
components such as exercise, education and behaviour change. Among those with 
COPD, it is an approach which aims to reduce COPD symptoms, improve health 
related quality of life and increase the physical and emotional involvement in 
everyday life.24  
Self-management of COPD is also an important aspect of managing the disease and 
improving patient outcomes. Recent evidence from a systemic review demonstrated 
that supported self-management programmes were able to significantly reduce 
hospitalisations (OR=0.60; 95% CI 0.40 to 0.89) and improve health related quality of 
life (mean difference in SGRQ score -3.51; 95% CI -5.37 to -1.65) in COPD patients, 
compared to those receiving usual care.63 In addition to the above, the important self-
management health behaviours that need to be considered include early symptoms 
recognition; action planning (accessing treatments promptly during an exacerbation); 
breathing techniques; exercise; bronchial hygiene techniques; nutritional 
programmes and stress management.64 
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1.7 Risk factors associated with COPD 
Although cigarette smoking is the main risk factor for COPD,24 it is not the only 
explanatory factor. Other known risk factors include indoor and outdoor air pollution, 
respiratory infections and factors associated with low socioeconomic status.24 
Occupational exposures are also recognised as playing an important role in the 
development of COPD.65-67 It is thought that the inhalation of particular gases and 
particles result in airway and lung inflammation, leading to the progression of 
COPD.66  
1.8 Occupation as a risk factor for COPD 
Fishwick and colleagues report that associations between chronic respiratory 
symptoms and workplace exposures have been suggested as early as the 15th 
century,68 although documentation of the connection between ‘dusty trades’ and 
chronic bronchitis  has been more prominent from the 19th century.68;69 The 
inconsistent definitions of COPD and unreliable measure of exposures have led to a 
delay in the recognition of the causal link between occupational exposures and 
COPD. However, over recent years strong associations have been found between 
particular occupational groups and exposures to vapours, gases, dusts and fumes 
(VGDF) and the development of COPD.  In particular, Margaret Becklake’s seminal 
work indicated a causal link between workplace exposures to dust and fumes and 
COPD,70 subsequently confirmed by a number of systematic reviews.66;71;72 
Research in this field has either focused on examining: 1) specific industries or 
workforces – providing homogenous populations in terms of occupational exposures, 
CHAPTER 1: INTRODUCTION 
11 
 
or 2) general populations with varied populations and occupational exposures.73 
Although both types of studies have their respective advantages in assessing the 
impact of occupation on COPD, prospective data collection among a general 
population may be seen as advantageous as it allows the assessment of the total 
burden of occupational exposures on COPD73 as well as reducing the problems 
related to the confounding of the “healthy worker effect”68 (where lower morbidity and 
mortality is observed in the working population, as those who are more ill tend to 
leave work).  
Based on a review by the American Thoracic Society (ATS), and a subsequent 
updated review it has been estimated that approximately 15% of COPD may be 
attributable to workplace exposures.71;72 This risk (population attributable fraction 
(PAF): “the fraction of cases in a population that arise because of certain 
exposures”)74 has been cited as  higher among non-smokers; using data from the 
NHANES survey, the estimated PAF due to occupation was 31.1% among non-
smokers.75 
It remains unclear which specific substances cause COPD as only a few studies 
have been conducted with the aim of measuring specific occupational exposures and 
their contribution towards the burden of COPD.74 However, an increased prevalence 
of COPD has been found in those exposed to asbestos, cadmium, coal dust, quartz, 
sawdust, silica, solvents, welding fumes and wood dust.69;76 Longitudinal studies 
have also shown exposure to cotton and grain dust as important risk factors in the 
development of chronic airflow limitation.76;77 Additionally, high prevalence of COPD 
has been noted in specific occupations and industries, such as: construction; 
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leather/rubber/plastics manufacturing and workers; spray painters; welders; repair 
services and gas stations; food products and textiles.75    
Although much of the previous literature has focused on the impact of occupation on 
the development of COPD, it is also important to understand the effect of COPD on 
employment and work performance. This is relatively new research area and is the 
focus of this thesis.  
1.9 Measures of work ability or work productivity 
There are 3 main measures of work ability. Employment is one of the main outcome 
measures when assessing the impact on work. Among those in work, worker 
productivity is also assessed. Historically, work productivity has predominantly been 
measured by assessing time taken off work for a scheduled working day(s) – 
“absenteeism”. However more recently, there has been a focus on an emerging 
concept known as “presenteeism”, focusing on an individual’s work performance 
when at work.  
1.9.1 Employment 
According to the Office for National Statistics being in work is defined as:  
“in paid employment at work for at least one hour over the reference week (or 
temporarily not at work during the reference period but have a formal attachment to 
their job) or, in self-employment at work for at least one hour over the reference week 
(or is a person with an enterprise who is temporarily not at work during the reference 
period for any specific reason)”.78 
This data is captured at population level through the Labour Force Survey (LFS), a 
periodical survey assessing the employment circumstances within the UK. 
CHAPTER 1: INTRODUCTION 
13 
 
Respondents are questioned: “Did you do any paid work in the 7 days ending 
Sunday the [date], either as an employee or as self-employed?”.79 
There is a risk of inaccurate reporting when collecting data on employment. As 
unemployed individuals within the UK are eligible for claiming benefits (e.g. job 
seekers allowance, housing benefit), individuals may chose not to disclose that they 
are in work in order to maintain their benefits income.80 Within the research context, 
this may be reflected in imprecise higher unemployment rates.  
1.9.2 Sickness absence  
Sickness absence (or absenteeism) has been defined as “absence from work that is 
attributed to sickness by the employee and accepted as such by the employer”.81 
Historically, sickness absence has been an important indicator of worker productivity 
and consequently, a method of measuring the financial impact on society and the 
economy. This may be officially recorded by the employer or self-reported by 
employees. 
The Office for National Statistics provides estimates on UK sickness absence over a 
12 month period. However, within research, varying recall periods have been used to 
measure sickness absence, for example, within COPD research this has ranged 
between one week and two years.22;82 
Self-reported measurement of sickness absence is frequent in the literature but is 
known to be at risk of recall error83; and the greater the recall period, the more prone 
the data is to recall inaccuracy. Previous work in this field suggests that the tendency 
is for employees to underestimate their sickness absence rates.83 Methods of 
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reducing this error include collecting the data prospectively through diaries or 
reducing the recall period. However, prospective data collection can be an onerous 
task and a shorter recall period may result in skewed data i.e. towards zero sickness 
absence 83. Social desirability bias is another potential issue related to the reporting 
of sickness absence. Respondents may feel the need to present themselves and 
their behaviour positively84 and therefore, under-report their sickness absence rates.  
Sickness absence data is also susceptible to occupational bias. Protocols and 
practices for sickness absence vary across occupations and work organisations; 
“these differences can contribute to error in estimating the effects of health on the 
work productivity of different groups”.83(p75-p76) For example, occupations which 
require careful consideration of the impact of an employee’s health on the health and 
safety of others, may have higher sickness absence, e.g. a sick nurse may be 
obliged to stay at home for the health and safety of patients.  
1.9.3 Presenteeism 
Presenteeism relates to a measurement of work productivity; a measure of an 
individual’s performance at work accounting for the impact of an illness or medical 
condition which may prevent him or her  working at full capacity. The term has been 
defined as “the problem of workers’ being on the job but, because of illness or other 
medical conditions, not fully functioning”.85 Although a relatively new concept, its 
potential impact on the productivity loss among workers has led to its increasing 
focus within the scientific literature. Evidence suggests that this “invisible, but 
significant drain on productivity”85 may be a far greater problem than the impact of 
sickness absence alone.86  
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In some occupations decreased work performance can be assessed by quantifying 
work tasks, for example, measuring and comparing the number of items produced or 
the number of telephone calls handled over a period of time.87 However this may be 
more difficult to assess in predominantly cognitive based occupations.87 
Consequently, to gauge and quantify work performance in a variety of occupations, a 
number of questionnaire-based presenteeism instruments have been developed. 
However, measuring presenteeism can be complicated. Within the literature 
presenteeism has been described using varying definitions, for example: “reduced 
productivity while at work”88 and “reduced on-the-job effectiveness due to health 
problems”,89 with a higher value – high presenteeism – indicating poorer work 
performance. Presenteeism has also been described as attending work when sick 
(sickness presenteeism).90;91 Somewhat confusingly, presenteeism has also been 
defined and measured as “a good thing, with higher scores indicating higher 
performance and job productivity”.92 An example of such a measure is the Stanford 
Presenteeism Scale (SPS-6), where decreased productivity is defined as “decreased 
presenteeism”.93 The various measurement scales – ranging from simple single 
questions to more complex instruments – may provide an explanation for the varying 
definitions and directional effects, and currently, there is lack of agreement on the 
best tool to capture presenteeism.92 Therefore, due to the varying definitions and the 
absence of a standard instrument to measure the phenomena, there may be a lack of 
clarity of what is actually being measured.85 Examples of the more common 
instruments used to measure presenteeism include the WHO Health and Work 
Performance Questionnaire (WHO-HPQ),94 The Work Limitations Questionnaire 
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(WLQ),95 The Stanford Presenteeism Scale (SPS-32)96 and the Work Productivity 
and Activity Impairment questionnaire (WPAI).89  
One of the less complex and shorter tools is the WPAI questionnaire: a single 
question related to productivity requiring the respondent to score using a visual 
analogue scale. It has a short, 7 day recall period. Consequently, its simplicity may 
provide an explanation for the WPAI’s frequent use within research, in particular, 
COPD research.  
However for the purpose of this thesis, the Stanford Presenteeism Scale (SPS-6) 
was chosen amongst the numerous instruments to measure presenteeism based on 
some of its potential advantages. The SPS-6 is a shortened version of the SPS-32 
and aims to capture the cognitive, emotional and behavioural aspects of work.93 The 
questionnaire was developed to assess and combine two main aspects of 
presenteeism: work processes and working outcomes.93 It is a relatively short 
questionnaire, consisting of 6 items, with a one month recall period – the past month. 
It is considered to be among the small number of tools possessing good 
psychometric properties (e.g. good level of measurement, validity and reliability).97;98 
However, defining presenteeism as fully productive/engaged with work may be 
considered as a shortcoming of the instrument when compared to other 
presenteeism questionnaires. Therefore, for the purpose of this thesis, presenteeism 
will be defined in keeping with the commonly used definition; decreased productivity 
signifying presenteeism (poor work performance), and thus a low SPS-6 score will be 
described as decreased productivity and high presenteeism.  
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1.10 The impact of COPD on employment and work 
productivity 
There are limited and inconsistent data on the impact of COPD on employment and 
work productivity. Data from other countries suggests patients with COPD are less 
likely to report being in work when compared to those without any chronic conditions 
(OR: 0.41; 95% CI 0.24 – 0.71); which is lower than those with asthma (OR: 0.82; 
95% CI 0.55-1.21) or other chronic conditions (OR: 0.86; 95% CI 0.68 – 1.08).99 
However the absolute risk may vary by country due to the diverse economies and 
employment rates. For example, data from a large cross-sectional study across Latin 
America demonstrated that 42.0% of those with COPD were in work,100 whereas an 
international survey found only 29.0% of those with COPD of working age were in 
work.22 Whilst it may seem intuitive that employment rates among those with COPD 
would vary according to disease severity, evidence for this is conflicting.100-103 
Increasing age,100;102 being female,100 lower educational level100 and poorer health 
related quality of life102 are factors which have also been noted to be significantly 
associated with being out of work among those with COPD in some studies, but this 
is not consistently shown among the limited evidence in this area. 
Work-related factors may also play an important role. High occupational exposures to 
irritants or dusts seem to increase the risk of being out of work among those with 
COPD,101 although evidence for this is limited and conflicting.101;102 These 
inconsistencies may be explained by the variability in the method of measuring 
occupational exposures – self-report and professional judgement – although both 
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methods may be considered crude and are susceptible to subjectivity and 
measurement error.  
There is also some limited evidence which suggests that unfavourable work 
experiences and patients’ perceived inability to work due to the disease may also be 
associated with lower employment rates; those whose employers commented 
negatively about their disease or felt that their employer did not adequately consider 
their disease, were less likely to be in work.101 Furthermore, patients who thought 
that their work worsened their COPD were more likely to be out of work (OR: 5.1; 
95% CI 2.87-9.04).101 
Among those who remain in work, work productivity may also be affected by their 
disease. Data from a large Australian cross-sectional survey show that patients with 
COPD are more likely to take time off work compared to those without COPD 
(adjusted IRR (95% CI): 1.22 (1.04 – 1.43), and have a higher risk of absenteeism 
than those with other chronic conditions such as cancer (adjusted IRR: 1.11 (1.04 – 
1.17) and arthritis (adjusted IRR: (95% CI): 1.07 (1.01 – 1.14)).104 Although a number 
of studies concur that COPD adversely affects sickness absence,104-108 the 
magnitude of the effect remains unclear. The amount of time off work has been 
shown to vary between studies,22;45;107-117 and although this may be reflective of the 
differing economies, other inconsistencies have been noted within previous research, 
such as definition of absenteeism, varying recall periods and study sample sizes.   
Fewer studies have assessed the impact of COPD on work performance (or 
presenteeism). There is inconsistent evidence about whether COPD patients are 
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more likely to have poorer work performance compared to those without 
COPD.22;104;111;112;116 Furthermore, a variety of scales have been used to measure 
presenteeism; making it difficult to compare the effect estimates between the studies.  
A number of socio-demographic factors have been shown to be associated with 
increased sickness absence among those with COPD for example, lower age 118 and 
lower education level.119 There is some evidence which suggests that although 
sickness absence is not associated with airflow obstruction,118 it is more common 
among those with severe breathlessness.22 There is also some inconsistent evidence 
of the negative impact of co-morbidities on sickness absence.118;119 Overall, there is 
limited amount of evidence; of which there are small sample sizes and limited 
analyses assessing a range of clinical characteristics (such as breathlessness, health 
related quality of life and exacerbations) which may be associated or confounding 
work productivity.  
Furthermore, currently no research has been conducted assessing which socio-
demographic, clinical or occupational factors are associated with presenteeism 
among those with COPD. Although evidence from an unadjusted analysis, assessing 
the prevalence of presenteeism according to breathlessness (presenteeism 
prevalence: mild=5.2%; moderate=16.8%; severe=18.9%, p-values unreported), 
suggests disease severity could be important.22 
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1.11 Other factors which might affect employment and 
work performance 
In other populations, various other work related factors have shown to be associated 
with poor work productivity, such as: poor control over work (e.g. employee’s ability to 
schedule own work)91;120; job insecurity121;122; understaffing121; lack of supportive 
work culture (particularly supervisory support)121-123; reduced job satisfaction121 and 
lack of time and resources.91;122 There is conflicting evidence on the impact of shift 
work on sickness absence, although fixed evening work may be an important factor 
for an increased risk of absenteeism.124 Types of employment seem to be associated 
with work productivity, for example those in paid employment (compared to self-
employed) and those working in the public sector (compared to private sector) take 
more time off work.125 Nature of occupation should also be considered, for example, 
those with a plant/process/machine operative background are 71.0% more likely to 
take time off work compared to those with a professional occupational background.125 
Individual patient characteristics also show some importance. For example, 
individuals who possess neurotic characteristics (such as anxiety, worry and 
insecurity) are less likely to achieve their work tasks126; with emotional stability being 
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1.12 Mechanisms and potential ways in which COPD 
patients may be affected in the workplace 
COPD patients are faced with a number of issues on a daily basis, which may also 
affect their ability to work. Dyspnoea (breathlessness) is a common symptom,128 
which in the work environment, may lead to a reduction in work load and therefore 
reduced work productivity. As a consequence, this may lead to a dyspnoea spiral129: 
a reduction in exertion to avoid dyspnoea may then reduce fitness levels and as a 
consequence, work tasks may become harder or patients may avoid tasks causing 
an earlier occurrence of dyspnoea.  
Fatigue, another symptom experienced by COPD patients,128 may limit work 
activities. Fatigue may increase with disease severity,130 negatively affecting 
functional performance.131 Therefore, as the condition progresses an activity may be 
more difficult to achieve. Similar to dyspnoea, patients may become part of a cycle 
where work tasks affect fatigue and fatigue affects the tasks. There is also some 
evidence for muscle wasting in COPD patients,132 which may result in difficulty in 
carrying out manual work tasks, leading to further breathlessness and muscle 
fatigue. As the disease progresses, health-related quality of life deteriorates and 
there may be a greater impairment in the patient’s ability to work.133 As a means of 
avoiding this vicious cycle and complications, patients may opt for early retirement.  
COPD is often associated with a number of co-morbidities such as cardiovascular 
disease, metabolic disorders and psychiatric disorders.27 Co-morbidities may present 
themselves as a further challenge to working COPD patients. For example, increased 
levels of anxiety are associated with more severe breathlessness134;135 and may 
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impact on work productivity and possibly lead to further anxiety. Hence, co-
morbidities may have an additional impact and lead to further problems at work for 
the patient.  
Workplace exposures to vapours, gases, dusts and fumes (VGDF) have been 
identified as an important risk factor in the development of COPD.68 However, further 
understanding about the characteristics of these exposures is required. Various ‘non-
specific exacerbating factors’ may, for example, induce cough in the workplace; 
general irritant exposures, cold temperatures, increased physical activity or talking for 
prolonged periods.136 An example, exposure to cleaning agents (bleach or air 
refreshing sprays) may also irritate the lungs and lead to an increase in respiratory 
tract symptoms137 and COPD exacerbations. Furthermore, heavy manual and blue-
collar work may be associated with work disability in respiratory disease patients.138 
Respiratory morbidity and mortality is increased in the winter months.139 Evidence 
suggests that the prevalence of COPD symptoms is greater in those working and 
living in cold environments.140;141 Exposure to a cold environment at work, for 
example through breathing cold air, may therefore worsen respiratory symptoms and 
lead to reduced work productivity.142   
Apart from the direct work environment, work productivity could also be affected 
indirectly. For example, poor self-management or non-adherence to medication or 
continuing to smoke may all affect disease control, possibly leading to poor work 
performance or time off work. Good self-management, for example regular 
medication use or infection control measures, can reduce symptom development and 
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associated COPD exacerbations.24;25;143 Infections, particularly respiratory infections, 
play an important role in COPD exacerbations. Influenza and pneumococcal 
vaccinations are recommended to patients as preventative measures for infection 
control.25 Long-term antibiotics are also advised to some patients.144   
1.13 Evidence for occupational health interventions among 
patients with COPD 
Occupational interventions aimed at working COPD patients need to address a 
number of aspects, focusing on improving work capacity and better planning of ill 
health retirement. As patients are at risk of hospitalisation due to COPD 
exacerbations, interventions should also accommodate the possibility of return to 
work (RTW) which may need to be phased. However, currently there are no UK 
occupational programmes focusing on improving poor work performance for patients 
with COPD. Furthermore, there is a scarcity of research on interventions among 
patients with respiratory disease, particularly among working COPD patients.  
1.14 Summary of research considerations 
Having a chronic condition affects working outcomes.145 This is also likely to be true 
for COPD patients. Disease related symptoms may affect functionality, for example 
fatigue and breathlessness, subsequently impacting on work performance, 
absenteeism and eventually job loss. Improving health through adopting a healthy 
lifestyle can generally improve health conditions and their associated symptoms.145 
However, some symptoms may require workplace adjustments, and therefore may 
need interventions to address work-related issues. There is a lack of evidence 
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assessing the impact of workplace interventions but a need for a need for timely 
interventions, involving treatment, guidance and advice to help prevent long term 
sickness absence and unemployment.1  
“Work should be accommodated to the condition and needs of the worker”.145 To 
inform the development of targeted interventions, it is important to understand why a 
particular individual’s work ability may be affected. However, research into the factors 
associated with working outcomes among those with COPD is limited and conflicting 
and although occupational exposures may be an important predictor of work ability, 
current research within COPD populations lacks objective measurement. 
Furthermore, there is suggestive evidence that disease severity may affect 
presenteeism, however, currently no research has been conducted in this emerging 
field among a COPD population. In addition, although there are a number of 
European studies, there is paucity of evidence based within the UK COPD 
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1.15 Aims and objectives of the thesis 
The overarching aim of this work is to investigate the impact of COPD on 
employment and work productivity by: 
1. Conducting a systematic review to assess the impact of COPD on 
employment, absenteeism and presenteeism. 
2. Conducting a cross-sectional analysis to assess which factors are associated 
with employment among patients with COPD. 
3. Conducting cross-sectional analyses to assess which factors are associated 
with absenteeism and presenteeism in COPD patients. 
4. Assessing the feasibility and acceptability of an occupational health 
intervention to improve work productivity among those with COPD. 
1.16 Thesis outline 
Chapter 2 consists of a systematic literature review which assesses the impact of 
COPD on employment, absenteeism and presenteeism. This chapter aims to 
consolidate the current evidence and clarify the impact of COPD and disease 
severity on employment and work productivity. The review should also identify the 
gaps in the current evidence and recommendations for future research.  
Chapters 3 and 4 investigate which socio-demographic, clinical and occupational 
factors are associated with employment and work productivity among those with 
COPD. These chapters aim to address the paucity of evidence in this field and 
identify the modifiable factors associated with work ability and poorer work 
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productivity to inform future interventions, and help improve working outcomes in 
COPD patients. 
Chapter 5 assesses the feasibility and acceptability of an occupational health 
intervention consisting of an occupational health assessment, subsequent 
occupational health recommendations as well as feedback on current COPD self-
management practices. The aim is to help patients better manage their COPD at 
work and improve their work productivity. Various methods are used to assess the 
feasibility and acceptability of the intervention, and this chapter aims to propose 
direction for future interventions aimed at working COPD patients.  
Finally, chapter 6 contains a summary of the main and novel findings within this 
thesis, and their implications for policy, practice and future research. 
  
 
   
2.  A SYSTEMATIC REVIEW TO ASSESS THE 
EFFECTS OF COPD ON EMPLOYMENT, 
ABSENTEEISM AND PRESENTEEISM 
 
2.1 Abstract 
Background Chronic obstructive pulmonary disease (COPD) is one of the leading 
causes of morbidity and mortality worldwide and is associated with a high economic 
burden to society; of which the indirect costs account for a large proportion. In the 
UK, productivity losses due to sickness absence are estimated to cost £1.1bn. There 
is a range of evidence assessing the impact of COPD on work ability and work 
productivity, however this relationship is poorly understood. 
Aim A systematic review of the evidence assessing the impact of COPD on 
employment, absenteeism and presenteeism 
Methods The review was conducted according to the Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses (PRISMA) guidance. Electronic databases 
CINAHL, EMBASE, MEDLINE, OSH references and the Cochrane Library were 
searched up to October 2015; identifying observational studies reporting 
employment, sickness absence and presenteeism in those with COPD.  
Results Of the 30 studies which met the inclusion criteria, 13 assessed the impact 
on employment, 21 assessed the impact on absenteeism and 9 assessed 
presenteeism. The majority of evidence was from cross-sectional surveys. COPD 
patients had lower employment rates than those without COPD. Among those who 




remain in work, patients with COPD were found to take more time off work than those 
without COPD. They were found to be more affected by poorer work performance 
than those without COPD, however evidence for this was limited and weak. The 
influence of disease severity on these outcomes was unclear, although of the limited 
evidence it appeared that increasing severity was associated with reduced likelihood 
of being in work. A number of methodological limitations were found amongst the 
evidence including the lack of adjusting for important confounders.  
Conclusions This is the first systematic review assessing the impact of COPD and 
disease severity on employment, absenteeism and presenteeism. COPD patients 
have lower employment rates and more time off work than those without COPD. 
Further research assessing the impact on presenteeism, using validated 
presenteeism instruments and consistent reporting methods, is required. Robust 
studies are now needed to identify modifiable factors associated with these poorer 
working outcomes among those with COPD to help inform future interventions. 
2.2 Background  
Chronic obstructive pulmonary disease (COPD) is a progressive lung disease 
characterised by airflow obstruction.25 It is the fourth leading cause of death 
worldwide24;146 and is associated with high healthcare utilisation costs; costing the UK 
NHS more than £800 million annually.41 The condition is also associated with indirect 
costs; in the UK, an estimated 44% of the COPD population are below retirement 
age, of which around one quarter are not in work due to their COPD.45 Among those 
with COPD who are in employment, an estimated 5% of sickness absence is due to 




COPD.45 Estimated costs of productivity losses due to COPD range between £1.1 
billion and £2.7 billion in the UK.41;45 
A large US general population-based survey found that patients with self-reported 
COPD (69.2%) had significantly lower employment rates compared to those without 
COPD (77.2%), and that as their disease severity increased, patients were less likely 
to be in work (p for trend <0.01).103 
A large multinational survey (the Confronting COPD survey) demonstrated the 
possible effects of COPD on absenteeism; which ranged from (mean) 0.4 days to 
18.7 days off annually across different populations.45;109;110;113-115;117 Researchers are 
now also considering the possible effects of COPD on “presenteeism” (poor work 
performance when at work), for which there are fewer studies. 
Although there is a range of literature assessing the effect of COPD on work, the 
relationship is poorly understood. The lack of consistency of the data, research 
conducted in a variety of settings/populations and no previous systematic collation of 
the evidence encourages the need for a systematic review.  
In doing so, this review will help to gain a better understanding of how COPD patients 
are affected as well as highlight the key areas where interventions may need to be 









Systematic review to evaluate the evidence for the effect of COPD on employment, 
absenteeism and presenteeism, conducted and reported according to the Preferred 
Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) statement.147 
2.3.1 Eligibility criteria 
Cohort or cross-sectional studies of COPD patients from any setting, which 
measured employment, absenteeism or presenteeism among COPD patients 
compared with participants without COPD were sought.  To examine the effect of 
disease severity, studies among only COPD patients where there was a standardised 
measure of disease severity or impact of symptoms were also included.   
2.3.2 Information sources and search strategy 
A systematic search was conducted until October 2015 using CINAHL, EMBASE, 
MEDLINE, OSH references and the Cochrane Library electronic databases. The 
combination of keywords used were: (“chronic obstructive pulmonary disease” or 
“COPD” or “chronic obstructive airways disease” or “chronic obstructive lung disease” 
or “emphysema” or “chronic bronchitis”) and (“employment” or “absenteeism” or “day 
off” “sickness absence” or “presenteeism” or “work productivity” or “work 
performance” or “occupational health”). MeSH terms and text words were used. All 
relevant studies were included. Citation lists were scanned to identify additional 
relevant articles. Non-English language articles were excluded. 
 




2.3.3 Study selection and data extraction 
Two independent reviewers assessed all titles and abstracts and relevant full-text 
articles for inclusion and independently extracted data. Outcome measures of 
interest included: employment rates, absenteeism (mean number of days off; mean 
hours off; proportion of patients reporting time off work) and presenteeism (mean 
presenteeism score; number of hours affected by presenteeism; proportion of 
patients reporting presenteeism). Due to the various definitions, it was important to 
have a working definition of presenteeism for this review. One known definition of 
presenteeism is: “the problem of workers being on the job, but, because of illness or 
other medical conditions, not fully functioning”85; therefore studies measuring the 
impact of COPD on work performance or working limitations were included, 
irrespective of whether a validated presenteeism tool was used. 
2.3.4 Risk of bias in studies 
The methodological quality of the included studies was independently assessed by 
two reviewers using an adaptation of the Cochrane risk of bias method148 and 
combination of questions from Crombie,149 Ajetunmobi150 and the CASP cohort 
tool151; which was piloted and adjusted as necessary. Risk of bias was classified as 
high, low or unclear. 
2.3.5 Data synthesis 
Due to the high heterogeneity amongst the papers and the data, the studies were 
tabulated and described, but not synthesised.  
 
 





2.4.1 Study selection 
Of 969 citations, 75 full-text articles were retrieved and 30 studies finally met the 
inclusion criteria. A detailed diagram of this review process is presented in Figure 2-1 
according to the PRISMA statement.147 The effect of COPD on employment was 
assessed in 13 studies99-103;152-159; 21 assessed the effect of COPD on 
absenteeism,22;104-108;111;112;116;118;152;153;158-166 whilst only 9 assessed the effect on 
presenteeism.22;104;105;111;112;116;158;159;165 
 
 966 articles identified through 
database searching                   
MEDLINE (n=133); EMBASE 
(n=539); CINAHL (n=46); The 
Cochrane Library (n=83); OSH 
references (n=165) 
210 duplicates excluded 
969 articles screened 
75 full text studies retrieved 
for a detailed evaluation 
683 did not meet inclusion 
criteria 
45 did not meet inclusion 
criteria 
30 articles included in the 
review 
Additional articles identified 
through other sources  
(n=3) 
 
























Figure 2-1 PRISMA flow diagram 




2.4.2 Study characteristics 
Nine cohort studies and 21 cross-sectional studies were included with study periods 
ranging between 1967 and 2014. The studies were conducted across 16 countries, 
with the majority based in the USA and Europe. Eleven studies were general 
population-based, one occupation-based, six among employed populations, eight 
primary care population based and four were COPD population based studies only 
(identified through a range of methods).  
Of the cohort studies, five were prospective and four were retrospective, with follow-
ups ranging from 1 to 16 years and overall study sample sizes from 212 to 263622 
(COPD samples ranged from 44 to 131811). Cross-sectional study samples ranged 
from 85 to 130880 (COPD samples ranged from 40 to 10711). Overall there was a 
greater male population in the cohort studies, but this varied in the cross-sectional 
studies (35.0% to 92.0%). Mean age varied from 37.9 to 68.0 years (for studies with 
characteristics for overall sample) and disease severity ranged from mild to severe, 
where reported. See Table 2-1 for summary of study characteristics and Table 2-2 for 
















     Table 2-1 Summary of study characteristics 





Study design (n)    
Cohort 4 6 1 
Cross-sectional 9 15 8 
Total sample size range 85 - 263622 85 - 130880 314 - 90279 
Setting: recruited population    
General population 7 6 3 
Employed population 1 5 3 
Primary care population 3 5 - 
COPD only population 2 4 3 
Occupation based population - 1 - 
    
Setting: country    
Australia - 1 1 
Canada - 1 - 
France - 1 - 
Latin America 1 - - 
Nordic countries 4 4 - 
Poland - 1 - 
Spain - 2 1 
The Netherlands 2 2 - 
USA 6 8 6 
Cross-country survey - 1 1 
Mean age range for overall study 
population 
37.9 – 68.0  
(unreported for n=8) 




mean age reported in 
only one study 
Male % range for overall study 
population 
40.1% - 66.7% 
(unreported for n=7) 
35.0% - 100% 
(unreported for n=9) 
35.0% - 53.4% 
(unreported for n=4) 
Disease severity range in those with 
COPD for overall study population 
(FEV1% predicted) 
45.2 – 63.5 
Moderate to severe 
(unreported for n=11) 
45.2 – 81.1 
Mild to severe 
(unreported for 
n=17) 
Reported in only one 
study 
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Table 2-2: table of study characteristics 
Author Study design Study aim 
Country and 
setting Population inclusion and exclusion criteria Participants 
Participants with lung disease Comparator Outcome 
measure 
E A P 
Cohort studies 






















 COPD diagnoses on national registry 
between 1998-2010  
 
 
N = 263622 
Mean age (years): unknown 
 
Sex (male) (%): unknown 
  
FEV1% predicted: unknown 
COPD (diagnosis on the national 
patient registry. Disease severity 




Matched on age, sex, 
educational level, 
residence and marital 
status. 
X - - 



















Participants recruited from the OLIN (obstructive 
lung disease in Northern Sweden) studies.  
Inclusion criteria: 
 COPD diagnosis based on GOLD  spirometry 
criteria 
N = 244 
Mean age (years) (range): 68 (39-84) 
 
Sex (male) (%): 52.0 
 
FEV1% predicted: unknown 
COPD (using spirometry data and 
defined according to the GOLD 
criteria): n=244 
None 
X X - 























 Retrospective data of all continental US 
employees for a vehicle manufacturing 
company with a minimum of a 6 month 
continuous coverage in a health plan other 
than a health maintenance organization 
 Must have completed the survey for 
respective timeframe 
 Participants to have sufficient data to permit a 
merge into integrated database 
No clear exclusion criteria defined. 
N = 9861 (2001-2002 data) 
N = 10113 (2008-2009 data) 
Mean age (years): 
2001-2002: 
COPD: 54.8; Control: 54.8 
 
2008-2009: 
COPD: 53.4; Control: 53.5 
 
Sex (male) (%) 
2001-2002: 
COPD: 81.8; Control: 81.1 
 
2008-2009: 
COPD: 16.7; Control: 75.8 
 
FEV1% predicted: unknown 
COPD  (a minimum of 2 reports 








Non-COPD (no COPD 






Matched on age, gender, 
salaried or hourly pay, 
length of employment 













































Analysis of two datasets: Thomson Reuters 
MarketScan commercial claims and encounters 
(CCAE) and Health and Productivity (HPM) 
databases.  
Inclusion:  
 Employees ages 18-65 
 >1 medical for COPD during 2000-2007 
 continuous enrolment in CCAE database for > 
6 months prior to and at least 12 months after 
the index COPD medical claim date 
 Prescription for drug benefit  
 Drug data throughout study period 
 >12 months enrolment in HPM database 
following COPD medical claim date with 
eligibility for absenteeism or short-term 
disability 
Exclusion criteria not stated   
 
N = 55224 
Mean age (years) (SD): 
COPD: 44.5; Non-COPD: 43.8 
 
Sex (male) (%): 
COPD: 59; Non-COPD: 60 
 
FEV1% predicted: unknown  
 
COPD (diagnosis based on a 
medical claim): 
n=27612 
Non-COPD (no medical 
claims for COPD):  
n=27612 
 
Matched to COPD 
patients by age, sex, risk 
score, index year, type of 
health plan, number of 
enrolment months 
following index date, 
geographic region, type 
of employment industry 









Table 2-2 Study characteristics 
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Table 2-2: table of study characteristics 
Author Study design Study aim 
Country and 
setting Population inclusion and exclusion criteria Participants 
Participants with lung disease Comparator Outcome 
measure 
E A P 















Analysis of the Health and Retirement Study 
(HRS) (long-term panel of Americans 
approaching and past retirement age).  
Participants aged >51.  
N = 28863 
Mean age (years): unknown 
 
Sex (male) (%): unknown 
 
FEV1% predicted: unknown 





X - - 



































using a claims 
database 
Data taken from a healthcare and disability 
database for 9 large companies. COPD 
inclusion:  
 Service date between 1st January 2001 to 31st 
March 2004 
 COPD diagnosis on 1 inpatient medical claim 
or,  
 COPD diagnosis on one emergency 
department medical claim or,  
 COPD on a minimum of 2 outpatient medical 
claims within 360 days 
Employees excluded if: 
 Not aged between 40 and 63 (based on index 
date)  
 No continuous coverage in the health plan 
 Not actively employed for at least 90 after 
index date 
 Had diagnosis of: cystic fibrosis, lung cancer 
or tuberculosis between 1st Jan 2001 and 31st 
March 2004 
 Employees had any claims indicating 
pregnancy during study period 
Employees had any workers’ compensation 
claims between index date and end of f/up   
N = 4045 
Mean age (years) (SD): 
COPD: 52.1 (6.0) 
Control: 51.9 (6.0) 
 




FEV1% predicted: unknown 
COPD (defined according to 
medical records): 
n=1349 (matched from 1355) 
Controls (defined as no 
evidence of COPD 
according to medical 
records):  
n=2696 (matched from 
142115) 
 
Matched on age, 
geographic region, 
employer, length of 
employment and salary 

















context on the 
process of 
transition from 







Study based on the Danish National Work 
Environment Cohort Study; a random sample of 
patients taken from the Denmark population 
register. 
 Participants,  aged 19-59 years, were re-
interviewed for current study 
 Additional random sample added to cohort  
(aged 18 – 22 years) 
 Study on participants whose workplace also 
contributed to data 
No clear exclusion criteria defined. 
N = 3240 (excluding retirees) 
Mean age (years): unknown 
 
Sex (male) (%): unknown 
 
FEV1% predicted: unknown 
Chronic bronchitis (self-reported; 
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Table 2-2: table of study characteristics (continued) 
Author Study 
design 
Study aim Country and 
setting 
Population inclusion and exclusion criteria  Participants Participants with lung disease Comparator Outcome 
measure 
E A P 




























Participants recruited from the OLIN (obstructive 
lung disease in Northern Sweden) studies. 
Patients with COPD were stratified by age and 
disease severity. 
Inclusion criteria: 
 FEV1<60% of predicted values 
 A random sample from each stratum was 




N = 212 
Mean age (years): 64.4  
 
Sex (male) (%): 56.6 
 
FEV1% predicted: 62.0 
COPD (using spirometry data and 
defined according to the British 



























Male workers from a fertilizer factory.  
 
Inclusion/exclusion criteria not clearly defined 
N = 248 
Mean age (years): unknown  
 
Sex (male) (%): 100 
 
FEV1% predicted: unknown 
Chronic bronchitis (diagnosis 
based on symptoms: chronic cough 
and phlegm for > 3 consecutive 
































 >40 years 
 Severe/very severe COPD diagnosis 12m 
prior to most recent GP visit 
 Chronic productive cough >3 months 
 >1 moderate or severe COPD exacerbation 
(according to ATS/ERS exacerbation severity) 
N = 314 
Mean age (years): 68.0 
 
Sex (male) (%): 51.3% 
 
FEV1 % predicted: 45.2 
COPD (spirometry based on GOLD 




Severe COPD: n=190 
Very severe COPD: n=124 
None 
X X X 
DiBonaventur






of COPD on 
health related 












Data taken from an internet based population 
study: the US National Health and Wellness 
Survey. Inclusion criteria for survey:  
>18 years 
Inclusion criteria for study: those in work and 
aged 40-64 assessed. 
 
No clear exclusion criteria defined. 
 
N = 20024 
Mean age: not reported 
 
Sex (male) (%): 53.4 (overall)  
COPD: 45.5 
Non-COPD: 53.9  
 
FEV1% predicted: unknown 
COPD (defined as self-reported 
physician diagnosed chronic 
bronchitis, emphysema or COPD 





























Data taken from an internet based population 
study: the US National Health and Wellness 
Survey. Inclusion criteria for survey: > 18 years 
Inclusion criteria for study: those in work and 
aged >65 years assessed. 
No clear exclusion criteria defined. 
 
N = 3358 
Mean age: not reported 
 




FEV1% predicted: unknown 
COPD (defined as self-reported 
physician diagnosed chronic 
bronchitis, emphysema or COPD 












CHAPTER 2: A SYSTEMATIC REVIEW TO ASSESS THE EFFECTS OF COPD ON EMPLOYMENT, ABSENTEEISM AND PRESENTEEISM 
38 
 
Table 2-2: table of study characteristics (continued) 
Author Study 
design 
Study aim Country and 
setting 
Population inclusion and exclusion criteria  Participants Participants with lung disease Comparator Outcome 
measure 
E A P 
Cross-sectional studies 
























methods in 6 
counties 
Inclusion criteria 
 45 – 67 years 
 Self-reported physician COPD diagnosis, 
emphysema, chronic bronchitis or alpha 1-
antitrpsin deficiency (A1AD) and prescribed 
respiratory medication in preceding 3 months.  
 Current or ex-smokers with minimal history of 
10 pack years (exception to those with A1AD) 
Participants from Brazil and China who did 
not meet cigarette pack years history were 
included if they met the other inclusion criteria 
and were at risk of COPD via biomass 
exposure (defined as exposure to indoor open 
fire and using solid fuel for cooking/heating for 
> 6 months in lifetime) 
No clear exclusion criteria defined. 
N = 2426 with complete data 
Age (years):  
45 - 54: n=1029 (42.0%) 
55 - 64: n=971 (40.0%) 
65 - 67: n=426 (18.0%) 
 
Sex (male) (%): 49 
 
FEV1% predicted: unknown 




























from 58 large 
companies 
Employees recruited from 58 large companies in 
urban and rural Australia. Large samples from 
health, education, government and finance 
organisations were recruited.   
N = 90279 (total responses) 
N = 78430 completed absenteeism 
N = 77455 completed presenteeism 
(assessed subset, 0.4% of sample) 
Age (years): 
18 - 29 (17.0%) 
30 – 44 (43%) 
45 – 59 (37.0%) 
60 – 70 (3.0%) 
Sex (male) (%): 35 (overall 
population) 
FEV1% predicted: unknown 
COPD (self-report of 
COPD/bronchitis or emphysema): 
































work in COPD 
subjects; to 
determine if 







Recruitment based on 2 stage cluster sampling 
methods.  
Inclusion criteria: 
 Participants aged > 40 years from the 
selected households invited to the study 
No clear exclusion criteria defined. 
N = 5314 with data (from 5571) 
Characteristics not reported for whole 
sample (split by COPD and work 
status)  
Age (years) (+SE): 
COPD (in work): 56.9 (0.55) 
COPD (not in work): 69.3(0.52) 
Non-COPD (in work):  
51.1 (0.18) 
Non-COPD (not in work): 60.2 (0.35) 
Sex (male) (%):  
COPD (in work): 64.7 
COPD (not in work): 43.4 
Non-COPD (in work): 49.9 
Non-COPD (not in work): 20.8 
FEV1% predicted (+SE): 
COPD (in work): 79.7 (1.2) 
COPD (not in work):  
78.7 (1.2) 
Non-COPD (in work):  
98.2 (0.32) 
Non-COPD (not in work): 98.5 (0.47) 
COPD (post-bronchodilator 
FEV1/FVC <0.7): n=759 
Non-COPD (GOLD 
criteria used to define 
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Table 2-2: table of study characteristics (continued) 
Author Study 
design 
Study aim Country and 
setting 
Population inclusion and exclusion criteria  Participants Participants with lung disease Comparator Outcome 
measure 
E A P 























Data taken from population survey – Hordaland 
County Respiratory Health Survey.  
Inclusion criteria:  
 Patients self-reporting asthma, bronchitis, 
emphysema or COPD.  
Responders with OLD attended for spirometry 
No clear exclusion criteria defined. 
N = 161 with spirometry data (from 
200) 
 
Age (years):  
27 – 49 (41.0%) 
50 – 69 (36.0%) 
> 70 (23.0%) 
 
Sex (male) (%): 44 
 
 
FEV1% predicted (SD): 81.1 (20.6)   
 
COPD pattern (defined as 
FEV1/FVC<0.7 irrespective of % 
predicted): n=50 




FEV1/FVC>0.7 and FEV1 























of COPD and 













Two surveys of the same design carried out. 
Recruitment from a public or private clinic by 
pneumologists. 5 consecutive patients from each 
clinic who met inclusion criteria:  
 > 40 years 
 Diagnosed with GOLD stage II (moderate) or 
GOLD stage III/IV (severe/very severe) 
 Not participating in another clinical trial 
 Able to read/understand documentation 
N = 3608 with COPD 
Mean age (years): 
Moderate COPD: 67.8 
Severe/very severe: 69.6 
  
Sex (male) (%): 
Moderate COPD: 88 
Severe/very severe: 87.3 
 
FEV1% predicted: unknown 
COPD (post-bronchodilator 




















with ability to 
predict the 







Patients selected consecutively by physicians in 
primary care.  
Inclusion criteria:  
 > 40years  
 Diagnosed with COPD for a minimum of 12 
months prior to recruitment. 
 Patients with a neurological or psychiatric 
illness (precluding their study assessment) or 
had an acute exacerbation of COPD in the 
previous month were excluded 
N = 10711 
Mean age (years) (SD): 64.1 (9.7) 
 
Sex (male) (%): 75.6 
 
FEV1% predicted (SD):  57.4 (13.4) 
COPD (diagnosed according to 
SEPAR criteria: FEV1<80% of 
%predicted and post-BD FEV1/FVC 
























 Recruited from primary care (31 health 
prevention centres)  
 Aged >40  
 Spirometry carried out on all participants 
 Sampling according to national age and sex 
distribution 
No clear exclusion criteria defined.  
N = 4764 with data (from 5008 
surveyed) 
Mean age (years) (SD): 59.9 (10.1) 
 
Sex (male) (%): 92.6 
 
FEV1% predicted:  
> 80% predicted: 59% 
50% - 80% predicted: 36.1% 
>50% predicted: 4.8% 
Chronic bronchitis symptoms:  
n=185 
 



























Recruited from 10 outpatient clinics and 25 GP 
practices. 
Inclusion criteria: 
 Doctor diagnosed COPD  
 Born 1940-1954 
 Visited outpatient clinic in preceding year 
(criterion for clinics only) 
 Excluded patients with history of lung cancer  
N = 617 with data (from 637) 
Mean age (years): 54.3  
 
Sex (male) (%): 57.0 
 
FEV1% predicted:  
In work: 67.9 
Not in work: 60.4 
















Table 2-2: table of study characteristics (continued) 
Author Study 
design 
Study aim Country and 
setting 
Population inclusion and exclusion criteria  Participants Participants with lung disease Comparator Outcome 
measure 
E A P 



















Data taken from a population based survey – the 
Canadian Community Health Survey: 
 136 health regions in 10 provinces 
 Geographic regions were stratified 
 Recruited via random digit dialling and 
telephone questionnaire carried out 
 Aged >12 
Study inclusion/exclusion criteria not clearly 
defined. 
N = 130880 (assessed subset of 
3705) 
Age range (years):  
12 – 50+ (overall population) 
 
Sex (male) (%):  
49.3 (overall population) 
 
FEV1% predicted: unknown 
COPD (self-reported; 
lasted/expected to last for a 
minimum of 6 months and 
diagnosed by a healthcare 
professional): 































Recruited via: advertisements in free local 
newspapers, posters (pharmacies, general 
practices and physical therapists) and patients of 
pulmonologists/occupational physicians/ medical 
advisors. 
Inclusion criteria:  
 Physician diagnosed obstructive lung disease  
 Employed/had been employed in last 12 
months  
Exclusion criteria: 
 Acute co-morbidity 
 Unable to read or understand Dutch  
 Self-employed participants 
N = 165 (assessed subset of 64) 
Mean age (years) (SD): 
COPD high sick leave:  
50.3 (8.7);  
COPD low sick leave:  
51.8 (6.1) 
 
Sex (male) (%): 
COPD high sick leave: 72;  
COPD low sick leave 47 
 
FEV1% predicted:  
COPD high sick leave:  
58.6 (16.2);  
COPD low sick leave: 
69.0 (19.2) 
































COPD patients from a RCT (recruited from 44 
general practices) 
Inclusion criteria:  
 GP physician diagnosed COPD 
 Current/ex-smoker 
 Persistent cough/sputum/dyspnoea on most 
days of the week for >3 consecutive months 
per year over preceding 2 years 
 Post BD FEV1 40-90% and/or FEV1/FVC 
<88% (male) or <89% (female) of the 
predicted value 
Excluded:  
 Patients with post-BD FEV1<35% 
 History of asthma, allergic rhinitis or atopic 
rash 
 Severe comorbid conditions 
 >65years 
N = 210  
Mean age (years) (SD): 53.9 (6.8) 
(overall) 
Paid work: 50 (6.2) 
Voluntary non-paid work: 59.5 (5.5) 
Disabled for work: 54.5 (6.0) 
 
Sex (male) (%):  
66.7 (overall) 
Paid work: 80.4 
Voluntary non-paid work: 62.2 
Disabled for work: 50.0 
 
FEV1% predicted:  
63.5 (overall) 
Paid work: 65.2 
Voluntary non-paid work: 59.1 
Disabled for work: 64.1 
COPD (diagnosis based on GP 






















Table 2-2: table of study characteristics (continued)  
Author Study 
design 
Study aim Country and 
setting 
Population inclusion and exclusion criteria  Participants Participants with lung disease Comparator Outcome 
measure 
E A P 
































Recruited via: advertisements in free local 
newspapers, posters (pharmacies, general 
practices and physical therapists) and patients of 
pulmonologists/occupational physicians/ medical 
advisors. 
Inclusion/exclusion criteria:  
 Physician diagnosed asthma or COPD 
 Using prescribed bronchodilators 
 Employed or had been employed in last 12 
months  
 Without acute co-morbidity  
 Able to read or understand Dutch 
N = 189 (assessed subset of 71) 
 
Mean age (years) (SD): 
COPD sick leave: 47.8 (9.5); COPD 
no sick leave:  
54.0 (6.3) 
 
Sex (male) (%): 
COPD sick leave: 67;  
COPD no sick leave: 62 
 
FEV1% predicted: unknown 
COPD (COPD confirmed using 






























Participants: one of 4 occupations recruited from 
4 companies: reservation agents (airline 
company), customer service representatives 
(telecommunications company), executives 
(automobile manufacturer) and railroad 
engineers (railroad company. Telephone 
questionnaire.  
N = 2363 (assessed subset of ~40) 
Mean age (years) (SD): unknown  
 
Sex (male) (%): unknown 
 
FEV1% predicted: unknown 
COPD/emphysema (%) (self-
reported and based on interviewer 
asking all conditions covered in the 
National Health Interview Survey 
checklist):  
n ~40 (1.7% of total population) 
 
No COPD/emphysema: 






















Data taken from a population based study: the 
California Work and Health Survey 
 Majority recruited using the random digit 
dialling method in 1998, 1999 and 2000 
 >18 years 
 
N = 3805 (3243 of usual 
employment age 18-64) 
Mean age (years) (SD): 
COPD: 54.7 (18.1) 
Asthma: 42.2 (16.3) 
Other chronic conditions: 50.3 (16.6) 
No chronic conditions:  
36.5 (14.4) 
 
Sex (male) (%) 
COPD: 41 
Asthma: 47 
Other chronic conditions: 45 
No chronic conditions: 56 
 
FEV1% predicted: unknown 
Of usual employment age: 
COPD (self-report of a physician’s 
diagnosis of a chronic lung disease 
like emphysema or chronic 
bronchitis via telephone 
questionnaire):  
n=113 





































Data from the national health surveys conducted 
by CDC’s National Center for Health Statistics.  
N = unknown  
Mean age (years) (SD): unknown 
 
Sex (male) (%): unknown 
 




n = unknown 
X - - 
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Table 2-2: table of study characteristics (continued)  
Author Study 
design 
Study aim Country and 
setting 
Population inclusion and exclusion criteria  Participants Participants with lung disease Comparator Outcome 
measure 
















COPD and its 
severity and 






Data taken from a population based survey: the 
Third National Health and Nutrition Examination 
Survey (NHANES III) 
 Aged: 18 – 64 years 
 
N = 12436 
Mean age (years) (SD): 37.9 (13.2) 
(overall population) 
Sex (male) (%): 46.5 
COPD: 58.5 
Non-COPD: 47.4 
FEV1% predicted: unknown 
COPD (self-reported chronic 
bronchitis/emphysema diagnosis):  
n=1073 
No COPD (did not 






























Data taken from a population based survey – the 
National Health Interview Survey (1993 – 1994).  
 Age range: 25 – 75+ 
 Data from persons answering positive have a 
respiratory condition 
No clear study inclusion/exclusion criteria 
defined. 
N = 8855 (with respiratory conditions) 
Mean age (years): unknown 
 
Sex (male) (%): 40.1% 
 
FEV1% predicted: unknown 
A self-report of (using a 
questionnaire): 
 





A self-report of: 
 










































A sub-sample for the purpose of this study was 
assessed, which included those with bronchial 
asthma and chronic bronchitis.  
Main sample was selected was based on a large 
random sample, aged 16-64 years. Stratified 2 
stage sample: age of housing and location in the 
city. 
 
N = 85 
Mean age (years): unknown 
 
Sex (male) (%):  
Chronic bronchitis: 52.4  
Bronchial asthma: 27.9 
 
FEV1% predicted: unknown 
Chronic bronchitis (diagnosis 
made my medical experts based on 
symptom questionnaire and 
anamnestic examination): n=42  
 
Bronchial asthma 
(diagnosis made my 


















2.4.3 Methodological quality of the studies 
The methodological quality varied (Table 2-3). Most studies did not compare 
responder with non-responder characteristics, therefore making it difficult to 
determine non-response bias. There was a high risk of misclassification of lung 
disease in 15 studies as these populations were characterised based on self-report 
alone.22;99;104;105;108;111;112;116;153;155-157;159;164;166 Although some studies used reliable 
data sources to classify patients with COPD, only 10/30 (33.3%) studies used clear 
spirometry criteria to define lung disease and disease severity.100;102;118;152;158;160-
163;165 There was uncertainty about the reliability and validity of the outcome 
measures (absenteeism and presenteeism) for approximately one third of the studies 
as it was unclear whether standardised questionnaires were used.101;118;152;153;160-165 
Of the five prospective cohort studies, four had good follow-up rates.108;152;155;162 Lack 
of controlling for confounders, an important predictor of bias in observational studies, 
was a problem in many (n=13) studies.22;101;102;108;152;153;158-161;163-165 A further 14 
studies reported controlling for some relevant confounders, however, omitted 
important factors e.g. smoking status and co-morbidities (statistical modelling varied 
widely).99;100;103-107;111;112;116;154;156;157;166 Generalisability of the study results to a 
COPD population was either unclear or limited amongst 25 studies.99;100;102;104-
108;111;112;116;118;152-161;163;165;166 For example, studies including only male workers, 
those from a specific occupational background or a specific disease severity had 
limited external validity.  
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Table 2-3: table of the methodological quality of the included articles (risk of bias: high/low/unclear) 
 Selection of population Lung disease Outcome measures Loss to follow-up 
Selective 
reporting Controlling for confounders 
Bias Generalisability Selection bias Non-response bias Misclassification Validity and reliability Recall bias 
Loss to 
follow-up Reporting bias Confounding 
Author  
Cohort studies 





unknown e.g. disease 
severity and smoking 
status 
Low 
Database used N/A 
Low 
Diagnoses are all 
registered on 




taken from central 
database  
N/A N/A Low 
High  
Although many socio-
demographic factors matched, 
other important factors e.g. 
co-morbidities and smoking 
status not adjusted for. 
Jansson et al 
(2013)152  
High 
Unequal distribution of 
disease severity 




High participation rate 







used to define 
COPD 
Unclear 







every 3 months 





No adjustment for 
confounders 










taken from 1 company) 
Unclear 
Many did not complete 




















Smoking status not accounted 
for 





smoking status and 
disease severity  are 
unknown 
Low 










Low N/A Low 
High 
Although many confounders 
accounted for, all relevant co-
morbidities and smoking 
status  not adjusted for  






of COPD patients – 
demographics 
unknown 




Low Low Unclear Low 
High 
Adjusted for a number of 
confounders, however disease 
severity and smoking status 
not adjusted for.  
Model 2 adjusted for income, 
but this is directly related to 
employment (reverse 
causation)  






unknown. Also limited 
range in occupations 
 
Low 
Database used N/A 
Low 






Low N/A  Low 
Low 
Follow-up length differed 
between groups but was 
adjusted for 
Table 2-3 Methodological quality of the included articles 
CHAPTER 2: A SYSTEMATIC REVIEW TO ASSESS THE EFFECTS OF COPD ON EMPLOYMENT, ABSENTEEISM AND PRESENTEEISM 
45 
 
Table 2-3: table of the methodological quality of the included articles (risk of bias: high/low/unclear) 
 Selection of population Lung disease Outcome measures Loss to follow-up 
Selective 
reporting Controlling for confounders 
Bias Generalisability Selection bias Non-response bias Misclassification Validity and reliability Recall bias 
Loss to 


















 Low Low Low  
Jansson et al 
(2002)162 Low 
Unclear 





Although not significant, 
those not participating 














every 3 months 














Not clear how 
population was chosen 
Unclear 












work records  
Low  Low  
High 
Univariate analysis and no 
adjustment 
Cross-sectional studies 
Solem et al 
(2013)158 
Restricted to those 




selected and were 
advised to randomly 
select up to 4 patients 
from their COPD list, 


















No adjustment for 
confounders 
DiBonaventura 







via internet, therefore 
may be restricted to 
those with IT skills. 
High 
Recruited via internet 
High 












Adjusted for a range of 
confounders 
Although sample stratified 
(working age), did not adjust 
for age and other co-
morbidities 
DiBonaventura 







via internet, therefore 
may be restricted to 
those with IT skills. 
High 
Recruited via internet 
High 












Adjusted for a range of 
confounders 
Although sample stratified 
(>65 years), did not adjust for 








Table 2-3: table of the methodological quality of the included articles (risk of bias: high/low/unclear) (continued) 
 Selection of population Lung disease Outcome measures Loss to follow-up 
Selective 
reporting Controlling for confounders 
Bias Generalisability Selection bias Non-response bias Misclassification Validity and reliability Recall bias 
Loss to 
follow-up Reporting bias Confounding 
Fletcher et al 
(2011)22 Low 
High 
Variety of methods 
used, some of which 
may not be random 
selection 
High 











% scores for 
presenteeism 
and mean time 
off work not 
provided 
High 
P-values not assessed and no 
adjustments 





population, unclear if 
generalisable to COPD 
patients e.g.  
unknown disease 
severity distribution;  
age distribution 
skewed towards 
younger population  
Low High Low response rate  
High  
Self-report Low Low N/A 
Presenteeism 
scores and 
mean days off 
work not 
detailed 
Adjusted for many except 
smoking status 
Montes de Oca 







High response rate 
(83.0%) but non-
responders not compared 
Low 
Spirometry  Low  Low N/A Low 
High/low 
Range of confounders 
assessed for some analyses, 
but not all 













(although did not 
take % predicted 






High N/A Low 
High 
Risks not calculated and 
confounders not adjusted for 
Rodriguez 
Gonzalez-Moro 
et al (2009)165 
High 
>male 
High mean age 
High 
Doctor selecting 
patients, therefore may 
not be random 
selection 
Unclear 





Lack of detail for 
questions related 






Risks not calculated and no 
mention of adjusting 
de Miguel Diez 





But if patient had acute 
exacerbation they 
were excluded and not 
rescheduled 
Unclear 
Do not know how many 


















No adjustment for 
confounders 
Roche et al 
(2008)164 Low 
Low  
Various centres for 
recruitment 
Low 



















No adjustment for 
confounders 
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Table 2-3: table of the methodological quality of the included articles (risk of bias: high/low/unclear) (continued) 
 Selection of population Lung disease Outcome measures Loss to follow-up 
Selective 
reporting Controlling for confounders 
Bias Generalisability Selection bias Non-response bias Misclassification Validity and reliability Recall bias 
Loss to 
follow-up Reporting bias Confounding 
was not clear 
 
 






Initial response was 47%. 









Due to nature 
of the questions 
N/A Low 
High 
No adjustment for 
confounders 













(National survey) Low N/A Low 
High 
Smoking status not adjusted 
for 
Boot et al 
(2005)160 
Unclear 
Small sample size; 
fewer females. 





Various methods used 
to recruit, however 
healthcare 
professional (HCP) 
may have introduced 
selection bias 
Unclear 
Not detailed how many 

















No adjustment for 
confounders 




Excluding those with 
severe disease 






















Univariate analysis only – no 
adjustments 
Boot et al 
(2004)118 
High 
Small sample size; 
fewer females; patients 
with less severe 
disease. 
High 
Various methods used 
to recruit, however 
healthcare 
professional (HCP) 
may have introduced 
selection bias 
Unclear 
Not detailed how many 



























included. Total sample 
baseline 
characteristics 
unknown. Small COPD 







Response rate among 







4 week period N/A Low 
High 
Adjusted for a range of 
confounders however, 
smoking status not accounted 
Eisner et al 
(2002)99 
Unclear 
No information on 
disease severity. 
Comparison groups 




Response rate 55-57%. 
















Adjusted for many, but not co-
morbidities or disease severity 




Table 2-3: table of the methodological quality of the included articles (risk of bias: high/low/unclear) (continued) 
 Selection of population Lung disease Outcome measures Loss to follow-up 
Selective 
reporting Controlling for confounders 
Bias Generalisability Selection bias Non-response bias Misclassification Validity and reliability Recall bias 
Loss to 
follow-up Reporting bias Confounding 
Mannino et al 
(2002)156 
Unclear 






Unclear High Self-report 
Low  
Population survey  Low N/A Low 
High 
Adjusted for age only 
Sin et al 
(2002)103 Low 
Low  
Population survey - 
NHANES 
Unclear 
No details provided 
High/low 
 
Although based on 
self-report, the 
disease severity was 
















Did not adjust co-morbidities  






NHIS – population 
survey 
Unclear 







Low  N/A 
All data as %. 














Lack of detail on sub-
sample selection 
Unclear 
Although main study 
under-represented 
patients with other 
disease and disabilities. 
High 





90 day recall 
period 
N/A Methods unclear 
High 
Statistical significance and 
confounders not assessed 
 
 




2.5 Results of studies 
2.5.1 Employment 
One prospective cohort study,157 one retrospective cohort study154 and six cross-
sectional studies99;100;103;153;156;159 compared employment rates among COPD 
patients compared to those without COPD (Table 2-4), of which six consisted of large 
sample sizes.99;100;103;154;157;159 The prospective cohort study collected data over 16 
years among a working age population and the data from the retrospective cohort 
study was collected over a 12 year period from a primary care population (patients 
from national patient register). Among the six cross-sectional studies, five were 
general population-based99;100;103;156;159 and one was a smaller study consisting of a 
chronic bronchitis/asthma sub-sample; initially recruited from a general population.153 
Consistently across five of these studies, patients with COPD had significantly lower 
employment rates than those without COPD,99;100;103;154;157 those with asthma99 and 
other chronic conditions99; with ORs ranging from 0.4 (95% CI: 0.2 – 0.7) (COPD 
patients compared to those with no chronic conditions)99 to 0.8 (95% CI: 0.7 – 1.00) 
(COPD patients compared to those without COPD).100 Mannino et al’s156 age-
adjusted estimates for each of the four time points (cross-sectional) (years 1980 to 
1996) consistently demonstrated lower employment rates among those with COPD 
compared to those without (p-values unreported), although the study failed to adjust 
for other relevant confounders.  
Evidence from the remaining cohort study found the presence of chronic bronchitis at 
baseline to be independently and significantly associated with having a disability 
pension after two years follow-up (OR 1.8; 95% CI 1.01-3.21).155 These findings were 




supported by a smaller cross-sectional study; unadjusted prevalence rates were 
higher among those with chronic bronchitis compared to bronchial asthma.153 Also, 
once out of work, COPD patients were more likely to remain unemployed (>5 years 
since regular employment) compared to those with no chronic conditions (OR: 2.92; 
95% CI: 1.35 – 6.29).99 
A ninth study enquired whether the patient’s inability to work was attributed to their 
lung condition; patients with self-reported emphysema (27.4%) were the most 
affected when compared to those with chronic bronchitis (0.6%) and asthma (4.8%) 
(p-values unreported).159    
Six studies assessed the relationship between COPD disease severity and 
employment (Table 2-5).100-103;152;158 Three studies found that with increasing severity 
of airflow obstruction, COPD patients were less likely to be in work (p<0.01),101;103;158 
although this was not confirmed in the other two studies.100;102 The sixth study (cohort 
study) supported the negative impact of disease severity on employment; patients 
were more likely to retire early with increasing airflow obstruction.152  
However, it was difficult to compare the study findings due to the heterogeneity in 
methods, samples and outcome measures: samples were recruited from a variety of 
settings (outpatients’ clinics,101 primary care setting101;102;158 and from the general 
population100;103;152; one study excluded severe COPD patients101 whereas another 
excluded those with mild to moderate airflow obstruction158; of the limited studies 
reporting overall sample distribution of disease severity, one study showed an 
unequal distribution100; and only Sin et al’s study adjusted for relevant 




confounders.103 Additionally, in one study it was unclear how spirometry was 
conducted as a measure of severity (e.g. information on whether spirometry was 
conducted post-bronchodilator and the number of attempts to calculate the final 
reading).101 
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% with income from 




Matched for: age, sex, 
education level, 
residence and marital 
status.  









n = 4095 
Without 
COPD 







Probability of working for 
pay (%) (SD) 
 
Probability of working for 
pay among those under 65 


















Adjusted OR (95% CI) 
0.58 (0.50 – 0.67)  
(model 1) 
 
Adjusted OR (95% CI) 




Adjusted for: age, age 
squared, age upon 
entering the panel, age 
upon entering the panel 
squared, sex, ethnicity, 
BMI, BMI upon entering 
the panel and various 
health conditions. 
Model 2 also included: 








2 yr f/up: 1995 















Disability retirement  
pension / sick leave benefits 
for > 10 weeks /receiving 
sick leave benefits for > 15 
weeks  
530 (16.4%) 2710 (83.6%) OR (95% CI)  1.8 (1.01 to 3.21) 
Adjusted for: age, sex, 
health, smoking status, 
work environment, 
organisational context, 
company size and 
public/private sector.  
Note: different 
information in text 






Table 2-4 The effect of COPD on employment 
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Worked for pay   
 
Mean + SE number of 
months for pay? 
 
Mean + SE number of days 
(per week) worked for pay? 
 
Mean + SE usual number of 
hours worked (per day) for 
pay? 
 
Health problems stop you 
from working for payment 
(yes, no, no response)? 
317 (41.8%)  
 
10.5 + 0.17 
 
 














10.9 + 0.06 
 
 










Adjusted OR = 0.83 (0.69 – 1.00)  
 
P = 0.02 
(adjusted for survey design) 
 
P = 0.09 
(adjusted for survey design) 
 
P = 0.23 
(adjusted for survey design) 
 
P<0.0001 
(adjusted for survey design) 
Multivariable analysis: 
age, sex, education, 
MRC and co-morbidity 
score 
 
Most analyses not 













































nonparticipation ( no regular 





Inability to work due to long-



















No chronic conditions 
(NCC): 1067 (71.1%) 
Other chronic conditions 
(OCC): 896 (66.2%) 




No chronic conditions: 
62 (4.2%) 
Other chronic conditions: 
106 (7.9%)  




No chronic conditions:  
18 (1.2%)  
Other chronic conditions: 
125 (9.2%)  
Asthma: 20 (7.5%) 
 
OR (95% CI): (no chronic 
conditions (NCC) as ref group):  
COPD vs. NCC: 
OR=0.41 (0.24 – 0.71)  
OCC vs. NCC:  
OR=0.86 (0.68– 1.08) 
Asthma vs. NCC:  
OR=0.82 (0.55 – 1.21) 
 
COPD vs. NCC:  
OR=2.92 (1.35 – 6.29)  
OCC vs. NCC:  
OR=1.09 (0.69 – 1.73) 
Asthma vs. NCC:  
OR=1.23 (0.58 – 2.59) 
 
COPD vs. NCC:  
OR=19.5 (8.17 – 46.5) 
OCC vs. NCC:  
OR=5.84 (2.95 – 11.58) 
Asthma vs. NCC:  




Adjusted for: age, sex, 
ethnicity, education and 
smoking status. 
 
Did not adjust for co-


















Adults who report being 


















Age adjusted only. 
 
Did not adjust for a wide 
range of confounders. 
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COPD Results comparator Effect size or p value 
Analysis/ 
adjustment 





















Working in past 2 weeks 69.21% 77.24% 
Adjusted results:  
-3.9% (-1.3 to -6.4) reduction in 
probability of being in work. 
P=0.032 
 
Adjusted for: sex, age, 
education, ethnicity, 
marital status, family 

















n  947 
Allergic 
rhinitis: 
n = 3306 
Asthma: 
n = 2632 
Other lung 
disease: 










Inability to work due to 












Allergic rhinitis: 6.8% 
Asthma: 25.2% 
Other lung disease: 47.1% 
 
 
Allergic rhinitis: 0.1% 
Asthma: 4.8% 
Other lung disease: 14.2% 
Not calculated 
 
Chronic bronchitis and 
emphysema not 
combined. Increased risk 
of misclassification 
through using  other lung 













n = 42 
Bronchial 
asthma 
n = 43 
Early 
retirement 
















































% patients who have engaged in early 













No adjustment for 
confounders 
Kruskal-Wallis test for 
differences between disease 
severity 
Cross-sectional studies 








COPD (spirometry based 




status at the 
time of 
survey 
Employment prevalence according to 
disease severity 
Severe COPD 





P<0.03 No adjustment for confounders 
Montes de Oca 




2003 - 2004 
 
COPD (spirometry based 
on GOLD criteria) 
n=759 
 
Employed:   
n=317 (41.8%) 





in past 12 
months 
Employment prevalence according to 
disease severity 
GOLD stage 1 
2 
3 and 4 
 



















P = 0.29 
(adjusted for survey 
design) 
 
P = 0.55 (adjusted for 
survey design) 
Descriptive statistics, Mann 
Whitney and Wald test  
Authors carried out 
multivariable regression: 
disease severity and FEV1 % 
pred were not associated with 
employment status 


















Mean FEV1 % predicted according to 












P < 0.001  
Descriptive statistics and 
appropriate significance test. 
Lung function data not 
available for all patients.  
ORs not calculated for 
employment and disease 
severity relationship 











Paid work:  
n=97(46.2%) 
Voluntary non-paid work: 
n=45 (21.4%) 






















P = 0.181 (NS 
differences in FEV1 % 
predicted) 
Descriptive statistics and 
univariate analysis. No 
adjustment for confounders. 
Unclear if all working age 
patients from the initial study 
were included in this analysis. 
Table 2-5 Employment according to disease severity among patients with COPD 
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1966 – 1970 
Self-reported COPD 
(chronic bronchitis or 
emphysema) (GOLD criteria 
used to define disease 
severity) 




in past 2 
weeks 
% reduction in work force participation 
according to disease severity compared to 













P for linear trend <0.01 
 
Adjusted for: sex, age, 
education, ethnicity, marital 
status, family size, area of 
residence, current smoker. 
Disease severity distribution 
among population not 
detailed. Number of 
participants with spirometry 
data not detailed. Sensitivity 
analysis excluding housework 
as primary occupation found 
similar trends. 
(continued) 





Twelve studies measured absenteeism104;105;107;108;111;112;116;153;159;163;164;166 and one 
study assessed disability (long term and short term)106 in patients with COPD 
compared to those without COPD (Table 2-6); of which the majority were large 
studies104-107;111;112;159;164 that were carried out in either an employed population,104-107 
a general population111;112;159 or primary care population.164 Seven studies were 
based in the US105-107;111;112;116;159; of which three were cohort studies.105-107  
Five cross-sectional studies reported information on the proportion of COPD patients 
affected by sickness absence111;112;153;159;163; ranging from 3.6% to 21.0%.112;153 
Recall periods amongst these studies however varied, from seven days to four years. 
Three out of these five studies assessed differences in sickness absence prevalence 
rates; of which all three large cross-sectional studies found no difference in sickness 
absence rates over the past week between those with and without COPD.111;112;163 
Prevalence rates in Darkow et al’s retrospective cohort study were measured 
according to disability days (short-term, long term and the combination of the two); 
the study found a significantly increased risk of disability (for all outcome measures) 
in those with COPD compared to those without.106 Unlike the cross-sectional studies, 
outcome measures in Darkow et al’s106 study were not based on self-report and 
therefore there was a low risk of recall error.   
Two cross-sectional studies assessed the risk of absenteeism in those with COPD 
compared to those without, for which there were conflicting results (IRR=1.22; 95% 
CI: 1.04 – 1.43104 and OR=0.96; 99.5% CI: 0.51 – 1.84.166 Holden et al’s104 significant 
finding, held true after adjusting for a range of important confounders, some of which 




were not considered by the other study (e.g. occupational characteristics).166 
Although, the differing recall periods (1 month104 vs. 1 week166) and varying COPD 
samples (n: 361104 vs. 3705166) may also explain the inconsistency in results. 
Nine studies compared the amount of time taken off work (days/hours) among 
patients with COPD compared to those without COPD.105-108;111;112;116;159;164 Three out 
of four cohort studies (with participants from an employed population106;107 and an 
occupation based study (fertilizer factory workers)108) found patients with COPD had 
significantly more time off work; of which the largest study, which matched for a 
number of important factors, had an 8 year follow-up (IRR: 1.53).107 The fourth cohort 
study (matched) also demonstrated COPD patients significantly take more time off 
work than those without COPD, however this was found in only one of the two time 
periods that were assessed.105 Similarly, four out of the five cross-sectional studies 
found patients with COPD taking significantly more time off work,111;112;116;164 
although they did not adjust for some important confounders (for example Roche et 
al164  reported unadjusted OR=6.0; 95% CI: 2.8-12.7).  
The mean number of days off among patients with COPD (over 12 months) ranged 
from 1.6 (projected) to 12.0 (calculated) days.107;159 Although Nair et al’s cohort study 
may provide a more reliable estimate – on average 1 day per month/per patient – as 
COPD diagnosis and sickness absence rates were taken from medical reports and 
the company database, respectively.107 
The relationship between disease severity and absenteeism was assessed in 
eight22;118;152;158;160-162;165 (Table 2-7); of which two cohort152;162 and two cross-




sectional studies118;158 found no significant associations between airflow obstruction 
and sickness absence after adjusting for range of confounders in two of the 
studies.118;162 Although 2 large and one smaller cross-sectional study showed a 
significant association (p<0.05) between airflow obstruction and sickness absence, 
these studies did not adjust for confounders.160;161;165 The sixth large cross-sectional 
study also indicated that absenteeism may be associated with increasing severity, 
however breathlessness (using MRC scale) was used as a measure of disease 
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Category Results COPD Results comparator Effect size or p value Analysis/adjustment/ comments 
Cohort studies 
Allen et al 
(2012)105 
Retrospective 




Between 6 to 













n =  181 
2008: 
















Difference in sickness 
absence hours per 
employee per year 
 
Difference in number 
of STD incidents /100 
employees /yr 
 
Difference in number 
of LTD incidents /100 
employees /yr 
No individual data; only the difference 
between the groups 
2001 – 2002:  9 hours 




2001 – 2002: 13.4 incidents 




2001 – 2002: 1.5 incidents 








P < 0.01 




P = 0.09 
P = 0.45 
T-test 
Matched on age, gender, whether 
salaried or hourly pay, length of 
employment and number of 
comorbidities using propensity 
scores 
Adjustments made for differences 
in age, gender and salaried/hourly 
pay carried out. 
Full dataset not provided. Do not 
know % of employees affected. 
Unable to determine definition of 
STD and LTD. 
Not adjusted for smoking status. 







Up to 8yr 
retrospective 
f/up 
2000 - 2007 
COPD 
n = 27612 
Without 
COPD 












Mean hours per month 
 
Mean number of 
COPD related hours 
per month 
 
Mean days per month 
 
Mean number of 






























Propensity score matching and 
negative binomial regression. 
Matched to COPD patients by age, 
sex, risk score, index year, type of 
health plan, number of enrolment 
months following index date, 
geographic region, type of 
employment industry and presence 
of selected co-morbidities using 
propensity scores. 
% reporting absenteeism not 
provided 
Smoking status not adjusted for. 



































Mean days (disability 
days adjusted for co-
morbidities and f/up) 
STD 





































OR= 2.11 (1.64 – 2.71) 
OR =4.21 (1.93 – 9.16) 






not reported  
 
 
Multivariate analysis and logistic 
regression 
 
Matched on age, geographic 
region, employer, length of 
employment and salary using 
propensity scores. Follow-up length 
and co-morbidities adjusted for in 
regression analysis. 
 
Disability not well defined.  
LTD data unavailable when 
adjusted for comorbidities as 
numbers too few. AD is influenced 
by large number for LTD. 
Table 2-6 The effect of COPD on absenteeism 
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P < 0.05 
Little detail 
Chi2 test 
No adjustment for confounders. 
Not clear if statistics are correct. 
 
Only analysed completers (n=197) 
Cross-sectional studies 
DiBonave

















% of work time missed in 
last 7 days (adjusted) 
 














Adjusted for sex, employment type, 
ethnicity, education, income, health 
insurance, smoking status, BMI 
and asthma diagnosis 
 
Age and co-morbidities not 
adjusted for 
DiBonave








n = 297 
Without 
COPD 
n = 3061 
Sickness absence 




% of work time missed in 
last 7 days (adjusted) 
 

















Adjusted for sex, employment type, 
ethnicity, education, income, health 
insurance, smoking status, BMI 
and asthma diagnosis. 
 





















over previous 4 
weeks (WHO-
HPQ) 
Risk of absenteeism for 
patients with COPD - - IRR=1.22 (1.04 -1.43) 
Adjusted for age, sex, marital 
status, number of children, 
education level, annual income, 
treatment seeking behaviour, 
number of co-morbidities, 
occupation, industry, public/private 
sector, job security, contractor, rate 
of workplace accidents, hours 
worked (in past 4 weeks), 
supervisory role and hours 
expected to work in 7-day week by 
their employer. Did not adjust for 
smoking status. Did not solely 
focus on COPD patients. 
(continued) 









































% with sick leave COPD pattern 10% 





P=0.04 (sick leave 
more frequent in those 
with asthma) 
One way ANOVA test. Did not 
adjust for confounders. 
Spirometry not available for all 
patients.  Sick leave definition 
unclear.  No information on mean 





















days in the last 
year 
 
Mean days off + SD 
(chronic bronchitis 
symptoms) 
5.56+ 15.45 1.75+ 16.54 OR= 6.0 (2.8 – 12.7) 
Descriptive statistics, ANOVA, 
unpaired t-test and logistic 
regression. Not clear but appears 
no adjustment for confounders. 
Used a number of populations to 
conduct analyses. However, data 
not shown for all analyses. 


















in the prior week 
due to illness or 
disability 
Weighted % (99.5% CI) 2.4% (1.4% - 4.3%) NS 
OR=0.96 (99.5% CI: 
0.51 – 1.84) 
Adjusted for: age, sex, education, 
income, number of chronic physical 
conditions and alcohol 
dependence. Small proportion 
used for analysis. Short recall 
period for absenteeism. 
Smoking status not adjusted. 
















over previous 30 
days (HPQ) 
(sickness 
absence due to 
condition) 
Annual excess days (SE) 19.4 (8.9) - P <0.05 
Analysis of covariance. 
Adjusted for age, sex, occupation, 
education and other conditions. 
Smoking status not accounted for. 
Small COPD sample. 















n = 3306 
Asthma: 
n = 2632 
Other lung 
disease: 
n = 388 
 Missed time 
from work in 
past 2 weeks 
due to illness 
 Missed days in 
past 2 weeks 
due to illness 
% who missed work 
 
Mean number of work 









Allergic rhinitis:  
<5% 
Asthma: <5% 
Other lung disease: 
<5% 
Allergic rhinitis: 0.8 
Asthma: 2.1 
Other lung disease: 
3.7 
Not calculated 
% reporting absenteeism not 
provided.  Chronic bronchitis and 
emphysema not combined. 
Increased risk of misclassification 


















more than 90 
days during a 4 
year period 
% affected 21% 30% Not calculated 
Long recall period – at risk of 
inaccurate reporting. 
 
No adjustment for confounders 
 





















study 12 months 
2009-2010 
COPD (based on 
GOLD guidelines) 
n=244 
Sick leave over the previous year 











No adjustment for 
confounders 
















Annual lost productivity due to 




Mean days absent  
FEV1%  >80% (mild) 
FEV1% 60 – 79% (moderate) 
FEV1% 40 – 59% (severe) 
FEV1% <40% (very severe) 
 
Weighted mean days off  












P >0.05 (NS) 
Adjusted for various 
confounders. 
Sickness absence definition 
unclear (e.g. general or 
COPD related) and whether 

















Work time missed due to COPD over 
the previous week 
Mean hours missed according to 







Not significant No adjustment for confounders 
Rodriguez 
Gonzalez-




2007 - 2008 





Severe COPD:  
n=2012 
Sick leave in the past year (overall) 
 
% who missed work according to 
disease severity 
Moderate  
Severe/very severe  
Mean days off according to 
disease severity  
Moderate  







30.5 (95% CI: 22.8 – 38.2) 
61.1 (95% CI: 42.2 – 73.9) 
P=0.0001 (for 
prevalence and 
mean days off)  
Appropriate bivariant  
analysis  
 






Table 2-7 Absenteeism according to disease severity among patients with COPD 




















COPD: n = 2426 
Mild: n = 849 
Moderate: n = 1012 
Severe: n = 521 
WPAI questionnaire 
Sickness absence due to lung health 
over previous week 





2.2% (1.2 – 3.2) 
8.3% (5.2 – 11.5) 
7.6% (2.1 – 13.0) 
Not calculated Mean time off work not provided. 
de Miguel 













Disability leave over the previous 12 
months (overall) 













7.22 (6.39 – 8.05) 
9.75 (8.77 – 10.73) 






Descriptive statistics and 
ANOVA. No adjustment for 
confounders. 
Disability leave not clearly 
defined. Mean absenteeism 
data is skewed. 










Low sick leave:  
n=17 (26.6%) 
High sick leave:  
n=47 (73.4%) 
Sickness absence (absent for 2 or 
more consecutive days) over 2 years: 
High sick leave: > 3 episodes in any 
year or 1 episode > 1 month in 
duration 
Low sick leave: < 2 episodes per year 
Mean FEV1 % predicted (SD) 
according to sick leave 
Low sick leave 








P < 0.05 
Descriptive statistics and 
logistic regression. No 
confounders adjusted for. 
Mean sick days/distribution 
not assessed. Sick leave 
over 2 years: risk of recall 
error. 











No sickness absence: 
n=26 (36.6%) 
Self-reported sickness absence in 
past 12 months  (at least 2  




















P > 0.05 (NS in 
disease severity 
between groups) 
Final model adjusted for: 
complaints/limitations, work 
characteristics, age and 
adaptation  
Found no relationship 
between disease severity 
and sickness absence. 
 





One retrospective cohort105 and five cross-sectional studies104;111;112;116;159  assessed 
the effect on work productivity in those with and without COPD (Table 2-8). Studies 
consisted of large samples and were based on  employed people104;105;116 or a 
general population,111;112;159 although Wang et al116 had a small COPD sample 
(n=40).  
When measured using the WPAI questionnaire, COPD patients were significantly 
more likely to report presenteeism compared to those without COPD (p<0.001).111;112 
A study which used the WHO-HPQ also suggested that COPD patients may be at an 
increased risk of presenteeism (IRR=1.43; 95% CI: 0.98 – 2.10), although these 
differences just failed to reach statistical significance.104 Allen et al’s matched-cohort 
study, which assessed presenteeism over two time periods also demonstrated a 
significant association between COPD and presenteeism (p<0.05) but only for one 
time period.105  
Ward et al’s findings suggest that among COPD patients, those with emphysema 
(43.5%) may be more affected than chronic bronchitis patients (3.4%), although it 
should be noted that classification of lung disease was based on self-report.159 
Three studies assessed the relationship between disease severity and presenteeism 
(Table 2-9), all of which signalled a greater impact on work performance with 
increasing disease severity,22;158;165 although only one study found this association to 
be statistically significant.165 Among these studies disease severity and work 
performance was measured using different methods (airflow obstruction and 




breathlessness). Furthermore, the lack of adjustment for confounders in all three 
studies suggests that these findings should be interpreted with caution.  
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Category Results COPD Results comparator 





Allen et al 
(2012)105 
Retrospective 











2001: n =  181 






n = 9680 
n = 9883 









2001 – 2002: 7.7 
2008 – 2009: 4.0 
HWP-1: 
2001 – 2002: 27.1 
2008 – 2009: 12.7 
WLQ: 
2001 – 2002: 5.8 
2008 – 2009: 4.5 
HWP-1: 
2001 – 2002: 18.8 







T-test (cross-sectional analysis) 
Matched on age, gender, 
whether salaried or hourly pay, 
length of employment and 













n = 1112 
Without 
COPD 





to lung health 
over previous 7 
days 
Mean % presenteeism 
(adjusted) 
 
Mean number of hours 























Adjusted for sex, employment 
type, ethnicity, education, 
income, health insurance, 
smoking status, BMI and asthma 
diagnosis. 
Would have been useful to 
assess number affected, and the 
range of the scores. Did not 
state the presenteeism 
parameters.  
DiBonave









n = 297 
Without 
COPD 





to lung health 
over previous 7 
days 
Mean % presenteeism 
(adjusted) 
 
Mean number of hours 

















Adjusted for sex, employment 
type, ethnicity, education, 
income, health insurance, 
smoking status, BMI and asthma 
diagnosis. Age and co-




















previous 4 weeks  
Risk of presenteeism for 
COPD patients - - 
IRR=1.43 (95% 
CI: 0.98 – 2.10) 
(NS) 
Adjusted for age, sex, marital 
status, number of children, 
education level, annual income, 
treatment seeking behaviour, 
number of co-morbidities, 
occupation, industry, 
public/private sector, job 
security, contractor, rate of 
workplace accidents, hours 
worked (past 4 
weeks),supervisory role and 
hours expected to work 
day/week by their employer. Did 
not adjust for smoking status. 
Did not solely focus on COPD 
patients. 
Table 2-8 The effect of COPD on presenteeism 















Category Results COPD Results comparator 


















to condition in 
previous 4 weeks  
Annual excess days (SE) 27.5 (15.6) -  P > 0.05 (NS) 
Analysis of covariance. Adjusted 
for age, sex, occupation, 
education and other conditions. 
Smoking status not accounted 
for. Small COPD sample. 
Ward et al 
(2002)159 
Cross- sectional 
1993 - 1994 
Chronic bronchitis: 





n = 3306 
Asthma: 
n = 2632 
Other lung 
disease: 
n = 388 
Condition is the 










Other lung disease: 
30.1%  
Not calculated 
Not assessed as a validated 
presenteeism measure. Chronic 
bronchitis and emphysema not 
combined. Increased risk of 
misclassification through using  
other lung disease group. 
  










description Comparison groups Outcome definition/criteria Category Results 






















Very severe: n=124 
WPAI questionnaire 
 
Presenteeism due to COPD 
over the previous week 








Not significant No adjustment for confounders 
Rodriguez 
Gonzalez-










Moderate COPD: n=1596 
Severe COPD: n=2012 
COPD impact on work in 
past 4 weeks 
Work impact questions 
taken from item 4 of SF-36. 
Specific questions not 
detailed 
% work time reduced  
Moderate 
Severe 




% quit doing some tasks 
Moderate 
Severe 





















P = 0.0001 
 
 
P = 0.0001 
 
 
P = 0.0001 
Chi squared test 














n = 2426 
Disease severity 
Mild: n = 849 
Moderate: n = 1012  
Severe: n = 521 
WPAI questionnaire 
 
Presenteeism due to lung 
health over previous week  





5.2 (3.7 – 6.7) 
16.8 (12.6 – 19.6) 
18.9 (10.4 – 27.3) 
 
 
Not calculated Mean presenteeism scores not reported 
   
Table 2-9 Presenteeism according to disease severity among patients with COPD 




2.6 Discussion  
2.6.1 Main findings 
Although the prevalence of employment among COPD patients varied from 16.7% to 
69.2%,103;154 there was clear evidence that employment rates among patients with 
COPD were lower compared to those without COPD. This was supported by a 16 
year cohort study,157 a large matched retrospective cohort study154 as well as four 
large cross sectional studies.99;100;103;156 There is some evidence to suggest that as 
disease severity increases patients are less likely to be in work, however the strength 
of the evidence was weak; consisting of a number of methodological issues.  
There were some inconsistencies when comparing the proportion of participants with 
sickness absence in those with COPD compared to those without; the recall periods 
(1 week to 4 years) and time of data collection (1964 to 2012) within the evidence 
varied widely. Although when measuring disability-related work loss, there was clear 
evidence from a relatively recent cohort study that COPD patients are approximately 
twice as likely to have a short term disability and more than 4 times more likely to 
have long term disability compared to those without COPD.106  
Strong evidence from 1 cohort study107  in addition to some evidence from 2 other 
cohort studies106;108 demonstrated that patients with COPD take more time off work 
compared to those without COPD. A fourth cohort study also supported this, but for 
only one of the two time periods assessed.105 Additionally, four cross-sectional 
studies supported these results, although they did consist of some methodological 
weaknesses.111;112;116;164 A reliable estimate was found in Nair et al’s study: COPD 




patients taking an average of 12 days off per year compared to 7.2 days off in those 
without COPD.107   
The evidence for associations between disease severity and absenteeism was 
unclear. It was difficult to compare study findings due to: methodological weaknesses 
of some of the literature e.g. small sample sizes, lack of adjusting for confounders; 
heterogeneity between studies e.g. measure of disease severity (FEV1/FVC ratio or 
GOLD staging), measure of absenteeism (any sick leave or high vs. low sick leave). 
For the third outcome measure, presenteeism, the majority of the cross-sectional 
evidence suggested that when at work, patients with COPD have poorer work 
performance than those without COPD, however, due to the various scales used to 
measure presenteeism it was difficult to quantify these differences. The cohort study 
reported inconsistency in results over the two time periods (similar to the 
absenteeism results), however it should be noted that there were imbalances in the 
male to female ratio over both time periods, which may have provided biased 
estimates.105 There was inconclusive evidence on the effect of disease severity on 
work performance. Only three studies assessed this association22;158;165; of which two 
used a standardised presenteeism instrument,22;158 possessing a short recall period, 
and none adjusted for the effect of confounding.  
 
 




2.6.2 Strengths and limitations of the review 
This appears the first systematic review to assess the effect of COPD on 
employment, absenteeism and presenteeism. The search strategy included a variety 
of methods to gain access a wide range of literature. However, it was restricted to the 
inclusion of English publications (although only two non-English publications were 
identified as potentially relevant to the review).  
A standardised tool was not available to evaluate the methodological strength of the 
evidence, and instead a variety of methods were used to develop the tailored risk of 
bias tool. However, to our knowledge, there is currently no gold-standard tool to 
assess the biases within cross-sectional studies.   
2.6.3 Strengths and limitations of the evidence included in the 
review 
There was high heterogeneity amongst the included studies, making it difficult to 
compare and synthesise the results. For example, absenteeism was measured using 
various recall periods and reasons (e.g. overall/COPD related absenteeism). 
Inconsistencies in the reporting of outcome data was also noted, for example, 
absenteeism was measured by any or some of the following: % affected; hours; days 
and reporting of an effect size e.g. risk ratio. Presenteeism was measured using 
various instruments, and a few measured work performance without the use of a 
standardised presenteeism instrument. 
Although the COPD population inclusion criteria were flexible – including self-
reported COPD patients – this approach may have inevitably increased the risk of 




misclassifying the disease, and therefore including articles with a diluted COPD 
population. 
There were some well-conducted observational studies included in this review, which 
either matched or adjusted for a range of important covariates. However, adjustment 
for confounders or important confounders was an identified issue among many 
studies, making it difficult to interpret the reported effect sizes. Additionally, some 
studies did not go beyond descriptive statistics and hence, reported no effect size. 
An objective of this review was also to examine the effect of COPD disease severity 
on all working outcomes. However, as this was not always measured, it was difficult 
to conclude on such associations. 
The studies included in this review were conducted over a number of countries, yet 
no study solely assessed a UK COPD population. Fletcher et al’s large cross-
sectional cross-country study included a UK COPD population, but combined the 
data from each country into one estimate.22 This is important to consider as the 
welfare and social settings may differ between countries. Many studies also 
displayed limited external validity, for example some studies included a skewed study 









2.6.4 Comparison with other reviews 
Whilst working on this systematic review, two relevant reviews were published: 1) a 
literature review focusing on the indirect costs of COPD in the US,43 and 2) a 
systematic review assessing the global impact of non-communicable diseases on 
macro-economic productivity.167  
Patel et al’s43 review involved assessing the impact on employment, absenteeism 
and presenteeism among the US COPD population. Despite differences in review 
methods, inclusion criteria and restriction to US studies only, the main results were 
similar. The authors also found lower employment rates among those with COPD 
compared to those without. They found that COPD patients with more severe 
disease, emphysema and comorbid asthma were more likely to be out of work 
compared to those with mild disease and chronic bronchitis. The estimates related to 
the impact on absenteeism and presenteeism were identified as disparate, although 
only 2 articles assessed presenteeism. The authors also appreciated the 
methodological weaknesses of the existing studies.   
Chaker et al’s167 review, however, assessed a wide range of health conditions, and 
therefore did not provide an in-depth commentary on the impact on COPD patients. 
Nevertheless, the authors found that COPD patients had a “higher chance of working 
fewer hours and of poorer work performance” and that COPD accounted for 
approximately 8.5 days lost work days per year.167 Overall, the results were broadly 
comparable with this review’s findings, although little was discussed on the impact on 
employment and the impact of COPD disease severity on the various working 
outcomes. There was a difference in the estimated lost working days between 




Chaker et al’s167 review (based on 2 studies) and this review (based on one study): 
8.5 vs. 12.0 days off per year. These differences in findings may be accounted by the 
differences in review inclusion criteria (Chaker et al’s167 estimate was based on 
studies not included in this review), methodological quality of the studies used to 
derive the estimate as well as potential variations in the definition “lost working days” 
– the review lacked clarity as to whether the lost days were attributed to absenteeism 
alone.167  
2.6.5 Implications for future research 
There were a number of methodological weaknesses within the current literature and 
thus, the following are required for future studies: prospective studies with matched 
controls or better control of confounders; use of validated scales; methods of data 
collection to minimise recall error (e.g. routine data on sickness absence, or data 
from company records) and robust methods in diagnosing lung disease (i.e. 
spirometry data). 
The effect of COPD on presenteeism is an emerging area of research. Future studies 
should measure work performance using an agreed and standardised questionnaire 
and recall periods, to allow comparisons between studies. 
The effect of disease severity on working outcomes was unclear. More studies with 
reliable methods to measure lung disease and work outcomes are needed. However, 
it is known from existing literature that the extent of airflow obstruction may not truly 
reflect the impact of COPD on patients, and therefore measuring disease severity 




through other measures, such as breathlessness, may be more important in 
assessing the impact on working outcomes in patients with COPD. 
From this review it is also unclear how COPD phenotype (e.g. emphysema or chronic 
bronchitis) affects working outcomes. Future research should use information from 
physician records rather than self-reported data, which may help reduce 
misclassification and clarify associations. 
Lastly, this review identified the scarcity of observational research based in the UK. 
Future research should focus on this to help develop a better understanding of the 
implications of COPD in the local working population.  
2.6.6 Conclusions 
COPD is associated with a significant cost to society and from this review there is 
consistent evidence from observational studies to show that patients with COPD 
have lower employment rates and take more time off work compared to those without 
COPD. To reduce this burden, there is a need for reliable data in this area to better 
understand the effect of COPD on working outcomes. 
Although it appears COPD affects work performance, this review highlighted there is 
insufficient evidence to support the effect of COPD on presenteeism. More studies 
with robust methods are required in this area. 
Being in work is good for both the physical and mental health and wellbeing of 
patients, and so there is also a need to understand how we may be able to keep 
COPD patients in work and reduce their sickness absence rates. The next step, 
therefore, would be to understand the reasons for these significant differences by 




assessing which factors may contribute to the lower employment rates and greater 
time off work in COPD patients; which would also include assessing the impact of 
disease severity (particularly as there is inconclusive evidence about this 
association). Identifying the factors which are associated with these working 
outcomes may provide information on how interventions can be targeted to COPD 
patients to help improve their work ability and productivity; which would not only 
benefit society, but also patients themselves. 
 
   
3.  THE ASSOCIATION BETWEEN COPD AND 
EMPLOYMENT: A CROSS-SECTIONAL ANALYSIS 




Background Employment rates among those with COPD are lower compared to 
those without COPD. Little is known about the factors which affect COPD patients’ 
ability to work.   We aimed to identify modifiable factors associated with being in work 
among working age COPD patients. 
Methods A cross-sectional analysis of the baseline data of the Birmingham COPD 
Cohort study to assess the associations between socio-demographic, clinical and 
occupational characteristics and employment among working age COPD patients, 
using logistic regression. 
Results Of the 1889 recruited to the cohort study, 608 were of working age (<65 
years) of whom 248 (40.8%) were in work. Individual factors associated with a lower 
probability of being in work were increasing age (p for trend<0.01), decreasing 
educational level (p for trend<0.05), increasing BODE score (p for trend<0.01) and 
high occupational exposure to vapours, gases, dusts and fumes (VGDF) (OR=0.32; 
95% CI 0.12 – 0.85). Exploration of the components of the BODE index revealed that 
only the breathlessness component was significantly associated with employment 
status. 
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Conclusions This is the first UK study assessing the impact of COPD on 
employment among patients in primary care.  COPD patients who are more 
breathless and have a higher exposure to VGDF are less likely to be employed. 
Future interventions should focus on managing breathlessness and reducing 
occupational exposures to VGDF to improve the work capability among patients with 
COPD. 
3.2 Introduction  
COPD is a progressive lung disease characterised by airflow obstruction,25 affecting 
6-10% of the global population.31 In the UK, an estimated 44% of the COPD 
population are of working age, of which around one quarter are not in work due to 
their COPD.45 These estimates are higher in the US: of the 69.0% of working age,168 
more than one third are not in work due to their COPD.113 There is insufficient 
evidence assessing the national economic impact of work loss due to COPD in the 
UK, however other estimates suggest COPD attributed work loss costs the US 
economy $18.5 billion annually.43  
The systematic literature review in the previous chapter (chapter 2) confirms the 
burden of COPD on employment. Although the employment rates among those with 
COPD varied widely – between 16.7% and 69.2% – there was strong evidence that 
patients with COPD have lower employment rates compared to those without COPD. 
They are also less likely to be in work compared to asthma patients or those with 
other-co morbidities.99 There was also some evidence to suggest that when out of 
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work, COPD patients are less likely to re-enter the labour market compared to those 
with no chronic conditions.99 
Remaining in work or returning to work is advised for those who develop a health 
condition,1 and to help improve work ability amongst these patients it has been 
suggested that early interventions should be put in place.1;10 However, before 
planning intervention strategies to address the low employment rates among patients 
with COPD, there is a need to understand what factors may affect employment 
amongst this group.  
Of the limited evidence, there are conflicting findings about the factors associated 
with employment among patients with COPD. Adjusted analyses indicate 
contradictory evidence related to the impact of current smoking status on being in 
work.100;101 Occupational exposures may also play a role,101 although evidence for 
this is limited and conflicting.101;102 Furthermore, as highlighted in chapter 2, there is 
inconclusive evidence related to the impact of disease severity on employment 
among those with COPD. Unadjusted estimates indicate that breathlessness may be 
an important factor associated with employment,22;100 although there is insufficient 
evidence to support this finding as yet. There is also some evidence which suggests 
that co-morbidities among patients with COPD may contribute towards work 
disability,101 although an adjusted analysis found that this was not a significant factor 
contributing to unemployment.100   
However, the few available studies contain a number of methodological weaknesses. 
Furthermore, socio-demographic profiles of these patients may differ compared to 
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that of the UK COPD population and motivation to remain in work may vary in 
different settings. Therefore, a cross-sectional analysis of the Birmingham COPD 
Cohort baseline data is presented in this chapter to evaluate which factors are 
associated with being employed among patients with COPD. 
3.3 Methods 
3.3.1 Study design 
Cross-sectional analysis of baseline data from the Birmingham COPD Cohort 
3.3.2 Setting: the Birmingham COPD cohort 
The Birmingham COPD Cohort is a unique primary care cohort, with a planned 3 
year follow-up.169 71 GP practices were recruited within the West Midlands, UK, from 
which 1889 patients were recruited to the cohort; including both existing COPD 
patients (from GP registers) and newly diagnosed COPD patients (from a linked 
case-finding RCT170). Patients were recruited from June 2012 to July 2014. 
3.3.3 Population 
For these analyses patients with a COPD diagnosis (existing and newly diagnosed 
patients) who were of working age (<65 years) were included. Existing COPD 
patients were those with a clinical diagnosis of COPD on the GP register. The newly 
identified COPD cases were defined according to the current NICE guidance 
(FEV1/FVC<0.7, in the presence of relevant respiratory symptoms: dyspnoea, 
wheeze, chronic cough or phlegm).170 
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3.3.4 Exposures: factors affecting employment status 
A number of clinical and physiological measures were carried out at baseline. 
Socio-demographic characteristics: Validated questionnaires were used to collect 
information on age, sex, smoking status, highest educational level achieved and 
gross household income. Height and weight measurements were obtained by trained 
research assistants. Social deprivation was measured using the Index of Multiple 
Deprivation (IMD) 2010 score171 based on individual patient postcodes. Co-
morbidities were a self-reported physician diagnosis of: CVD, diabetes, gastro-
intestinal disease, diabetes, cancer, depression, osteoarthritis, rheumatoid arthritis, 
hayfever, eczema and allergies. 
Clinical characteristics: Participants completed questionnaires on breathlessness 
(the MRC score)172; symptom impact (CAT score)173; and exacerbations (self-
reported steroid or antibiotic treatment for an exacerbation in the previous 12 
months). Pre and post-bronchodilator spirometry, according to the ATS/ERS 2005 
guidelines,174 was carried out by the research assistants who received intense 
training based on a modified version of the ARTP spirometry course. Airflow 
obstruction was determined using the post-bronchodilator results; % predicted FEV1 
was calculated using GLI reference equations175 and GOLD staging criteria24 used 
for severity of airflow obstruction. Patients also completed an exercise capacity test, 
which assessed the number of sit-to-stand repetitions patients completed in one 
minute (carried out post bronchodilator): counting the number of times the patient 
stood from a seated position, without using their arms to stand up. 
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The BODE index was adapted using the sit-to-stand test as a proxy for the exercise 
capacity element of the BODE (in place of the 6 minute walk test). Cut-off points were 
derived from the research by Ozalevli et al,176 which assessed the correlation 
between the 6 min walk test and the sit-to-stand test. 
Occupational characteristics: SOC (standard occupational classification) 2010 
codes were generated for the longest held occupation by trained research assistants 
using the CASCOT (computer assisted structured coding tool) software.177  
For accurate and standardised SOC coding, one researcher (KK) delivered a 
standardised training programme to all research assistants. The training programme 
provided instructions on software navigation, the factors to consider when coding 
occupations (job title and job tasks) and practice sessions for coding a range of 
occupations. RAs were directed to contact the researcher (KK) in the event of 
ambiguous patient occupations (which were difficult to code) for advice on the correct 
SOC code.  
For quality control, the occupational coding by each research assistant was assessed 
by identifying and telephoning a random sample of 25 to 30 patients (seen by each 
research assistant). Blind to the patient’s occupational history and SOC code 
originally generated by the research assistant, the researcher (KK) obtained the 
relevant occupational details from each patient and used this information to 
independently generate a SOC code. Patient SOC codes generated by the 
researcher and research assistant were compared. Any discrepancies in coding were 
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rectified by the researcher, and research assistants were informed and explained 
about the correct coding for such occupations. 
An unpublished job exposure matrix (JEM) was used to assign the risk (none, low, 
medium and high) of occupational exposures to vapours, gases, dusts and fumes 
(VGDF) for each SOC code. This was developed based on previous work178 by the 
main author (through personal communication). Self-reported employment type 
(employed for wages/self-employed) was collected in a subset of patients. 
3.3.5 Outcome measure 
Self-report of whether the patient was in any current paid employment (full-time or 
part-time) at the baseline visit was obtained by the research assistant. 
3.3.6 Sample size 
As this study was nested within the Birmingham COPD Cohort, no formal sample 
size calculations were carried out. Instead a convenience sample was used for this 
analysis. 
3.3.7 Ethical approval 
The Birmingham COPD Cohort received ethical approval from the National Research 
Ethics Service Committee West Midlands - Solihull (ref: 11/WM/0304). 
3.3.8 Statistical analysis 
Univariate and multiple logistic regression were undertaken in STATA version 13.0. 
An initial model consisted of known clinically important covariates: age, sex, smoking 
status and number of co-morbidities. Using the likelihood ratio test, we assessed the 
additional contribution of significant covariates identified in the univariate analysis: 
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education level, MRC score, CAT score, number of exacerbations, exercise capacity, 
the BODE index and exposures to VGDF.  
Initially, the BODE index (a composite measure) was chosen to describe disease 
severity. We then assessed the individual components within the BODE index in a 
further model. 
Sub-group analysis: In a subset of patients for whom there were data, the impact of 
employment type (employed/self-employed) on being in work was additionally 
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3.4 Main results 
3.4.1 Characteristics of the participants 
Of the 7176 eligible patients, 1889 (26.3%) patients were recruited to the cohort 
study. 608 (32.2%) were of working age, and form the group that was studied in this 




















Did not consent: 
n=308  
Participants invited to 
the cohort: n=7176 
(existing COPD: n=6383 








Consented at baseline: 
n=1889                  
(existing COPD: n=1558 
newly identified: n=331) 
Occupational sub-cohort of 
working age: n=608                        
(in work=248; not in work=359)                   
Complete data used for final 
multivariable logistic regression 
analysis: n=347 
Figure 3-1 Participant flow chart for the recruitment to the Birmingham COPD Cohort 
study 
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Table 3-1 describes the baseline characteristics of those of working age. 
Approximately 50% of the participants were aged 60-64 years, current smokers and 
had no formal educational qualification. The majority of patients were either 
overweight or obese (70.4%) and had at least one co-morbidity (85.3%).There was a 
range of disease severity (including dyspnoea, impact on quality of life and airflow 
obstruction). Approximately 50% were from a manual occupational background 
(skilled trade; process/plant/machine operatives; elementary) and many patients 
(66.9%) had either no or low occupational exposures to VGDF.  
Characteristics Participants of working age N=608 
Socio-demographic characteristics 
Sex  
Female (%) 265 (43.6%) 
Male (%) 343 (56.4%) 
Age categories  
38 – 49 68 (11.2%) 
50 – 59 253 (41.6%) 
60 - 64 287 (47.2%) 
Smoking status  
Never smoked 42 (7.5%) 
Ex-smoker 239 (42.8%) 
Current smoker 278 (49.7%) 
Education level  
Degree or higher level 58 (12.0%) 
A level/AS level or equivalent 36 (7.5%) 
GCSE, CSE, O level or equivalent 140 (29.1%) 
No formal qualification 248 (51.5%) 
Gross household income  
£28081-£45241+ 91 (16.2%) 
£18721-£28080  72 (12.8%) 
£9361-£18720 111 (19.7%) 
<£2600-£9360 173 (30.7%) 
Prefer not to say 116 (20.6%) 
 
 
Table 3-1 Baseline characteristics among those of working age 
recruited to the Birmingham COPD Cohort study 
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Table 3-1Baseline characteristics among those of working age recruited to 
the Birmingham COPD Cohort study (continued) 
Characteristics Participants of working age N=608 
IMD score quintiles  
1 91 (15.0%) 
2 93 (15.4%) 
3 136 (22.5%) 
4 132 (21.8%) 
5 153 (25.3%) 
BMI categories  
Normal (18.5-24.9) 156 (26.8%) 
Underweight (<18.5) 16 (2.8%) 
Overweight (25 - 30) 205 (35.2%) 
Obese (30+) 205 (35.2%) 
Clinical characteristics 
Number of co-morbidities  
0 89 (14.6%) 
1-2 250 (41.1%) 
3+ 269 (44.2%) 
MRC  
1 125 (21.4%) 
2 103 (17.7%) 
3 130 (22.3%) 
4 to 5 225 (38.6%) 
CAT score  
Low (high QOL) 66 (14.0%) 
Medium 174 (36.8%) 
High 166 (35.1%) 
Very high (poor QOL) 67 (14.2%) 
Disease severity (GOLD stage criteria)  
Mild 175 (30.2%) 
Moderate 287 (49.5%) 
Severe to very severe 118 (20.3%) 
Exacerbations in the last 12 months  
0 228 (41.5%) 
1 – 2 202 (36.8%) 
3+ 119 (21.7%) 
Sit-to-stand repetitions quintiles  
1 80 (16.2%) 
2 80 (16.2%) 
3 109 (22.0%) 
4 119 (24.0%) 
5 107 (21.6%) 
BODE index score quartiles  
1 185 (40.2%) 
2 129 (28.0%) 
3 95 (20.7%) 
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Table 3-1 Baseline characteristics among those of working age recruited 
to the Birmingham COPD Cohort study (continued) 
Baseline characteristics Participants of working age N=608 
Occupational characteristics 
Occupational background (SOC 2010)  
Managers, directors and senior officials 40 (6.8%) 
Professional 55 (9.3%) 
Associate professional and technical 39 (6.6%) 
Administrative and secretarial 57 (9.6%) 
Skilled trade 113 (19.1%) 
Caring, leisure and other services 48 (8.1%) 
Sales and customer service 31 (5.3%) 
Process, plant and machine operatives 113 (19.1%) 
Elementary 95 (16.1%) 
Exposures to VGDF in longest held job  
None 196 (32.9%) 
Low 202 (34.0%) 
Medium 124 (20.8%) 
High 73 (12.3%) 
Employment status  
Employed 359 (59.1%) 
Not employed 248 (40.9%) 
 
3.4.2 Univariate analysis 
Participants who were female, older, current smokers, had a lower level of education, 
a lower gross household income and a higher deprivation score were less likely to be 
in work (although not all effects were statistically significant) (Table 3-2). Dose 
response relationships were found between a number of clinical characteristics and a 
reduced probability of being in work: increasing breathlessness (p for trend<0.01); 
poorer quality of life (p for trend<0.01); increasing airflow obstruction (p for 
trend<0.01); increasing number of exacerbations (p for trend<0.01); decreasing 
exercise capacity (p for trend<0.01) and worsening prognosis (BODE index; p for 
trend<0.01). Participants with high exposures to VGDF were less likely to be in work 
compared to those who were exposed to no VGDF in their work environment 
(OR=0.36; 95% CI 0.19 – 0.65). A dose response relationship was also found for 
Increasing occupational 
exposure 
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(95% CI) for being 
employed 
Adjusted ORs (95% CI) 
for being employed 
Sex    
Male (%) 147 (42.9%) 1.0 1.0 
Female (%) 101 (38.3%) 0.83 (0.60 – 1.15) 0.60 (0.36 – 1.01) 
Age categories    
38 – 49 38 (55.9%) 1.0 1.0 
50 – 59 122 (48.4%) 0.74 (0.43 – 1.27) 0.55 (0.24 – 1.26) 
60 - 64 88 (30.7%) 0.35 (0.20 – 0.60 ) 0.28 (0.12 – 0.65) 
Smoking status    
Never smoked 19 (45.2%) 1.0 1.0 
Ex-smoker 103 (43.1%) 0.92 (0.47 – 1.78) 0.98 (0.37 – 2.60) 
Current smoker 106 (38.3%) 0.75 (0.39 – 1.44) 0.79 (0.29 – 2.10) 
Education level    
Degree or higher level 40 (69.0%) 1.0 1.0 
A level/AS level or equivalent 21 (58.3%) 0.63 (0.27 – 1.50) 0.65 (0.23 – 1.90) 
GCSE, CSE, O level or equivalent 64 (45.7%) 0.38 (0.20 – 0.72) 0.55 (0.25 – 1.25) 
No formal qualification 68 (27.5%) 0.17 (0.09 – 0.32) 0.43 (0.19 – 0.97) 
Gross household income   
 
£28081-£45241+ 78 (85.7%) 1.0 
£18721-£28080  51 (70.8%) 0.40 (0.18 – 0.88) 
£9361-£18720 33 (29.7%) 0.07 (0.03 – 0.14) 
<£2600-£9360 16 (9.3%) 0.02 (0.01 – 0.04) 
Prefer not to say 54 (46.6%) - 
IMD score quintiles   
1 53 (58.2%) 1.0 
2 52 (55.9%) 0.91 (0.51 – 1.63) 
3 52 (38.5%) 0.45 (0.26 – 0.77) 
4 49 (37.1%) 0.42 (0.25 – 0.73) 
5 41 (26.8%) 0.26 (0.15 – 0.45) 
BMI categories   
Normal (18.5-24.9) 66 (42.3%) 1.0 
Underweight (<18.5) 4 (25.0%) 0.45 (0.14 – 1.47) 
Overweight (25 - 30) 94 (45.9%) 1.15 (0.76 – 1.76) 
Obese (30+) 72 (35.1%) 0.74 (0.48 – 1.13) 
Clinical characteristics 
Number of co-morbidities    
0 44 (50.0%) 1.0 1.0 
1-2 118 (47.2%) 0.89 (0.55 – 1.45) 1.14 (0.52 – 2.49) 
3+ 86 (32.0%) 0.50 (0.29 – 0.77) 0.70 (0.32 – 1.57) 
Table 3-2 Univariate and multivariable analysis of socio-demographic, clinical and occupational 
characteristics associated with being employed among working age COPD patients 
Increasing 
deprivation 
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Table 3-2 Univariate and multivariable analysis of socio-demographic, clinical and occupational characteristics 






(95% CI) for being 
employed 
Adjusted ORs (95% CI) 
for being employed 
MRC   
 
1 79 (63.2%) 1.0 
2 59 (57.3%) 0.78 (0.46 – 1.33) 
3 67 (51.5%) 0.62 (0.38 – 1.02) 
4 to 5 36 (16.0%) 0.11 (0.07 – 0.18) 
CAT score   
Low (high QOL) 42 (63.6%) 1.0 
Medium 88 (50.6%) 0.58 (0.33 – 1.05) 
High 52 (31.3%) 0.26 (0.14 – 0.47) 
Very high (poor QOL) 13 (19.7%) 0.14 (0.06 – 0.31) 
Disease severity (GOLD stage criteria)   
Mild 91 (52.0%) 1.0 
Moderate 111 (36.7%) 0.58 (0.40 – 0.85) 
Severe to very severe 38 (32.2%) 0.44 (0.27 – 0.71) 
Exacerbations in the last 12 months   
0 106 (46.5%) 1.0 
1 – 2 91 (45.1%) 0.94 (0.65 – 1.38) 
3+ 34 (28.6%) 0.46 (0.29 – 0.74) 
Sit-to-stand repetitions quintiles   
1 67 (62.6%) 1.0 
2 69 (58.0%) 0.82 (0.48 – 1.41) 
3 45 (41.3%) 0.42 (0.24 – 0.73) 
4 26 (32.5%) 0.29 (0.16 – 0.53) 
5 15 (18.8%) 0.14 (0.07 – 0.27) 
BODE index score quartiles   
1 116 (62.7%) 1.0 1.0 
2 63 (48.8%) 0.57 (0.36 – 0.90) 0.84 (0.48 – 1.47) 
3 25 (26.3%) 0.21 (0.12 – 0.37) 0.38 (0.19 – 0.74) 
4 5 (9.8%) 0.06 (0.02 – 0.17) 0.10 (0.03 – 0.33) 
Occupational characteristics 
Occupational background (SOC 2010)    
Managers, directors and senior officials 27 (67.5%) 1.0 
Professional 33 (60.0%) 0.84 (0.35 – 1.98) 
Associate professional and technical 20 (51.3%) 0.57 (0.23 – 1.43) 
Administrative and secretarial 28 (49.1%) 0.45 (0.19 – 1.06) 
Skilled trade 28 (24.8%) 0.27 (0.12 – 0.58) 
Caring, leisure and other services 26 (54.2%) 0.57 (0.23 – 1.38) 
Sales and customer service 10 (32.3%) 0.18 (0.06 – 0.54) 
Process, plant and machine operatives 33 (29.2%) 0.29 (0.13 – 0.63) 
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Table 3-2 Univariate and multivariable analysis of socio-demographic, clinical and occupational characteristics 






(95% CI) for being 
employed 
Adjusted ORs (95% CI) 
for being employed 
Exposures to VGDF in longest held job    
None 94 (48.0%) 1.0 1.0 
Low 86 (42.6%) 0.80 (0.54 – 1.19) 0.93 (0.51 – 1.71) 
Medium 47 (37.9%) 0.66 (0.42 – 1.05) 0.91 (0.43 – 1.91) 
High 18 (24.7%) 0.36 (0.19 – 0.65) 0.32 (0.12 – 0.85) 
Employment type*    
Employed 52 (43.7%) 1.0 
Self-employed 12 (57.1%) 1.72 (0.67 – 4.39) 
*subset of patients completed information on employment type 
3.4.3 Multivariable analysis 
After mutual adjustment, age, education level, BODE index and occupational 
exposures to VGDF remained the significant covariates independently associated 
with employment status (Table 3-2). Females were less likely to be in work compared 
with males, although this did not reach statistical significance.  
3.4.4 Exploring importance of components of the BODE index 
Table 3-3 presents a further analysis exploring the relative importance of the different 
components of the BODE index after adjustment for all other important covariates. 
Only the dyspnoea component of the BODE index was independently associated 
with employment (p for trend<0.01). Point estimates of airflow obstruction and 
exercise capacity were suggestive of possible weak trends; of which exercise 
capacity demonstrated a larger effect. The BMI component within BODE was not 
significantly associated with employment. 
When each component was added sequentially to the final model predicting 
employment (in place of the composite BODE index), only the dyspnoea component 
improved it (LR test<0.01). 
Increasing occupational 
exposure 
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*Adjusted for: age, sex, smoking status, education level, number of co-morbidities and exposures to       
VGDF 
 
3.4.5 Effect of employment type 
Data on employment type were available in a subset of patients (n=140; 23.0%). 
After adjustment, patients with a self-employed occupational background were more 
likely to be in work compared to those who were employed for wages (OR=3.84; 95% 





Table 3-3 Exploring the BODE components in the final model 
The BODE index components Adjusted ORs* CIs P-value 
B: BMI 
>21 1.0 Reference - 
<21 0.80 0.33 – 1.92 0.61 
O: airflow obstruction (FEV1 % predicted) 
>65 1.0 Reference - 
P for 
trend=0.60 
50 – 65 0.95 0.47 – 1.89 0.88 
35 – 49 0.83 0.39 – 1.77 0.63 
<35 0.82 0.25 – 2.71 0.75 
D: dyspnoea (mMRC score) 
mMRC 0-1 1.0 Reference - 
P for 
trend<0.01 
2 1.18 0.64 – 2.18 0.59 
3 0.23 0.08 – 0.62 <0.01 
4 0.36 0.15 – 0.85 0.02 
E: exercise capacity (sit-to-stand repetitions) 
>26 1.0 Reference - 
P for 
trend=0.09 
21-25 0.84 0.40 – 1.77 0.65 
16-20 0.80 0.38 – 1.71 0.57 
<15 0.41 0.16 – 1.03 0.06 
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3.5.1 Key results 
This is the first study in the UK to explore the association between socio-
demographic, clinical and occupational characteristics and the ability to work among 
patients with COPD. The main findings showed that nearly 60% of working age 
COPD patients were not in work and that being older, having a lower educational 
level, worse breathlessness and high occupational exposures to VGDF were 
independently associated with the reduced probability of being in work.  
Compared with a recent UK labour force survey among a working age population 
(16-64 years), this COPD study sample had higher unemployment rates than the 
general population, those with a long term health condition  and those with a 
disability179; which is consistent with previous work.99  
The socio-demographic factors – age and educational level – which were 
independently associated with employment within this study are consistent with other 
published research in this area,100 and are well recognised factors affecting 
employment in the general population.180;181 Although recent UK employment trends 
show that there has been a rise in the proportion of women and a fall in the 
proportion of men that are now in work, employment rates among women remain 
lower than men.182 This is supported by the findings in this study: women with COPD 
were less likely to be in work. Although this was not significant, a larger sample size 
may have clarified this relationship.  
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Smoking status has been shown to be associated with employment status in the UK; 
those who are unemployed are nearly twice more likely to smoke.183 Although our 
findings were not statistically significant, the point estimates were indicative of a 
weak similar trend, which again might be clarified with a larger sample size.  
It was surprising to find that the presence of multiple co-morbidities was not 
independently associated with being in work, especially as in the unadjusted 
analyses it appeared to be an important factor. Although this finding is consistent with 
those reported in other studies of patients with COPD,100;102 the direction of the point 
estimates and width of the confidence intervals suggest that multiple co-morbidities 
may be an important factor affecting employment which might also be clarified with a 
larger sample.  
This is the first study to use a standardised and objective measure of exposure to 
VGDF (the JEM) within a model assessing factors associated with employment 
status among COPD patients. Previous research methods have used self-report101 
and professional judgement102 as measures of determining workplace exposures. 
This variation in measurement may lend some explanation for the conflicting results 
of the role of occupational exposures in employment among COPD patients.101;102  
An interesting finding was that of the several clinical factors describing disease 
severity, only breathlessness was strongly and independently associated with 
employment, and was the only component which significantly contributed to the final 
model. The other measures of disease severity within the composite BODE measure 
– airflow obstruction and exercise capacity – were less important. However, although 
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not statistically significant, they did indicate weaker trends, and a larger sample size 
may have increased the precision of the results.  
Findings from previous studies have revealed conflicting results between the 
association of airflow obstruction and employment status.100-103 These differences 
may be explained by the methodological differences between the studies as well as 
the measurement used to describe disease severity (e.g. using GOLD staging or 
mean FEV1 % predicted).  There has been little work assessing the impact of other 
measures of disease severity, for example symptoms and the degree of 
breathlessness. 
It is now accepted that airflow obstruction does not fully capture the impact of COPD 
on patients’ lives184;185 and this study confirms that symptoms are more important in 
determining whether or not a patient is in work. 
In a sub-group analysis employment type was suggestive of being associated with 
being in work, however our analysis did not have sufficient power to detect significant 
differences. 
3.5.2 Study limitations 
As this is a cross-sectional study, it was not possible to determine causality. Factors 
such as income and deprivation were significantly associated with employment in the 
unadjusted analyses. However, these are particularly susceptible to reverse 
causation and therefore were not included in the adjusted models. Workplace 
exposures to VGDF may also have preceded COPD diagnosis and may be an 
important factor in the development of COPD. Some data were based on self-report 
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e.g. number of co-morbidities and exacerbations; possibly introducing errors in 
prevalence rates and diluting the findings. Additionally, there was a low response rate 
for some measures (smoking status; exercise capacity; exacerbations), which may 
have led to less reliable estimates. It was interesting to explore the BODE prognostic 
index, however we used a modified version – replacing the 6MWT with the sit-to-
stand test as a measure of exercise capacity, and this requires further validation. 
3.5.3 Implications for practice and research 
These findings reveal some important differences among patients with COPD who 
are in work compared to those not in work, suggesting that there are possible 
opportunities to modify certain factors to improve work capability. Breathlessness 
was the most important clinical factor identified; therefore it suggests the need for 
healthcare professionals to work alongside patients and focus on improving the 
management of breathlessness in those with COPD, in particular among the working 
age population. The UK NICE guidelines for COPD25 provide guidance for healthcare 
professionals on the management of breathlessness. This may involve providing 
advice on better medication management (e.g. the correct inhaler usage), advice on 
smoking cessation and referral to pulmonary rehabilitation (for example, among 
those that have a MRC score >3), or self-management advice. Within the workplace, 
patients (alone or in conjunction with their employer) may want to consider modifying 
aspects of their job which may otherwise exacerbate their breathlessness, for 
example, carrying heavy loads, regular use of stairs or tasks which involve lifting and 
bending.  
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The second important modifiable factor identified was high workplace exposures to 
VGDF. This suggests that employees should potentially undergo an occupational 
health (OH) risk assessment to determine the level of exposure to VGDF in their 
working environment and thus, for OH services to advise accordingly on how those in 
high exposure jobs may be able to modify their job role, job tasks or working 
environment. In the workplace, it may be difficult to justify conducting a risk 
assessment in COPD patients alone, and therefore it is suggested for all employees 
to receive a risk assessment and potentially benefit from reductions in workplace 
exposures to VGDF. 
Although being in work is associated with better health among patients with COPD, 
there is a need for prospective longitudinal studies to establish the temporal 
relationships between disease severity, occupational exposures to VGDF and 
employment. Further research is also required to determine the effectiveness of 
managing breathlessness and reducing workplace exposures on work capability 
among patients with COPD. 
3.6 Conclusions 
This study demonstrates the high levels of unemployment among those with COPD. 
Two potentially modifiable factors associated with the reduced probability of being in 
work were identified: increased breathlessness and history of higher workplace 
exposures to VGDF. Future interventions should focus on improving the 
management of breathlessness and reducing workplace exposures to VGDF in order 
to help improve the work capability in those with COPD. 
 
   
4.  THE ASSOCIATION BETWEEN COPD AND WORK 
PRODUCTIVITY: A CROSS-SECTIONAL ANALYSIS 




Background Patients with COPD are more likely to take time off work (absenteeism) 
and report poor performance at work (presenteeism) compared to those without 
COPD. Little is known about the modifiable factors associated with these work 
productivity outcomes.  
Aim To identify and quantify the factors associated with work productivity among 
COPD patients. 
Methods Cross-sectional analyses of baseline data from the Birmingham COPD 
Cohort study including participants who were in paid employment. Absenteeism was 
defined by self-report of time off work over the previous 12 months. Presenteeism 
was assessed using the Stanford Presenteeism Scale (SPS-6) questionnaire. 
Logistic regression analysis was used to assess the effects of sociodemographic, 
clinical and occupational characteristics on work productivity, adjusted for key 
covariates. 
Results 348 patients in the cohort were in work at baseline. Increasing 
breathlessness (p for trend<0.01) was the only clinical factor associated with both 
absenteeism and presenteeism. Additionally, increasing occupational exposures to 
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vapours, gases, dusts and fumes (VGDF) (p for trend<0.01) was independently 
associated with presenteeism.  
Conclusions This is the first study to identify the most important modifiable factors 
which lead to poor work productivity among patients with COPD. COPD patients who 
are more breathless take more time off work. In the workplace, those who are more 
breathless and have higher occupational exposures to VGDF are more likely to 
perform poorly. Future interventions should focus on managing breathlessness and 
reducing occupational exposures to VGDF to improve the work productivity of COPD 
patients. 
4.2 Introduction 
COPD is a common progressive lung disease affecting 6-10% of the global adult 
population,31 with a high morbidity and mortality burden.29;30  COPD is usually 
diagnosed in middle age, and a high proportion of those with the disease are of 
working age (around two thirds in the US168 and 40% in the UK45). However, among 
these, lower proportions are in paid employment compared to the general population 
(see chapter 2). Indirect societal costs attributable to COPD (largely due to sickness 
absence) are high, estimated at between £1.1bn and £2.7bn annually in the UK41;45 
(~2003 costs for Britton et al45) and $3.9bn in the US (2010 costs).44 
From the literature identified in the systematic review of Chapter 2, it was confirmed 
that COPD patients who are in paid employment have higher rates of absenteeism 
(time off work) than those without COPD. There was also evidence that the risk of 
absenteeism was greater in those with COPD than those with other chronic 
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conditions such as asthma and cardiovascular disease.104 However, the extent of the 
effect on COPD patients, for example, the proportion of patients affected and the 
annual average days off work, was unclear. As found in chapter 2, this may be due to 
the varying recall periods, sample sizes, countries/settings and inconsistency in the 
measurement of absenteeism in previous research.  
There is also some limited evidence that even when at work, some patients with 
COPD may have poor work performance (presenteeism) compared to those without 
COPD, and although results were conflicting,104;105;111;112;116 there is evidence in other 
diseases that costs associated with presenteeism may be of greater concern than 
costs associated with absenteeism or even health care.86;186 
In the general population, poor work productivity (absenteeism and/or presenteeism) 
is more common among women,187 those with a lower education level,188 self-
reported poor health91 and who over-commit to their work.122 Occupational factors 
such as job insecurity,121;122 longer working hours (>45h per week)122 and reduced 
job satisfaction121 are also important among those with poor work productivity. 
However, only a few studies have focused on the factors associated with poor work 
productivity among COPD patients; and none of these have assessed the factors 
associated with presenteeism. Among the available studies the findings are 
inconsistent. Chapter 2 highlighted the unclear associations between disease 
severity and sickness absence. There is also limited and inconsistent evidence of the 
impact of comorbid conditions on work productivity in COPD patients.118;119  
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In addition to methodological weaknesses, heterogeneity between studies may 
provide some explanation for the difference in findings, for example variations in 
defining work productivity or absenteeism.118;119;160 Furthermore, due to the paucity of 
evidence, it is not clear to what extent poor work productivity is attributable to disease 
related factors, rather than sociodemographic and occupational factors.  
A better understanding of the modifiable factors that might influence work productivity 
among COPD patients could inform and focus future interventions, which in turn, 
could influence a better work experience for patients and employers, as well as 
contribute to reducing the burden and societal costs related to COPD. The aim of this 
cross-sectional study was to evaluate factors associated with absenteeism, and 
presenteeism among working patients with COPD. 
4.3 Methods 
4.3.1 Study design and participants 
A cross-sectional analysis of baseline data from the Birmingham COPD Cohort. 
A total of 1889 patients with COPD from 71 primary care practices across the West 
Midlands, UK, were recruited to The Birmingham COPD Cohort study during the 
period June 2012 to July 2014.169 These included 1558 patients with a previous 
COPD diagnosis (from GP registers) and 331 newly identified COPD patients from a 
related case finding RCT.170 
For this analysis 348 patients (existing and newly identified COPD patients) from the 
cohort who reported they were in paid employment or self-employed at baseline were 
included. 
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4.3.2 Exposure measures 
At baseline, all cohort participants completed a series of questionnaires to obtain 
detailed information on their health, occupation, lifestyle and socioeconomic 
circumstances. They also underwent examination and had a range of measurements, 
including spirometry. Relevant measures included for the analysis in this paper are 
outlined in more detail below. 
COPD and clinical characteristics: Pre and post-bronchodilator spirometry, 
according to ATS/ERS 2005 guidelines,174 was carried out by trained researchers 
using the ndd Easy One spirometer (ndd, Switzerland). The degree of airflow 
obstruction was categorised using GOLD stage criteria.24 Breathlessness (MRC 
score) was assessed from responses to the MRC respiratory questionnaire172 and 
respiratory quality of life determined using the CAT.173 The number of exacerbations 
over the previous 12 months was assessed by self-report (steroid or antibiotic 
treatment for an exacerbation in the previous 12 months). 
Occupational characteristics: Occupational data (current occupation) were 
obtained through an interview-administered questionnaire by trained research 
assistants. Patients were asked details about their current job title, job tasks as well 
as the name and nature of the company they work for to ascertain their correct 
occupation. Research assistants used this information to generate a 4-digit SOC 
(standard occupational classification) 2010 code – a method used to classify and 
group occupations according to skill level and content – using the CASCOT 
(computer assisted structured coding tool) software.177 Quality assessment of the 
SOC data was carried out by one researcher through contacting a random sample of 
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patients for each research assistant, obtaining occupational data and generating a 
SOC code for each patient. This code was then compared to the patient’s original 
SOC code generated by the research assistant.  
A job exposure matrix (JEM)178 (adapted to 2010 codes) was used to assign the risk 
(none, low, medium and high) of occupational exposures to vapours, gases, dusts 
and fumes (VGDF) for each SOC code.  
Where possible, validated questionnaires were used to collect information on: 
working hours189; job satisfaction189; job training over previous 12 months (excluding 
health and safety training)189; supervising other employees189; type of contract189; 
length in current employment189; work involving walking/standing; work involving 
manual/physical work and usual shift pattern. 
4.3.3 Work productivity measures 
Absenteeism: Patients who reported having taken any time off work during the 
previous 12 months were classified as exhibiting absenteeism. The reason (i.e. 
respiratory or other health problems or other) and duration of any absenteeism were 
also noted. Absenteeism was further categorised into “low” (reporting 0 to 5 days) or 
“high” (defined as > 6 days off work), based on the average number of days off work 
reported in UK employees (4.4 days).125  
Presenteeism: The Stanford Presenteeism Scale (SPS-6) was used to assess the 
impact of the patient’s “chest problems” on their work performance over the previous 
month.93 The scale results in scores between 6 and 30, with lower scores indicating a 
greater impact on work performance due to COPD (i.e. poorer work performance and 
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high presenteeism).93 The lower and upper quartiles of the distribution of 
presenteeism scores in the cohort population was used to categorise patients into 
those with high (SPS-6 score ≤19), or low (SPS-6 score >28) presenteeism. 
4.3.4 Other measures 
Validated questionnaires were used to collect information on smoking status, 
educational level and gross income. Information on age, sex, height and weight were 
obtained by trained research assistants. Social deprivation was measured using the 
Index of Multiple Deprivation (IMD) 2010 score based on individual patient 
postcodes.171 Co-morbidities were self-reported physician diagnoses of: 
cardiovascular disease, gastro-intestinal disease, diabetes, cancer, depression, 
osteoarthritis, rheumatoid arthritis, hayfever, eczema or skin allergies. 
4.3.5 Sample size 
As this study was nested within the Birmingham COPD Cohort, no formal sample 
size calculations were carried out. Instead, a convenience sample was used for the 
analyses. 
4.3.6 Ethical approval 
The Birmingham COPD Cohort received ethical approval from the National Research 
Ethics Service Committee West Midlands - Solihull (ref: 11/WM/0304). 
4.3.7 Statistical analysis 
Univariate and multivariable logistic regression analyses were undertaken in STATA 
version 13.0 to assess: (1) the risk of having high levels of absenteeism (>6 days) 
and (2) the risk of having poor work performance (SPS-6 score ≤19). Statistically and 
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clinically important variables were included in the models. The first model included 
known clinically important covariates: age, sex, smoking status, GOLD stage and 
number of co-morbidities. Using the likelihood ratio test, the contributions of the 
statistically significant clinical and occupational covariates identified in the univariate 
analyses were assessed. 
4.3.8 Additional analyses  
The relationship between absenteeism and presenteeism was assessed by 
correlation (as continuous data) and comparing the pre-defined categories. 
The effect on absenteeism was explored using various cut off points to denote high 
levels of sickness absence: 4, 5, 7 and 8 days, and a separate analysis of specific 
COPD related sickness absence was conducted.  
The effect on presenteeism was also explored using two further cut off points to 
define poor work performance: SPS-6 score <18, as suggested by previous 
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4.4.1 Characteristics of the participants 
Of the 7176 eligible patients identified, 1889 (26.3%) consented to taking part in the 
Birmingham COPD Cohort study; of whom 348 (18.4%) were employed and eligible 
for the analyses in this study (Figure 4-1).  
4.4.1.1 Sociodemographic and clinical characteristics 
A high proportion of the participants were male (62.4%), of working age (<65 years: 
71.3%) and ever-smokers (91.3%) (Table 4-1). The majority were either overweight 
or obese (68.5%) and had >1 co-morbidity (83.0%). The most common co-
morbidities included: cardiovascular disease (45.5%), allergies (39.9%), depression 
(24.0%) and gastrointestinal disease (21.8%). 
Based on MRC dyspnoea score, health related quality of life and level of airflow 
obstruction, most patients had mild to moderate COPD, although over half reported 
one or more exacerbations in the previous year.  
4.4.1.2 Occupational characteristics 
Patients were from a range of occupational backgrounds, and the majority had either 
no or low occupational exposures to VGDF (79.5%). In a sub-sample of 91 patients 
where the information was available, approximately 20% were self-employed. The 
majority of patients had jobs which involved either walking/standing (82.3%) or 
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Participants invited to 
the cohort: n=7176 
(existing COPD: n=6383 








Consented at baseline: 
n=1889                  
(existing COPD: n=1558 
newly identified: n=331) 






Did not consent: 
n=308  
Complete presenteeism data: 
n=301 
 
Figure 4-1 Participant flow chart for the recruitment to the Birmingham COPD Cohort 
study 
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Male (%) 217 (62.4%) 
Female (%) 131 (37.6%) 
Age categories (years)  
38 – 49 38 (10.9%) 
50 – 59 122 (35.1%) 
60 - 64 88 (25.3%) 
>65 100 (28.7%) 
Smoking status  
Never smoked 28 (8.7%) 
Ex-smoker 161 (50.0%) 
Current smoker 133 (41.3%) 
Education level  
Degree or higher level 53 (19.8%) 
A level/AS level or equivalent 26 (9.7%) 
GCSE, CSE, O level or equivalent 84 (31.3%) 
No formal qualification 105 (39.2%) 
Gross income (before tax)  
£28081 – £45241> 63 (19.8%) 
£18721 - £28080 59 (18.6%) 
£9361 - £18720 80 (25.2%) 
<£2600 - £9360 67 (21.1%) 
Prefer not to say 49 (15.4%) 
IMD score quintiles  
1 77 (22.3%) 
2 76 (22.0%) 
3 71 (20.6%) 
4 72 (20.9%) 
5 49 (14.2%) 
BMI  
Normal (18.5-24.9) 100 (29.9%) 
Underweight (<18.5) 5 (1.5%) 
Overweight (25 - 30) 125 (37.4%) 
Obese (30+) 104 (31.1%) 
Clinical characteristics 
Number of co-morbidities  
0 59 (17.0%) 
1-2 164 (47.1%) 
3+ 125 (35.9%) 
Cardiovascular disease 140 (45.5%) 
Diabetes 33 (10.7%) 
Gastrointestinal disease 72 (21.8%) 
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Table 4-1 Characteristics of the patients in the occupational sub-
cohort (continued) 
Characteristics 
Patients with COPD in 
paid employment 
n=348 
Cancer 27 (8.7%) 
Depression 74 (24.0%) 
Osteoarthritis 32 (10.5%) 
Rheumatoid arthritis 24 (8.0%) 
Allergies (hayfever, eczema and other) 125 (39.9%) 
MRC score  
1 101 (30.6%) 
2 94 (28.5%) 
3 85 (25.8%) 
4 28 (8.5%) 
5 22 (6.7%) 
CAT score  
<10  58 (21.6%) 
10 - 20 133 (49.4%) 
21-30   64 (23.8%) 
>30  14 (5.2%) 
Disease severity (GOLD stage criteria)  
Mild 117 (34.8%) 
Moderate 171 (50.9%) 
Severe 40 (11.9%) 
Very severe 8 (2.4%) 
Exacerbations in the last 12 months  
0 151 (46.6%) 
1 – 2 127 (39.2%) 
3+ 46 (14.2%) 
Occupational characteristics 
Occupational background (SOC 2010)  
Managers, directors and senior officials 39 (11.6%) 
Professional 41 (12.2%) 
Associate professional and technical 27 (8.0%) 
Administrative and secretarial 36 (10.7%) 
Skilled trade 41 (12.2%) 
Caring, leisure and other services 40 (11.9%) 
Sales and customer service 17 (5.0%) 
Process, plant and machine operatives 43 (12.8%) 
Elementary 53 (15.7%) 
Exposures to VGDF  
None 154 (45.7%) 
Low 114 (33.8%) 
Medium 54 (16.0%) 
High 15 (4.5%) 
Employment status*  
Employed 72 (79.1%) 
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Table 4-1 Characteristics of the patients in the occupational sub-
cohort (continued) 
Characteristics 
Patients with COPD in 
paid employment 
n=348 
Working hours  
Full time (>37 hours) 161 (54.6%) 
Part time (<37 hours) 134 (45.4%) 
Job involving walking/standing  
Never/rarely 58 (17.7%) 
Sometimes 89 (27.1%) 
Usually/always 181 (55.2%) 
Job involving manual/physical work  
Never/rarely 140 (42.7%) 
Sometimes 116 (35.4%) 
Usually/always 72 (22.0%) 
Job satisfaction score quartiles  
1 76 (27.1%) 
2 82 (29.3%) 
3 53 (18.9%) 
4 69 (24.6%) 
Training received at work  in previous 12m  
 0 days to <1 day 184 (57.7%) 
1 to <2 days 27 (8.5%) 
2 to <5 days 56 (17.6%) 
>5 days 52 (16.3%) 
Supervise other employees  
No 220 (67.7%) 
Yes 105 (32.3%) 
Work pattern  
Regular daytime schedule 234 (71.8%) 
Regular evening shift 10 (3.1%) 
Regular night shift 7 (2.2%) 
Rotating shift 36 (11.0%) 
Another schedule 39 (12.0%) 
Type of contract  
Permanent 281 (85.7%) 
Temporary – with no agreed end date 39 (11.9%) 
Fixed period – with an agreed end date 8 (2.4%) 
Length of current employment  
<  5 years 79 (24.1%) 
5 – 10 years 63 (19.3%) 
>10 years 185 (56.6%) 
      *subset of patients completed information on employment type 
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4.4.2 Absenteeism  
Absenteeism data were available on 270 (77.6%) of the occupational sub-sample. 
Overall 44.3% (n=154) reported >1 day off work in the previous 12 months, of whom 
59 (17.0%) reported COPD related absenteeism. Among those with reported 
absenteeism, days off work ranged from 1 to 365; mean (SD) and median (IQR) days 
off were 27.9 (63.9) and 7 (3 to 21). The mean (SD) and median (IQR) days off work 
in the total working population with complete data (n=270) were 10.4 (41.3) and 0 (0 
to 4) respectively. 216 had low levels of absenteeism (0 to 5 days) and 54 (16.7%) 
high absenteeism (>6 days). 
4.4.3 Presenteeism  
There were 301/348 (86.5%) patients with data on presenteeism. The mean (SD) 
and median (IQR) SPS-6 scores were 23.5 (5.0) and 24.0 (19 to 28), respectively. 77 
patients were categorised as having little/no presenteeism and 82 patients as high 
presenteeism (poor work performance).  
4.4.4 Relationship between absenteeism and presenteeism 
The two measures were weakly correlated (r= -0.14; p=0.03). Categorised data 
(Table 4-2) showed that approximately 34% (n=85) of patients might be considered 
as non-concordant i.e. although 13% had high sickness absence, when at work they 
functioned well; whereas 21% had poor work performance, but had little or no time 
off work.  
 
 
Table 4-2 Relationship between absenteeism and presenteeism 
 Low presenteeism 
(SPS-6 score >20) 
High presenteeism 
(SPS-6 score <19) 
Low sickness absence 
(0 to 5 days) 
148 (59.4%) 52 (20.9%) 
High sickness absence 
(> 6 days) 
33 (13.3%) 16 (6.4%) 
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4.4.5 Factors associated with absenteeism 
There was a tendency for high all-cause absenteeism to be more common among 
women, ever smokers and those with lower income levels, although none of these 
trends were statistically significant (Table 4-3). High sickness absence was more 
common in those with ≥1 comorbidity, and there were positive dose-response 
relationships with increasing breathlessness (p for trend<0.01); increasing CAT score 
(poorer quality of life) (p for trend=0.08); increasing airflow obstruction (p for 
trend=0.38) and increasing number of exacerbations (p for trend<0.01). 
Those with a professional occupational background, with occupations which 
always/usually involved walking/standing and length of employment >5 years were 
more likely to report high levels of absenteeism, although effects were not statistically 
significant.  
There was no apparent relationship between occupational exposures to VGDF or job 
satisfaction and absenteeism.  
After adjustment for covariates, only increasing levels of breathlessness was 
significantly associated with higher levels of absenteeism (p for trend<0.01) (Table 
4-3). No trend was found between absenteeism and airflow obstruction or any other 
clinical or occupational factors. 
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4.4.5.1 Additional analyses 
Irrespective of the cut-off points used to denote high absenteeism, the overall 
patterns of associations remained, with increasing dyspnoea being the only 
statistically significant feature associated with high absenteeism levels. The patterns 
also remained when considering COPD-related absenteeism, however the 
relationship with airflow obstruction (severe to very severe adjusted OR=3.92; 95% 
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(95% CI) for risk of 
high absenteeism 
Adjusted ORs* (95% 
CI) for risk of high 
absenteeism 
Sex    
Male (%) 29 (17.1%) 1.0 1.0 
Female (%) 25 (25.0%) 1.62 (0.89 – 2.96) 1.39 (0.62 – 3.10) 
Age categories    
38 – 49 3 (10.7%) 1.0 1.0 
50 – 59 25 (26.9%) 3.06 (0.85 – 11.04) 4.66 (0.88 – 24.75) 
60 - 64 11 (17.2%) 1.73 (0.44 – 6.75) 2.20 (0.37 – 12.97) 
>65 15 (17.7%) 1.79 (1.48 – 6.69) 2.91 (0.51 – 16.71) 
Smoking status    
Never smoked 2 (10.0%) 1.0 1.0 
Ever smoker 50 (21.3%) 2.43 (0.55 – 10.84) 2.33 (0.40 – 13.76) 
Education level   
 
Degree or higher level 10 (23.8%) 1.0 
A level/AS level or equivalent 6 (33.3%) 1.60 (0.48 – 5.37) 
GCSE, CSE, O level or equivalent 12 (16.7%) 0.64 (0.25 – 1.64) 
No formal qualification 19 (24.4%) 1.03 (0.43 – 2.48) 
Gross income (before tax)   
£28081 – £45241> 8 (13.8%) 1.0 
£18721 - £28080 10 (20.8%) 1.64 (0.59 – 4.57) 
£9361 - £18720 10 (15.9%) 1.18 (0.43 – 3.28) 
<£2600 - £9360 13 (25.5%) 2.14 (0.81 – 5.68) 
Prefer not to say 10 (27.0%) - 
IMD score quintiles   
1 7 (12.1%) 1.0 1.0 
2 12 (20.3%) 1.86 (0.68 – 5.12) 1.43 (0.43 – 4.81) 
3 13 (22.4%) 2.10 (0.77 – 5.74) 1.72 (0.53 – 5.53) 
4 13 (21.1%) 1.94 (0.70 – 5.36) 0.89 (0.25 – 3.24) 
5 10 (28.6%) 2.91 (0.99 – 8.56) 2.20 (0.57 – 8.49) 
BMI   
 
Normal (18.5-24.9) 16 (20.8%) 1.0 
Underweight (<18.5) 0 (0%) 0 
Overweight (25 - 30) 25 (23.6%) 1.18 (0.58 – 2.39) 
Obese (30+) 13 (16.7%) 0.77 (0.34 – 1.72) 
Clinical characteristics 
Number of co-morbidities    
0 3 (6.7%) 1.0 1.0 
1+ 51 (22.7%) 4.10 (1.22 – 13.79) 2.91 (0.74 – 11.41) 
Cardiovascular disease 29 (25.7%) 1.92 (1.01 – 3.62) 
 
Diabetes 5 (19.2%) 0.97 (0.35 – 2.73) 
Gastrointestinal disease 12 (23.5%) 1.32 (0.63 – 2.74) 
Cancer 6 (26.1%) 1.49 (0.55 – 3.99) 
 
Table 4-3 Association between socio-demographic, clinical and occupational characteristics and risk of 
high absenteeism among COPD patients 
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Table 4-3 Association between socio-demographic, clinical and occupational characteristics and risk of high 







(95% CI) for risk of 
high absenteeism 
Adjusted ORs* (95% 
CI) for risk of high 
absenteeism 
Depression 15 (26.3%) 1.61 (0.80 – 3.23) 
 
Osteoarthritis 5 (20.0%) 1.01 (0.36 – 2.85) 
Rheumatoid arthritis 3 (21.4%) 1.21 (0.30 – 4.19) 
Allergies (hayfever, eczema and other) 22 (45.8%) 1.38 (0.73 – 2.61) 
MRC Dyspnoea score   
1 13 (15.5%) 1.0 1.0 
2 6 (17.5%) 0.44 (0.16 – 1.23) 0.57 (0.17 – 1.88) 
3 16 (23.9%) 1.71 (0.76 – 3.87) 2.33 (0.86 – 6.32) 
4 - 5 17 (54.8%) 6.63 (2.64 – 16.67) 9.04 (2.85 – 28.68) 
CAT score   
 
Low (high QOL) 7 (14.3%) 1.0 
Medium 25 (23.4%) 1.83 (0.73 – 4.58) 
High   16 (27.5%) 2.27 (0.89 – 6.23) 
Very high (poor QOL) 2 (40.0%) 4.0 (0.56 – 28.40) 
Severity of airflow obstruction (GOLD stage 
criteria)   
Mild 16 (17.2%) 1.0 1.0 
Moderate 27 (20.0%) 1.20 (0.61 – 2.38) 0.89 (0.37 – 2.12) 
Severe to very severe 8 (24.2%) 1.54 (0.59 – 4.03) 1.17 (0.36 – 3.80) 
Exacerbations in the last 12 months   
 
0 9 (7.0%) 1.0 
1 – 2 32 (32.7%) 6.46 (2.91 – 14.36) 
3+ 11 (36.7%) 7.72 (2.83 – 21.09) 
Occupational characteristics 
Occupational background (SOC 2010)   
 
Managers, directors and senior officials 7 (21.2%) 1.0 
Professional 9 (26.5%) 1.34 (0.43 – 4.14) 
Associate professional and technical 6 (24.0%) 1.17 (0.34 – 4.06) 
Administrative and secretarial 5 (17.9%) 0.81 (0.23 – 2.90) 
Skilled trade 7 (22.6%) 1.08 (0.33 – 3.54) 
Caring, leisure and other services 5 (17.9%) 0.81 (0.23 – 2.90) 
Sales and customer service 2 (16.7%) 0.74 (0.13 – 4.20) 
Process, plant and machine operatives 5 (15.2%) 0.66 (0.19 – 2.35) 
Elementary 7 (17.1%) 0.76 (0.24 – 2.45) 
Exposures to VGDF   
None 26 (20.8%) 1.0 1.0 
Low 16 (18.2%) 0.85 (0.42 – 1.69) 1.15 (0.49 – 2.73) 
Medium to high 11 (21.2%) 1.02 (0.46 – 2.26) 1.27 (0.45 – 3.54) 
Employment status**   
 Employed 11 (23.4%) 1.0 
Self-employed 4 (26.7%) 1.19 (0.33 – 4.28) 
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Table 4-3 Association between socio-demographic, clinical and occupational characteristics and risk of high 







(95% CI) for risk of 
high absenteeism 
Adjusted ORs* (95% 
CI) for risk of high 
absenteeism 
Working hours   
 
Full time (>37 hours) 25 (19.2%) 1.0 
Part time (<37 hours) 22 (20.2%) 1.06 (0.56 – 2.01) 
Job involving walking/standing   
Never/rarely 8 (16.7%) 1.0 
Sometimes 13 (19.4%) 1.20 (0.46 – 3.18) 
Usually/always 33 (21.9%) 1.40 (0.60 – 3.28) 
Job involving manual/physical work   
Never/rarely 25 (21.6%) 1.0 
Sometimes 17 (18.9%) 0.85 (0.43 – 1.69) 
Usually/always 12 (20.0%) 0.91 (0.42 – 1.97) 
Job satisfaction score quartiles   
1 11 (19.0%) 1.0 
2 12 (17.1%) 0.88 (0.36 – 2.18) 
3 9 (19.6%) 1.03 (0.39 – 2.77) 
4 12 (22.2%) 1.22 (0.49 – 3.06) 
Training received at work  in previous 12m   
 0 days to <1 day 27 (18.4%) 1.0 
1 to <2 days 5 (23.8%) 1.39 (0.47 – 4.12) 
2 to <5 days 8 (18.2%) 0.99 (0.41 – 2.36) 
>5 days 11 (23.4%) 1.36 (0.61 – 3.00) 
Supervise other employees   
No 38 (21.6%) 1.0 
Yes 16 (18.6%) 0.83 (0.43 – 1.59) 
Work pattern   
Regular daytime schedule 43 (22.8%) 1.0 
Regular evening shift 1 (12.5%) 0.49 (0.06 – 4.05) 
Regular night shift 0 (0%) 0 
Rotating shift 5 (17.2%) 0.71 (0.25 – 1.97) 
Another schedule 4 (12.1%) 0.48 (0.16 – 1.41) 
Type of contract   
Permanent 49 (21.5%) 1.0 
Temporary – with no agreed end date 3 (9.4%) 0.38 (0.11 – 1.29) 
Fixed period – with an agreed end date 2 (33.3 %) 1.83 (0.32 – 10.27) 
Length of employment   
< 5 years 10 (17.5%) 1.0 
>5 years 44 (21.2%) 1.26 (0.59 – 2.69) 
*Adjusted for: age, sex, smoking status, social deprivation (IMD score), number of co-morbidities, MRC score, airflow 
obstruction and occupational exposures to VGDF 
**subset of patients completed information on employment type 
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4.4.6 Factors associated with presenteeism  
In unadjusted analyses, there were non-significant trends towards higher 
presenteeism (poorer work performance) among current smokers, those with a lower 
educational level, a lower income, a higher deprivation score, those who were 
overweight or obese and those with ≥1 comorbidity (OR=1.53; 95% CI 0.67 – 3.49). 
Increasing breathlessness (p for trend<0.01), increasing CAT score (lower QoL (p for 
trend<0.01) and increasing number of exacerbations (p for trend<0.05) were all 
associated with poor work performance (Table 4-4).  
Patients with an elementary or caring/leisure/other services occupational background 
were significantly more likely to report poor work performance compared to 
managers/directors/senior officials. Those with jobs which usually/always required 
walking/standing or manual/physical work were more likely to report poor work 
performance (although associations were not statistically significant). A positive 
dose-response relationship was noted between increasing exposure to VGDF and 
increased probability of reporting poor work performance (p for trend<0.01).  
After adjustment for covariates, increasing breathlessness (p for trend<0.01) and 
increasing exposures to VGDF (p for trend<0.01) remained independently associated 
with poor work performance. The presence of co-morbidities and current smokers 
increased risk of reporting poor work performance, although these effects did not 
reach significance.  
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4.4.6.1 Additional analyses 
In the analyses focussing on the effect of the two alternative cut off points to denote 
poor work performance (SPS-6 score: <18 and <24) the overall patterns remained 
the same, although not all were significant.  
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Number (%) with poor 
work performance 
(SPS-6 score <19) 
n=82 
Unadjusted ORs 
(95% CI) for risk of 
having poorer work 
performance 
Adjusted ORs* (95% 
CI) for risk of having 
poorer work 
performance 
Sex    
Female (%) 28 (48.3%) 1.0 1.0 
Male (%) 54 (53.5%) 1.23 (0.65 – 2.35) 0.71 (0.28 – 1.81) 
Age categories:    
38 – 49 10 (52.6%) 1.0 1.0 
50 – 59 27 (49.1%) 0.87 (0.31 – 2.47) 0.36 (0.08 – 1.68) 
60 - 64 18 (56.3%) 1.16 (0.37 – 3.62) 1.15 (0.22 – 6.11) 
>65 27 (50.9%) 0.93 (0.33 – 2.67) 0.41 (0.08 – 2.12) 
Smoking status    
Never smoked 6 (42.9%) 1.0 1.0 
Ex-smoker 39 (47.0%) 1.18 (0.38 – 3.71) 2.28 (0.44 – 11.69) 
Current smoker 32 (60.4%) 2.03 (0.62 – 6.70) 3.39 (0.64 – 17.99) 
Education level   
 
Degree or higher level 13 (50.0%) 1.0 
A level/AS level or equivalent 3 (20.0%) 0.25 (0.06 – 1.10) 
GCSE, CSE, O level or equivalent 21 (52.5%) 1.11 (0.41 – 2.97) 
No formal qualification 26 (59.1%) 1.44 (0.54 – 3.83) 
Gross income (before tax)   
£28081-£45241+ 12 (38.7%) 1.0 
£18721-£28080  17 (60.7%) 2.45 (0.86 – 6.98) 
£9361-£18720 17 (60.7%) 2.45 (0.86 – 6.98) 
<£2600-£9360 20 (52.6%) 1.76 (0.67 – 4.61) 
Prefer not to say 12 (44.4%) - 
IMD score quintiles   
1 13 (35.1%) 1.0 1.0 
2 21 (52.5%) 2.04 (0.82 – 5.10) 2.56 (0.76 – 8.63) 
3 20 (60.6%) 2.84 (1.08 – 7.51) 3.01 (0.85 – 10.68) 
4 16 (55.2%) 2.27 (0.84 – 6.15) 2.15 (0.54 – 8.54) 
5 11 (57.9%) 2.54 (0.82 – 7.89) 2.22 (0.45 – 11.00) 
BMI   
 
Normal (18.5-24.9) 24 (48.0%) 1.0 
Underweight (<18.5) 0 (0%) 0 
Overweight (25 - 30) 27 (51.9%) 1.17 (0.54 – 2.54) 
Obese (30+) 28 (54.9%) 1.32 (0.60 – 2.88) 
Clinical characteristics 
Number of co-morbidities    
0 12 (42.9%) 1.0 1.0 
1+ 70 (53.4%) 1.53 (0.67 – 3.49) 2.15 (0.67 – 6.86) 






Diabetes 6 (42.9%) 0.75 (0.25 – 2.28) 
Gastrointestinal disease 13 (50.0%) 0.97 (0.42 – 2.25) 
Cancer 9 (64.3%) 1.94 (0.62 – 6.10) 
 
Table 4-4 Association between socio-demographic, clinical and occupational characteristics and risk of 
poor work performance among COPD patients 
CHAPTER 4: THE ASSOCIATION BETWEEN COPD AND WORK PRODUCTIVITY: A CROSS SECTIONAL ANALYSIS OF 
DATA FROM THE BIRMINGHAM COPD COHORT 
121 
 
Table 4-4 Association between socio-demographic, clinical and occupational characteristics and risk of poor 
work performance among COPD patients (continued) 
Characteristics 
Number (%) with poor 
work performance 
(SPS-6 score <19) 
n=82 
Unadjusted ORs 
(95% CI) for risk of 
having poorer work 
performance 
Adjusted ORs* (95% 
CI) for risk of having 
poorer work 
performance 
Depression 15 (57.7%) 1.54 (0.65 – 3.63) 
 
Osteoarthritis 5 (41.7%) 0.71 (0.22 – 2.37) 
Rheumatoid arthritis 8 (80.0%) 4.58 (0.94 – 22.38) 
Allergies (hayfever, eczema and other) 30 (41.1%) 0.79 (0.38 – 1.68) 
MRC   
1 20 (40.8%) 1.0 1.0 
2 15 (34.9%) 0.78 (0.33 – 1.81) 0.83 (0.28 – 2.48) 
3 21 (55.3%) 1.79 (0.76 – 4.22) 2.65 (0.88 – 7.95) 
4 - 5 23 (92.0%) 16.67 (3.53 – 78.81) 18.11 (2.93 – 112.21) 
CAT score   
 
Low (high QOL) 12 (31.6%) 1.0 
Medium 26 (47.3%) 1.94 (0.82 – 4.61) 
High – very high (poor QOL) 24 (80.0%) 8.67 (0.82 – 4.61) 
Severity of airflow obstruction (GOLD 
stage criteria)   
Mild 23 (45.1%) 1.0 1.0 
Moderate 46 (56.8%) 1.60 (0.79 – 3.24) 1.08 (0.40 – 2.90) 
Severe – very severe 11 (50.0%) 1.22 (0.45 – 3.31) 1.03 (0.26 – 4.09) 
Exacerbations in the last 12 months   
 
0 35 (44.9%) 1.0 
1 – 2 24 (48.0%) 1.13 (0.56 – 2.31) 
3+ 18 (78.3%) 4.42 (1.49 – 13.11) 
Occupational characteristics 
Occupational background (SOC 2010)   
 
Managers, directors and senior officials 6 (33.3%) 1.0 
Professional 9 (47.4%) 1.8 (0.48 – 6.81) 
Associate professional and technical 3 (25.0%) 0.67 (0.13 – 3.41) 
Administrative and secretarial 7 (58.3%) 2.8 (0.62 – 12.67) 
Skilled trade 14 (58.3%) 2.8 (0.78 – 9.99) 
Caring, leisure and other services 14 (70.0%) 4.67 (1.19 – 18.35) 
Sales and customer service 4 (30.8%) 0.89 (0.19 – 4.11) 
Process, plant and machine operatives 8 (57.1%) 2.67 (0.63 – 11.28) 
Elementary 17 (68.0%) 4.25 (1.17 – 15.45) 
Exposures to VGDF   
None 27 (38.6%) 1.0 1.0 
Low 34 (60.7%) 2.46 (1.20 – 5.06) 3.50 (1.25 – 9.79) 
Medium to high 21 (67.7%) 3.34 (1.37 – 8.17) 4.34 (1.26 – 14.93) 
Employment status**   
 Employed 14 (56.0%) 1.0 
Self-employed 5 (50.0%) 0.96 (0.20 – 4.54) 
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Table 4-4 Association between socio-demographic, clinical and occupational characteristics and risk of poor 
work performance among COPD patients (continued) 
Baseline characteristics 
Number (%) with poor 
work performance 
(SPS-6 score <19) 
n=82 
Unadjusted ORs 
(95% CI) for risk of 
having poorer work 
performance 
Adjusted ORs* (95% 
CI) for risk of having 
poorer work 
performance 
Working hours   
 
Full time (>37 hours) 36 (52.2%) 1.0 
Part time (<37 hours) 39 (54.9%) 1.12 (0.57 – 2.17) 
Job involving walking/standing   
Never/rarely 11 (42.3%) 1.0 
Sometimes 18 (46.2%) 1.17 (0.43 – 3.18) 
Usually/always 52 (57.8%) 1.87 (0.77 – 4.51) 
Job involving manual/physical work   
Never/rarely 32 (48.5%) 1.0 
Sometimes 30 (53.6%) 1.23 (0.61 – 2.50) 
Usually/always 19 (57.6%) 1.44 (0.62 – 3.35) 
Job satisfaction score quartiles   
1 18 (60.0%) 1.0 
2 19 (47.5%) 0.60 (0.23 – 1.57) 
3 16 (66.7%) 1.33 (0.44 – 4.09) 
4 22 (51.2%) 0.70 (0.27 – 1.80) 
Training received at work  in previous 
12m   
 0 days to <1 day 41 (48.8%) 1.0 
1 to <2 days 7 (70.0%) 2.45 (0.59 – 10.11) 
2 to <5 days 20 (64.5%) 1.91 (0.81 – 4.47) 
>5 days 13 (50.0%) 1.05 (0.44 – 2.53) 
Supervise other employees   
No 52 (51.5%) 1.0 
Yes 28 (52.8%) 1.06 (0.54 – 2.05) 
Work pattern   
Regular daytime schedule 62 (54.4%) 1.0 
Regular evening shift 3 (50.0%) 0.84 (0.16 – 4.33) 
Regular night shift 0 (0%) 0 
Rotating shift 5 (45.5%) 0.70 (0.20 – 2.42) 
Another schedule 10 (52.6%) 0.93 (0.35 – 2.47) 
Type of contract   
Permanent 69 (52.3%) 1.0 
Temporary – with no agreed end date 9 (47.4%) 0.82 (0.32 – 2.15) 
Fixed period – with an agreed end date 3 (75.0%) 2.74 (0.28 – 27.02) 
Length of employment in current 
workplace   
< 5 years 26 (61.9%) 1.0 1.0 
>5 years 55 (48.7%) 0.58 (0.28 – 1.20) 0.45 (0.15 – 1.29) 
*Adjusted for: age, sex, smoking status, social deprivation (IMD score), number of co-morbidities, MRC score, airflow 
obstruction, occupational exposures to VGDF and length of employment 
**subset of patients completed information on employment type
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4.5 Discussion  
4.5.1 Key results 
In this primary care working COPD population with predominantly mild to moderate 
airflow obstruction, there were relatively high rates of absenteeism, with over one in 
six patients (17.6%) reporting ≥6 days sickness absence over the previous 12 
months. Whilst absenteeism was high, we found low presenteeism rates, suggesting 
that when at work, COPD patients are generally functioning well.  
Both absenteeism and presenteeism were more common with greater levels of self-
reported breathlessness. Although there was no significant association with other 
socio-demographic or clinical characteristics and all-cause absenteeism, being 
female and increased severity of airflow obstruction were additional factors 
associated with COPD related sickness absence. Occupational related factors were 
not associated with absenteeism, whereas there was a clear association between 
higher exposures to VGDF and greater presenteeism.   
A large number of patients (~35%) reported only high absenteeism or high 
presenteeism; demonstrating the importance of using both outcome measures in 
identifying patients with poor work productivity. 
4.5.2 Findings in relation to other studies 
The finding that on average, patients with COPD had taken 10.4 days sick leave in 
the previous 12 months (compared with the national average of 4.4 days125), is in 
keeping with findings from other studies that show that patients with COPD have 
higher rates of absenteeism.107;108;111;112;116;164 
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Conversely, the results of this study indicate that on average, COPD in the primary 
care population has little impact on work performance when comparing the average 
SPS-6 presenteeism score (mean (SD) 23.5 (5.0)) to employees reporting no 
disability (mean score (SD): 23.5 (3.8)),93 those with arthritis (mean SPS-6 score 
(SD) 13.3 (5.2))191 and employees within the medical profession (mean SPS-6 score: 
17.3).192 Furthermore, data among those with cystic fibrosis suggests other 
respiratory disease has little impact on work performance (mean SPS-6 score 
25.1).193  
However, patients with more severe dyspnoea do experience more presenteeism. 
The observed relationship between increasing dyspnoea and absenteeism and 
presenteeism confirm similar findings reported in a large international cross-sectional 
survey.22 Although there are conflicting results from other studies on the association 
between airflow obstruction and absenteeism,118;152;158;160-162;165 our findings confirm a 
significant relationship between increasing airflow obstruction and COPD related 
absenteeism, but not all-cause absenteeism. 
Other studies have reported that the presence of co-morbidities and smoking are 
associated with poor work productivity in the general population,116;186;194-196 in those 
with health conditions194;197-199 and amongst patients with COPD.119;200 Whilst both 
absenteeism and presenteeism findings showed similar trends, the results were not 
statistically significant.  
Clear associations between exposure to VGDF and absenteeism (respiratory related) 
have been demonstrated among an asthmatic population (OR=1.96; 95% CI 1.06 – 
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3.64), and those with respiratory symptoms (OR=2.20; 95% CI 1.01 – 4.77).201 This 
was not observed in this study sample, although the wide CIs suggest there may not 
have been sufficient power to detect any effects. In contrast, we found that increasing 
exposure to VGDF was associated with greater presenteeism, which has not been 
previously reported in patients with COPD. A number of other occupational 
characteristics (such as job satisfaction, working hours, lack of supportive work 
culture and size of organisation) have been shown to be associated with work 
productivity in other studies.121-123 These associations were not observed in this 
sample, possibly due to the limited sample size, or the cross-sectional nature of the 
study. 
Research suggests that although there is a strong association between sickness 
absence and presenteeism, presenteeism may be a stronger predictor of poor health 
compared to absenteeism,121 and therefore, may better measure the health of 
employees; lending to suggest that the two measure different facets of work 
productivity.  However, within this emerging field of research, confusingly the terms 
presenteeism (measure of work performance) and sickness presenteeism (work 
attendance when ill) have been used inter-changeably.121;202-204 This, in addition to 
the heterogeneous evidence (e.g. various instruments measuring presenteeism) and 
varying definitions of presenteeism, reduces the clarity of the relationship between 
the two measures. This analysis demonstrated that although there is a correlation 
between absenteeism and presenteeism, measuring absenteeism alone does not 
capture all patients with high presenteeism; approximately 1/5 of patients had poor 
work performance but there was limited impact on sickness absence. 
CHAPTER 4: THE ASSOCIATION BETWEEN COPD AND WORK PRODUCTIVITY: A CROSS SECTIONAL ANALYSIS OF 
DATA FROM THE BIRMINGHAM COPD COHORT 
126 
 
4.5.3 Strengths and limitations 
This is the first study internationally to assess the impact of COPD on work 
productivity in a primary care population mainly with mild to moderate COPD, and to 
assess factors that contribute to poor work performance. Participants included those 
from a wide range of backgrounds and occupations, with mainly mild to moderate 
COPD. The study also has limitations. There were a high number of never smokers 
in this group of patients; hence, other respiratory conditions within this population, 
such as chronic asthma, cannot be excluded. The cross-sectional nature precludes 
the ability to draw inferences on causality. Whilst compared to other studies, this 
study included a large sample of patients, the wide confidence intervals for a number 
of estimates indicate that there was insufficient power to clarify associations. For 
example, whilst there was a trend towards poorer work productivity among those with 
a greater number of co-morbidities or lifestyle behaviours (smoking), the relationships 
were not statistically significant. Factors such as income and exacerbations 
(absenteeism model only) were important in the unadjusted analyses, however, as 
they are susceptible to reverse causation they were not included in the fully adjusted 
models. 
Sickness absence rates were based on self-report; which are susceptible to under-
reporting due to recall error205 and social desirability bias84; hence, the effect 
estimates may not accurately reflect the true impact of COPD on absenteeism. Some 
other covariates were also based on self-report e.g. number of co-morbidities; 
possibly introducing errors in prevalence rates and diluting the findings. Additionally, 
there was a low response rate for number of days off work and some other measures 
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(e.g. smoking status and job satisfaction), which may have led to less reliable 
estimates. Evidence suggests that employment type (employed/self-employed) is 
associated with sickness absence,125;203 however this measure was only completed 
in a subset of patients and therefore had limited power in the final analyses.  
4.5.4 Implications for practice and research 
Some important and potentially modifiable clinical differences were identified. Firstly, 
breathlessness was identified in both analyses. It is therefore suggested to 
healthcare professionals to work alongside patients and focus on improving the 
management of breathlessness in COPD working patients. The UK NICE guidelines 
for COPD provide guidance for healthcare professionals on the management of 
breathlessness.25 In the workplace, patients may want to consider assessing aspects 
of their job role which may exacerbate their breathlessness, for example tasks 
involving lifting and bending. It may be beneficial to conduct this assessment with 
occupational health (OH) services, who are better equipped to provide solutions to 
symptom management. OH services may also consider oxygen therapy; which may 
play a role in reducing breathlessness amongst patients who experience desaturation 
on physical activity.    
Increasing exposures to VGDF was the second modifiable factor we identified; it is 
suggested that employees undergo an OH assessment to determine the level of 
exposure to VGDF in their working environment. OH services can advise accordingly 
on how those in jobs with exposures to VGDF may be able to modify their job role, 
job tasks or working environment to reduce exposure. It is suggested for all 
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employees to receive an occupational risk assessment and potentially benefit from 
reductions in workplace exposures to VGDF. 
Additionally, it is suggested that healthcare professionals identify current smokers 
and provide clear guidance on the benefits of smoking cessation, and the various 
options available. This advice would help patients manage their breathlessness and 
prevent the occurrence of exacerbations. 
There is a need for prospective longitudinal studies to establish the temporal 
relationships between disease severity, occupational exposures to VGDF and work 
productivity. Further research to determine the effectiveness of managing 
breathlessness and reducing workplace exposures on the work productivity among 
patients with COPD is also recommended. 
There is a risk of misinterpreting populations to have better health when assessing 
the impact on sickness absence alone.121 Furthermore, presenteeism may be more 
costly to employers than absenteeism alone,86;186 and so it is suggested that future 
research assesses the impact on presenteeism in addition to absenteeism for a 
holistic assessment of the effect on work productivity. 
In conclusion, patients with COPD are affected in the working environment and on 
average, take more time off work in a year than the general population. We found a 
number of modifiable factors associated with poorer work productivity and therefore it 
is suggested that future interventions focus on improving the management of 
breathlessness and reducing workplace exposures to VGDF to help improve 
sickness absence rates and work performance in those with COPD.  
  
   
5.  FEASIBILITY OF DELIVERING AN 
OCCUPATIONAL HEALTH INTERVENTION AIMED 
AT IMPROVING WORK PRODUCTIVITY, AMONG 
WORKING COPD PATIENTS  
 
5.1 Abstract 
Background There is evidence that COPD patients have poorer working outcomes 
than those without COPD. Occupational health (OH) interventions have been 
effective in improving work productivity in other chronic conditions. However, little is 
known about the feasibility and acceptability of such interventions among those with 
COPD. 
Methods Nested within a primary care COPD cohort (n=1889), the study included all 
those who were in work (n=309). Eligible patients were invited for an assessment 
with an OH practitioner. The aim was to explore and identify workplace factors that 
may contribute to their work performance or exacerbate their condition, and to 
suggest approaches to minimise any respiratory symptoms and improve work 
capability. Patient’s self-management practices were also assessed. 
Recommendations were sent to the patient, and with their permission, to their GP 
and employer. Qualitative interviews (n=19) were conducted to explore the 
acceptability of the intervention among those who took part in the study as well as 
those who did not.  
Results Of those eligible, 35 (11.3%) agreed to take part, 109 (35.3%) declined and 
153 (49.5%) did not respond. Barriers to taking part in the study included: patients 
CHAPTER 5: FEASIBILITY OF DELIVERING AN OCCUPATIONAL HEALTH INTERVENTION AIMED AT IMPROVING WORK 




reporting they are fine at work; lack of time; concern about employer involvement; 
travel/distance to assessment and negative patient perceptions or attitudes towards 
COPD. Most (80.0%) participating patients received OH recommendations and all 
received self-management recommendations. The most common OH 
recommendations included modifications to job tasks/work methods/physical aspects 
of the job and to seek OH advice and education. However, only half reported to be 
likely to take up the OH recommendations. Qualitative interviews were conducted in 
those taking part in the intervention as well as those who did not; in which the 
acceptability of the intervention was explored and future considerations for OH 
assessments were discussed.  
Conclusions This is the first study to assess the feasibility of delivering an OH 
intervention to patients with COPD working in diverse occupations. Uptake rates 
were very low. Although modifiable factors in the work environment that could 
improve their symptoms and condition were identified for the majority who were 
assessed, only half would be likely to take these up. The current format of the study 
was identified as unsuccessful; however from the results we are able to provide 
direction for future interventions to encourage an improved uptake rate and a holistic 
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5.2.1 COPD and work 
There is increasing evidence that being in work is good for physical and mental 
health and wellbeing.1 Being in work provides a feeling of self-worth1 and has 
economic advantages for both the individual and society. In contrast, being out of 
work may be harmful with increased risk of premature mortality and poorer mental 
health outcomes.3;206 Similarly, following illness or disability, there is evidence that 
remaining in or returning to work is therapeutic, promotes recovery and rehabilitation 
and is associated with better health outcomes for patients.2;10 However, despite the 
beneficial impacts of working on health, as discussed in the preceding chapters, 
COPD affects a number of work-related outcomes, including employment, 
absenteeism and presenteeism.  
5.2.2 Government intervention to improve work-related outcomes 
In 2008, the Black report – focusing on tackling work-related issues (e.g. sickness 
absence and return to work) among the working age population – challenged 
prevalent views that “it is inappropriate to be at work unless 100% fit and that being 
at work normally impedes recovery”.1 It recognised that an all-inclusive shift in 
attitude is required among employees, employers and GPs; focussing on what the 
individual is able to do as opposed to what they are unable to do.1;10 GPs are usually 
the first point of contact for those who are unwell, and they often act as the 
gatekeepers to incapacity benefits.207 However, they often feel “ill-equipped” to offer 
work-related advice.1   
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The Government’s response to this report included setting out a plan to change 
perspectives on ‘health and work’, which included the introduction of the fit note (from 
the former sick note): promoting the idea that “being in work is good for health” by 
helping GPs switch their focus to the individual’s capacity,10 helping to improve 
communication between all stakeholders and promoting workplace adaptions. The 
strategy also incorporated a National Education Programme for GPs to address the 
concerns of GPs by helping to improve their knowledge, confidence and skills for 
work-related advice.10 Subsequent to the introduction of the fit note, in 2010, some 
promising outcomes have been noted which include positive GP attitudes and 
improved GP consultations for patients.208 There are also suggestive trends of an 
increase in GPs providing advice for workplace adjustments as well as reductions in 
certified sickness absence (although not all were significant).209 
Whilst there is increasing research to test methods of improving employment 
outcomes, a gap remains in the evidence on how remaining or returning to work 
maybe best achieved. Thus, there is a need for studies to assess  the effectiveness 
of interventions aimed at improving work related outcomes1 so that successful 
interventions based on well-evaluated and robust evidence can be provided to the 
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5.2.3 Occupational health interventions and interventions to 
improve work related outcomes among patients with COPD and 
those with chronic disease 
Given the impacts of COPD on work and work performance, occupational 
interventions aimed at working COPD patients need to address a number of aspects, 
focusing on improving work capacity and better planning of ill health retirement. As 
patients are at risk of hospitalisation due to COPD exacerbations, interventions 
should also accommodate the possibility of return to work (RTW) which may need to 
be phased. 
Currently there are no UK occupational programmes focusing on improving poor 
work performance for patients with COPD. Furthermore, there is a scarcity of 
research about workplace interventions among working COPD patients. The limited 
research that has been undertaken focuses on particular work settings and how to 
improve work performance in all employees (including those with COPD), rather than 
taking a COPD disease focus and considering common features that impact on work 
in a variety of workplaces. 
The evaluation of a workplace intervention across four factories in Sweden, 
suggested some promising results.210 A workplace intervention, comprising of 
screening, individual feedback and generic self-management advice, targeting those 
with a range of chronic problems, including COPD was implemented. People with 
COPD were offered a clinical examination by occupational health (OH) services, 
including spirometry and if appropriate, advice on smoking cessation and referral to 
rehabilitation and treatment for symptoms. Over three years, they observed a 
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reduction in smoking rates and an improvement in HRQoL among employees in the 
intervention factories, compared to employees in a control company, and some 
reduction in sickness absence. However, the intervention was not targeted at only 
those with COPD, and it is not clear whether the benefits were different for particular 
disease groups. Furthermore, the study was confined to a limited number of 
workplaces which included predominantly male middle aged, blue collar workers, and 
therefore may not be representative of a COPD working population. 
There are examples of interventions to improve work performance in other chronic 
conditions. Occupational intervention studies have been undertaken in relation to 
musculoskeletal disorders,211 neck pain212 or after a major event such as a 
myocardial infarction213;214 or cancer.215;216 Systematic literature reviews and 
randomised controlled trials in these areas identified some evidence of benefit with 
respect to the effect on work outcomes. However, intervention components and 
methods varied widely and some were specific to the particular chronic condition. 
Results from studies were also variable, with conflicting evidence about whether 
interventions were effective in improving occupational performance. For example, a 
systematic review assessing workplace interventions to reduce work disability among 
sick-listed employees found workplace interventions were more effective in improving 
time until first return to work among those with musculoskeletal disorders, but did not 
show a considerable effect among those with mental health conditions.211 In cancer 
patients, multidisciplinary multi-component interventions have been shown to be 
more effective in improving return to work rates, compared to psychological, physical 
activity or medical interventions.215 
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However, a number of common characteristics from successful interventions were 
identified to be effective in both reducing sickness absence rates and improving RTW 
outcomes. First, multi-component interventions (including, for example, self-
management education and workplace adaptations) were consistently shown to be 
more effective than single component interventions.211;215-217 
Another important component included an all-inclusive multi-disciplinary approach 
(e.g. involving employee, employer, supervisor and health care professional) and 
carrying out an individualised assessment of the patient.211;215;217 This is particularly 
evident from Schandelmaier et al’s217 systematic review and meta-analysis, where 
return to work co-ordination programmes (involving a co-ordinator/team who co-
ordinates relevant services and communication among all involved stakeholders) 
showed a consistent positive benefit on working outcomes despite the heterogeneity 
between intervention components.   
Self-management, as part of a multi-disciplinary intervention, through encouragement 
of physical activity (only in some studies, where relevant to the disease), and 
education about the disease appeared to be important components, particularly 
among cancer patients.215;216 A promising component related to the method of patient 
education, was addressing the negative health beliefs and illness perceptions of 
patients; leading to improved RTW rates in myocardial infarction patients.213 
Occupational assessments, which might include assessing the work, working 
conditions and work environment and identifying barriers for returning to work were 
identified as possible important components but not always addressed in 
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research.213;215;216 Ergonomic modifications were particularly important for patients 
with cancer, musculoskeletal disorders and neck pain,211;212;215;216 although these 
types of interventions may have limited relevance for working COPD patients. 
However, an important overarching theme identified from the literature was the need 
to address work related issues, such as assessment of the environment and 
workplace accommodations (shift hours, modified work tasks). OH services support 
and improved communication between employer and health professionals was also 
identified as important, but often deficient in many studies.212;213;215;216 
Chronic conditions which may affect work capability in a similar way to COPD include 
diabetes and asthma. There is some evidence that health promotion interventions 
improve occupational outcomes for diabetic patients,218;219 but there are few studies 
of specific occupational interventions in this patient group. Among the few available 
studies, the main focus of interventions was education about the disease and self-
management with an aim to improve diet and physical activity. In one RCT, disability 
days and working days lost were significantly reduced in the intervention group 
compared to the control group, perhaps mediated by the weight loss achieved by the 
participants.219 From the occupational health perspective, little attention has been 
given within UK national guidance on approaches to managing diabetes in the 
workplace,220 although information from other sources focuses on conducting risk 
assessments (such as risk of hypoglycaemic episodes) and assessing fitness for 
work (e.g. if job tasks can be carried out by the patient safely) in this patient 
group.221;222 Recommendations about specific workplace adjustments for diabetic 
patients appear to be scarce. For asthmatics, a number of workplace asthmagens 
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have been identified which may lead to worsening of symptoms, and guidelines 
advise avoidance of such exposures.223  
One randomised controlled trial assessed the impact of a self-management 
intervention on work absenteeism among individuals with asthma.224 Patients were 
recruited from outpatient clinics. The intervention included individual patient 
education by specialist trained nurses, and physio-therapeutic counselling (breathing 
and relaxation techniques and daily peak flow monitoring) by physiotherapists. The 
study showed a significant reduction in work absence among the intervention 
compared to the control group (relative risk=0.47; 95% CI 0.24 – 0.92), suggesting 
that individualised education with a multidisciplinary approach to empower patients 
about their condition may increase work productivity.224 
Summary: From the available evidence, it appears that few interventions assess 
patients holistically in the work environment. This is important to consider, as a 
number of factors which are disease, as well as non-disease related, may affect an 
individual’s ability to work. Promising intervention components appear to be: a multi-
disciplinary approach; promotion of self-management; considering the effect of the 
work/work environment on disease (workplace triggers); and remediation of any 
factors identified.  
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5.2.4 The impact of COPD on work related outcomes 
As discussed in chapter 1, a number of factors may affect work performance among 
people with COPD. These include the presence of symptoms (e.g. breathlessness, 
fatigue), workplace exposures, poor self-management and the complexities 
associated with managing co-morbidities alongside COPD. These factors may impact 
on work performance in a variety of ways, such as patients avoiding certain work 
tasks, working at a reduced pace or sickness absence induced by the aggravation of 
symptoms. 
Findings from the cross sectional analyses (chapter 3 and chapter 4) identified two 
important factors affecting work related outcomes among patients with COPD. Firstly, 
increased breathlessness was significantly associated with lower employment, higher 
absenteeism and presenteeism. Furthermore, those with high exposures to vapours, 
gases, dusts and fumes (VGDF) in the workplace were less likely to be in work and 
were more likely to experience presenteeism.  
Thus, interventions aiming to improve work productivity among COPD patients need 
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5.3 Aim and rationale for this study 
The aim of this study was to assess the feasibility and acceptability of an 
occupational health assessment (focussing on exploring how the patient’s work may 
impact their lung health) and identification of a suitable personalised intervention(s) 
aimed at improving work productivity, among patients with COPD who are in work. 
The approach developed and used in this study was unique, in that patients were 
approached based on their COPD diagnosis, rather than using a specific workplace 
or workplace exposure(s) to identify them. 
5.4 Study objectives 
A number of objectives were set: 
Feasibility of an OH assessment 
1. To assess the feasibility of identification of patients  
2. To assess the feasibility of delivering an occupational health assessment 
among patient with COPD and their employers 
3. To assess the acceptability of undertaking an occupational health assessment 
among working COPD patients 
Nature and applicability of the recommendations 
4. To assess the range and type of recommendations and workplace 
adjustments identified through an occupational health assessment for patients 
with COPD 
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5. To explore the facilitators and barriers to engagement with any 
recommendations arising from the occupational health assessment amongst 
employers and COPD patients 
6. To assess the acceptability of the identified recommendations and identify 
barriers towards implementation (involving: patients, employers and the 
patient’s GP) 
Measuring the impact of the recommendations 
7. To gain an initial assessment of the effect of the occupational health 
intervention on workability (e.g. presenteeism and absenteeism) 
8. To assess the feasibility of a range of outcome measures that could be used 
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5.5.1 Study setting and participants 
The 3-year Birmingham COPD Cohort study169 recruited COPD patients (n=1889) 
from 71 GP practices within the West Midlands, UK, between June 2012 and July 
2014. Cohort patients consisted of those with an existing COPD diagnosis (from the 
GP COPD register) as well as those who were newly identified to have COPD 
through a related case-finding RCT.170 A number of clinical and physiological 
measures were carried out at baseline. Patients also completed questionnaires at 6 
monthly intervals and returned for a 3 year face-to face assessment. 
This COPE (COPD Occupation and work PErformance) feasibility study – an OH 
intervention among working COPD patients – was nested within the Birmingham 
COPD Cohort study, and is the study which is presented in this chapter.  
The COPE study was undertaken from April 2014 to April 2015. Patient OH visits 
(intervention) took place at the University of Birmingham from May to October 2014, 
the qualitative interviews were conducted between November 2014 and February 
2015 and follow-up data were collected 6 months post OH assessment. 
5.5.2 Identification of eligible patients 
The questionnaires completed at baseline and at 6-monthly intervals in the cohort 
study included occupational measures: patient’s current working status, sickness 
absence and work performance. All patients identified to be in employment in April 
2014 were eligible for the COPE feasibility study. This was determined using their 
most recent questionnaire data. 
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5.5.3 Measures of employment, absenteeism and work performance 
Employment status: Data on employment status was collected at baseline 
(research assistant administered questionnaire); patients self-reported whether they 
were in any current paid employment (full-time or part-time). Any changes to 
employment status were captured in the 6-monthly postal questionnaires. 
COPD related sickness absence: At baseline, patients self-reported any time taken 
off work in the previous 12 months, the duration and the reason for sickness absence 
(i.e. respiratory related, other health problems or other reasons). Patients in work 
were also provided daily diary cards to complete, and return monthly; this involved 
daily documentation of respiratory symptoms and work attendance/absence. 
Reasons for any work absences were provided (i.e. holiday, respiratory related, other 
health problems, scheduled time off or other reasons). 
Presenteeism: The Stanford Presenteeism Scale (SPS-6) was used to assess the 
impact of the patient’s “chest problems” on their work performance over the previous 
month at baseline.93 The scale generates scores between 6 and 30, with a lower 
score indicating poorer work performance (high presenteeism) due to COPD.93   
5.5.4 Inviting eligible patients 
Initially, those whose work performance was most affected were invited to take part. 
To assess this, a combination of measures were used: baseline sickness absence 
(over previous 12 months), baseline presenteeism (SPS-6 questionnaire) and 
prospective sickness absence (using daily diary card data). This involved inviting 
patients with: 1 or more days per year sickness absenteeism for lung disease or, 1 or 
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more days off due to lung disease as collected prospectively from daily diary cards or 
a low presenteeism score.  A low presenteeism score was defined based on a score 
below the lowest quartile in the sample.  
Invitations were initially ordered, so that those further down the list would only be 
invited if the initial groups declined. However, due to the low response rates all cohort 
working patients were eventually invited. 
Patients who had died, withdrawn their participation from the cohort study or 
expressed not to be contacted regarding other studies related to the Birmingham 
COPD Cohort study were not included. 
5.5.5 Patient recruitment 
Eligible patients were sent a patient information sheet (PIS) (appendix 1) with a reply 
slip (appendix 2), detailing the patient’s interest in taking part (yes/no) with the 
opportunity to select from an available list or comment about their personal reason 
for declining participation. Those that did not reply within 2 to 3 weeks were sent a 
reminder which included a one-page brief summary letter (appendix 3) of the COPE 
feasibility study in addition to the PIS. 
Participants who consented were contacted by the researcher (KK) to discuss the 
study in more detail and to arrange an appointment at the University to meet with the 
occupational health (OH) practitioner for an OH assessment. Travel costs for all 
patients were covered by the research team.  
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5.5.6 Sample size 
As this was a feasibility study, no formal sample size calculations were conducted. 
Instead, a pragmatic approach was taken with the aim of recruiting up to 60 patients. 
5.5.7 Intervention 
The intervention consisted of an occupational health assessment, a COPD self-
management assessment and the generation of a number of reports with 
recommendations (related to these assessments) (Figure 5-1). 
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Ask the patient if they are happy 
for the OH practitioner to speak 
with their line manager  
Send report to 
employer followed 
by discussion 
Employer to be 
contacted 








= patient occupational health (OH) 
recommendations 
= employer OH recommendations for 
the workplace 
= patient self-management (SM) 
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Study population: Birmingham COPD working sub-cohort 
Invite patients to the OH intervention 




made to patient 
OH 
recommendations 
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Contact the non-responders 
OH report(s) after assessment SM topics assessed 
No SM 
recommendations 









Figure 5-1 Occupational health intervention participant flow 
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5.5.7.1 The OH assessment 
Participants attending the OH assessment were met by the researcher (KK) and 
seen by the OH practitioner for ~60 minute assessment of the patient’s work and 
workplace, with the aim of identifying any potential modifications which could improve 
their work performance/capability.  
Advice from the OH practitioner (with >20 years OH experience) about generic OH 
assessments was used to develop a semi-structured tool to standardise the OH 
assessments (see appendix 4); focusing on factors which may exacerbate the 
symptoms of a COPD patient within their working environment. As a result, the 
following areas were explored when assessing patients: 
1. Nature of the job and industry (e.g. tasks, work hours, shift pattern, 
exposure to airborne chemical pollutants, work load, wearing 
respirators) 
2. Issues with managing their condition in the workplace (e.g. workplace 
triggers that exacerbate symptoms) 
3. Work environment (e.g. working in cold environments) 
4. Work practices (e.g. ergonomics, manual handling, physical nature of 
the job ) 
5. Barriers to completing tasks (e.g. fatigue, breathlessness) 
6. Access to occupational health services and reporting of symptoms 
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5.5.7.2 Self-management assessment 
The NICE COPD self-management guidelines25 were used as a framework to assess 
the patient’s reported practices and identify areas for greater attention. This involved 
assessing 8 areas of self-management (Table 5-1) using the patient’s responses 
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* Patients are advised that their self-management practices have been considered based on their responses to questions from 
the cohort questionnaires, in relation to the recommendations for self-management of COPD in the national guidelines (National 
Institute for Health and Clinical Excellence). Patients are also advised that the self-management recommendations highlighted 





Table 5-1 Self-management advice areas based on NICE recommendations 
NICE 
recommendations25 









advice inserted in the 
recommendation 
letter to the patient* 
Smoking cessation 
advice 
Do you still smoke now? Yes 
“Support to help you 
with smoking cessation” 
Adherence to current 
therapy 
Do you try to take your inhalers or medicines exactly 
as you have been instructed by a doctor or nurse? 
Sometimes people don’t take their medications 
exactly as prescribed. For each statement, please 
rate to what extent they apply to you: 
 
No to any 
statement 
“Support with taking 
inhalers regularly” 
Referral to pulmonary 
rehabilitation if 
functionally disabled 
by COPD (MRC > 3) or 
recent hospital 
admission 
In the last 12 months have you been admitted to 
hospital for your lung problems? 
During the last 12 months did you ever attend 
casualty or A&E for your lung problems? 
MRC score 
Yes to either 
question or 
MRC > 3 





Have you received the flu jab in the last 12 months? No 





Have you been given written advice on what to do if 
your symptoms get worse? 
No 
“A plan for what to do 
when your symptoms 
get worse” 
Stress management 
In the past 2 weeks, have you been bothered by:  
1. Little interest or pleasure in doing things 
2. Feeling down, depressed or hopeless 




Dietetic assessment BMI BMI > 25 “Referral to a dietician” 
Exercise 
Have you been told by a doctor or nurse to try to do 
some physical activity? 
Report the amount of physical activity the patient 
does (data taken from the International Physical 
Activity Questionnaire (IPAQ))  
No to question 




“Approaches to support 
you doing more 
physical activity” 
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5.5.7.3 The reports  
Potentially, there was a maximum of three reports produced following each patient 
assessment: the patient report, employer report and GP report (Figure 5-1). 
Individualised report for patient 
The information from the OH assessment was used by the OH practitioner to make 
OH recommendations on the following six areas: (1) avoiding substances/materials 
(2) modification of job tasks/methods/physical aspects of the job (3) modifications of 
the work environment (4) modifications to the work organisation (5) use of personal 
protective equipment (PPE) and (6) referral to OH services and education. 
The researcher (KK) produced an individualised report for each patient combining the 
occupational health and self-management recommendations. Example reports for 2 
patients can be found in appendix 5.  
To further encourage optimum self-management, each patient was provided a British 
Lung Foundation patient information leaflet (COPD: living with chronic obstructive 
pulmonary disease), which provided simple guidance in an easy to read format 
(appendix 6). 
Recommendations for the employer/line manager/health and safety officer 
A second report – generic workplace recommendations for the patient’s employer – 
was first provided to patients who consented to receive this report; offering them with 
the opportunity to make an informed decision before employer involvement in the 
study (see appendix 7 for example report). The report aimed to provide employers 
with suggestions on the possible changes which could be made within the workplace 
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to promote the wellbeing of their workforce; particularly focusing on those with 
respiratory symptoms. Employees remained anonymous within this report.  
Patients were asked at the follow-up telephone call (~3 weeks after posting the 
report(s)), whether they would consent to involve their employer. Of those agreeing, 
invitation letters (appendix 8) were sent to their employers for participation in the 
COPE study. The generic OH report was sent to the employers who agreed to 
participate. 
Recommendations report for the GP 
A copy of the patient’s report (containing OH and self-management 
recommendations) was sent to the patient’s GP for those consenting to this. It was 
anticipated that the self-management recommendations would be explored by the 
patient in consultation with their GP; highlighting potential areas for the GP to help 
the patient achieve better management of their disease and symptoms. 
5.5.8 Outcome measures 
5.5.8.1 Primary outcome measures 
The main aim of the study was to assess the feasibility and acceptability of the 
intervention, which included: determining the OHI uptake rates; assessing the 
reasons for declining participation; assessing the range of recommendations; 
assessing the likelihood of the uptake of the OH recommendations; exploring the 
patient’s reasons for not implementing the recommendations; determining the 
employer uptake rates; exploring the employer’s reasons for declining the workplace 
recommendations and uptake of the workplace adaptations recommendations by the 
employer (~ 3 month follow-up). The following measures were therefore used: 
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Patient satisfaction questionnaire: A semi-structured questionnaire (appendix 9) 
was administered over the telephone, ~3 weeks subsequent to sending the patient’s 
report(s). The first part of the questionnaire was developed using questions from the 
Royal College of General Practitioners patient satisfaction questionnaire.225 The latter 
half involved assessing the usefulness and potential barriers to implementation of 
each recommendation suggested by the OH practitioner. Patients were asked the 
following questions for each recommendation they received:  
1. Would this recommendation help other individuals with COPD who do a similar 
job as your current job? 
2. Would this recommendation help you to manage your COPD at work? 
3. Are you likely to implement the proposed recommendation at work? If not, why 
not? 
Employer feedback: Among the employers who agreed to take part in COPE, a 
follow-up telephone call was planned to discuss the generic OH recommendations for 
the workplace, to determine the usefulness of the suggestions and potential barriers 
to implementing the recommendation. 
Patient  interviews: There are various functions of qualitative research, which 
include: 1) contextual, describing the nature of what exists, 2) explanatory, assessing 
associations between what exists, 3) evaluative, appraisal of the effectiveness of 
what exists, and 4) generative, developing theories, strategies or actions.226 It is 
concerned with experiences of people and the meanings related to these 
experiences, and therefore “generally deals with talk or words rather than 
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numbers”.227(p3) Thus, as qualitative research considers a dimension which often 
cannot be explored by quantitative research, it was used to explore in greater detail 
the patient’s views and experiences.  
A purposive sample  of patients who took part in the OH intervention (aiming for up to 
15) were invited to take part in semi-structured interviews to explore their 
experiences of the occupational health intervention, its relevance and the interaction 
between COPD and work. Interviews were conducted approximately 3 months after 
attending the OH assessment. Up to five patients who declined or did not respond to 
taking part in the feasibility study were also invited to explore their reasons for 
declining. Participants were chosen to include a wide range of patients according to 
their socio-demographic, occupational and clinical characteristics and range of OH 
recommendations. The interview schedule involved a number of key areas to be 
explored with the patient: 1) factors affecting participation in the research study, 2) 
experience and feedback on the OH intervention, 3) health at work and 4) self-
management and COPD annual reviews (see appendix 10 and 11 for the interview 
schedules). Interview questions were modified based on previous interviews and 
patient responses. Interviews took place either at the patient’s home or by telephone, 
based on patient preference. All interviews were audio-recorded and transcribed 
verbatim using Microsoft Word by an administrative assisant. Eventual sample size 
for the qualitative interviews was determined by reaching data saturation – where no 
new concepts arise from the data.228  
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5.5.8.2 Other outcome measures 
Questionnaires were administered pre and post intervention and we assessed scores 
of the following quantitative outcome data:  
 Respiratory symptoms: from the St George’s respiratory questionnaire 
(SGRQ-C)229 
 Symptom impact on quality of life: from the COPD Assessment Test (CAT)173 
 Work productivity: based on sickness absence over previous 6 months 
(absenteeism) and the Stanford Presenteeism Scale-693 (presenteeism) 
GP feedback: GPs of the patients who participated in COPE were contacted to 
conduct a short semi-structured telephone interview to explore the usefulness of the 
OH and self-management recommendations in managing COPD patients (see 
appendix 12 for brief interview schedule). 
5.5.9 Data analysis 
This was a mixed methods study. The quantitative data involved descriptive statistics 
and was undertaken in STATA 13.0.  
Qualitative interviews: The role of the researcher (KK) was consistently considered 
(reflexivity) for all interviews. Patients were informed by the researcher (KK), prior to 
the interview, that a non-judgemental approach would be adopted throughout the 
interview. This was maintained throughout the interviews to encourage patients to 
feel comfortable about expressing their opinions. 
A rapport had been established with most of the interview participants (those 
attending the OH visit). For those that did not participate, the researcher (KK) 
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devoted time to develop a rapport prior to commencing the telephone interview. 
Developing a rapport was important to consider so that patients felt encouraged to be 
open about sharing their opinions, particularly with sensitive topic areas such as their 
working environment and their employer. 
Data were analysed using the thematic analysis approach: a commonly used 
approach in health research which “groups the data into themes, and examines all 
cases in the study to make sure that all manifestations of each theme have been 
accounted for and compared”.227(p69) Thematic analysis was undertaken by the 
researcher (KK). Independently, both supervisors and a qualitative researcher 
assessed two transcripts (with rich data) for emerging themes and compared the 
findings with the main researcher’s (KK) developed themes. 
5.5.10 Ethical approval and informed consent 
Ethical approval was obtained from the NRES (National Research Ethics Service) 
Committee West Midlands – Edgbaston. Written informed consent was obtained from 
patients after a full explanation of the study (appendix 13). Patients participating in 
the qualitative interviews were provided with a patient information sheet (appendix 14 
and 15) prior to their telephone interview. At the time of interview, the researcher 
(KK) provided each patient with a full explanation of the interview and an opportunity 
to ask any questions. The consent form (appendix 16) was read out over the 
telephone, signed and dated by the researcher (KK) and then posted to the patient 
with instructions on completing the form. 
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5.6.1 The COPE feasibility study uptake rates 
Initially, 109 patients were contacted to take part in the feasibility study; of whom 19 
(17.4%) consented. In response to these low uptake rates, the patient selection 
strategy was adjusted – inviting all working patients (n=309). Uptake rates remained 
low (Figure 5-2), and among the 44 patients (14.2%) who agreed to take part, only 35 
(overall uptake rate: 11.3%) were translated in to a patient visit. The majority of 
patients either declined participation (n=109; 35.3%) or did not respond (n=152; 
49.2%) to the invitation letter.  
5.6.2 Reasons for declining participation 
All patients who responded provided a reason for declining participation by either 
choosing one of the available options on the reply slip or by writing in the free text 
area. The majority of patients (n=54) selected “I am fine at work”. Some patients 
reported having already made adjustments in their work place (n=8), whereas some 
expressed concerns about employer involvement (n=5), despite this aspect of the 
study being voluntary. Approximately 1/3 of patients used the free text area to 
express their reason for declining and these were grouped into the main identified 
themes: self-employed; retiring soon; do not have lung problems or COPD. 
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5.6.3 Comparison of the characteristics of patients agreeing, 
declining and not responding to take part 
Table 5-2 provides a description of the characteristics of patients who agreed to take 
part, declined or did not respond. Patients who took part in the COPE feasibility study 
compared with those who declined were more likely to be male (74.3% vs. 56.0%), 
slightly older (mean age: 61.9 vs. 60.9), have more severe disease (greater 
breathlessness; more airflow obstruction; greater number of co-morbidities), have a 
poorer quality of life (CAT score≥21: 33.3% vs. 26.5%), have poorer work 
performance (mean SPS-6 score: 22.3 vs. 24.2) and greater sickness absence (>8 
days off: 23.3% vs. 19.2%). 
Non-responders compared with all responders (whether or not agreeing to take part) 
were more likely to be: younger, current smokers, have milder disease and lower 
sickness absence when compared to those participating in the feasibility study. The 
mean IMD score was higher for the non-responders compared with all responders, 
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cohort consented at 
baseline: n=1889                   
 
Occupational sub-cohort: n=348                         
Working patients invited to feasibility 
study: n=309 
Patients agreeing to take part 
in the feasibility study: n=44 
Declining to take part in the 
feasibility study: n=265 
Declined: n=109 
No response: n=153 
Retired: n=3 
 
Qualitative interviews: n=14 
(identified through purposive 
sampling) 
Decliners and non-responders 
invited to take part in the 
qualitative interviews: n=274 
Patients taking part in the 
feasibility study: n=35 
 
Unable to contact: n=6 
Declined participation: n=2 
Ineligible: n=1 
 
Patients agreeing to take part 
in the qualitative interviews: 
n=44 
Declined 




Qualitative interviews: n=5 
(identified through purposive 
sampling) 
Figure 5-2 Participant flow chart for the recruitment to the COPE feasibility study 
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Table 5-2 Comparison of characteristics of patients agreeing, declining and not 
responding to take part in the feasibility study 
Comparison of characteristics of 
patients agreeing, declining and not 
responding to take part 
Patients seen for 
an OH 
assessment 
N = 35 
Patients declining to 
take part in COPE 
N = 109 
Non-responders 
N = 152 
Socio-demographic characteristics 
Male 26 (74.3%) 61 (56.0%) 97 (63.8%) 
Female 9 (25.7%) 48 (44.0%) 55 (36.2%) 
Mean age (SD) 61.9 (8.2) 60.9 (7.8) 58.2 (8.2) 
Smoking status    
Never 2 (5.9%) 10 (9.7%) 12 (8.8%) 
Ex-smoker 20 (58.8%) 54 (52.4%) 61 (44.9%) 
Current smoker 12 (36.0%) 39 (37.9%) 63 (46.3%) 
Mean IMD score (SD) 25.2 (11.6) 24.8 (16.0) 28.7 (16.2) 
Clinical characteristics 
MRC dyspnoea score    
1 7 (20.6%) 31 (29.3%) 46 (32.6%) 
2 10 (29.4%) 38 (35.9%) 32 (22.7%) 
3 8 (23.5%) 25 (23.6%) 37 (26.2%) 
4-5 9 (26.5%) 12 (11.3%) 26 (18.4%) 
Disease severity    
GOLD stage 1 9 (26.5%) 36 (34.0%) 57 (38.8%) 
GOLD stage 2 18 (52.9%) 57 (53.8%) 70 (47.6%) 
GOLD stage 3-4 7 (20.6%) 13 (12.3%) 20 (13.6%) 
CAT score    
0-10 6 (20.0%) 23 (27.7%) 20 (18.2%) 
11-20 14 (46.7%) 38 (45.8%) 52 (47.3%) 
21-40 10 (33.3%) 22 (26.5%) 38 (34.6%) 
Number of co-morbidities    
0 6 (17.1%) 17 (15.6%) 24 (15.8%) 
1-2 14 (40.0%) 55 (50.5%) 73 (48.0%) 
3+ 15 (42.9%) 37 (33.9%) 55 (36.2%) 
Number of exacerbations    
0 15 (44.1%) 47 (44.3%) 65 (47.8%) 
1-2 14 (41.2%) 44 (41.5%) 50 (36.8%) 
3+ 5 (14.7%) 15 (14.2%) 21 (15.4%) 
Occupational characteristics 
Occupational exposures to VGDF    
None 11 (31.4%) 55 (51.4%) 58 (39.2%) 
Low 13 (37.1%) 34 (31.8%) 56 (37.8%) 
Medium 9 (25.7%) 12 (11.2%) 29 (19.6%) 
High 2 (5.7%) 6 (5.6%) 5 (3.4%) 
Employment type    
Employed  26 (74.3%) 19 (73.1%) 15 (79.0%) 
Self-employed 9 (25.7%) 7 (26.9%) 4 (21.0%) 
Mean SPS-6 score (SD) 22.3 (4.4) 24.2 (5.1) 23.0 (5.1) 
Sickness absence (over previous 
12 months)    
0 days 16 (53.3%) 60 (63.8%) 69 (61.1%) 
1-7 days 7 (23.3%) 16 (17.0%) 27 (23.9%) 
8+ days 7 (23.3%) 18 (19.2%) 17 (15.0%) 
CHAPTER 5: FEASIBILITY OF DELIVERING AN OCCUPATIONAL HEALTH INTERVENTION AIMED AT IMPROVING WORK 




5.6.4 Summary of occupational health recommendations 
Among the 35 patients who had an occupational health assessment, the majority 
(n=28: 80.0%) received at least one OH recommendation: ranging from 1 to 8 per 
patient. The median number of recommendations was 2 (IQR: 1 to 3) per patient.  
Summary statistics of OH recommendations N=35 
Received OH recommendations (n, %)  28 (80.0%) 
Distribution of recommendations per patient  
Range 0 to 8 
Mean (SD) 2.4 (1.9) 
Median (IQR) 2 (1 to 3) 
OH recommendation areas  
Avoid substances/materials 8 (22.9%) 
Modification of job tasks/work methods/physical aspects of the job 16 (45.7%) 
Modification of the work environment  11 (31.4%) 
Modification to the work organisation 7 (20.0%) 
Use of personal protective equipment 11 (31.4%) 
Referral to OH services and education 17 (48.6%) 
 
Although there were a range of recommendations (Table 5-3), 17 (48.6%) patients 
were advised to seek OH service input and education and 16 (45.7%) had 
recommendations to modify their job tasks/work methods/physical aspects of their 
job. Eleven (31.4%) patients were advised to use personal protective equipment and 
11 (31.4%) received recommendations to modify their working environment. Table 
5-4 outlines some examples for each recommendation; individual recommendations 





Table 5-3 Summary statistics of occupational health recommendations 
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Recommendation area Patient examples Occupation Recommendations 
Avoid substances/materials Cleaner Avoid using strong cleaning agents particularly in confined spaces or in poorly ventilated areas 
Modification of job tasks/work 
methods/physical aspects of the job Truck washer 
To avoid lifting and carrying large heavy 
equipment (e.g. 25L containers) 
Modification of the work environment Car mechanic Workshop should be heated, particularly in the winter months 
Modification to the work organisation Bricklayer 
Schedule jobs and work activity to avoid 
continuous work (e.g. working >2 hours without 
a break) 
Use of personal protective equipment Plumber To wear a dust respirator when conducting all cleaning activities after completion of job tasks 
Referral to OH services and education Museum attendant 
Those with respiratory problems should contact 
OH services who can advise on the need for 
routine health surveillance, any workplace 
adjustments and monitor the effects of work on 
health 
 
5.6.5 Patterns associated with the number of recommendations 
An exploratory analysis was carried out to compare participant characteristics with 
the mean number of recommendations (Table 5-5). However, as the number of 
participants was small, it was not possible to assess for statistical significance. 
Furthermore, although there was overlapping between some of the characteristics 
between the participants, the results could not be adjusted for confounding. 
Therefore the patterns identified below should be interpreted with caution. 
A higher number of recommendations were given to male participants compared to 
females (2.6 vs. 1.8), those with severe breathlessness (MRC 1 vs. MRC 5: 2.1 vs. 
4.7), those with more severe airflow obstruction (GOLD stage 1 vs. GOLD stage 3 to 
4: 1.8 vs. 2.7), and patients who had experienced >3 exacerbations in the previous 
year compared to those who had no exacerbations (3.8 vs. 2.7).  
Occupational characteristics were also related to the number of recommendations 
received: those with higher exposures to VGDF in the workplace had a greater 
number of recommendations compared to those with no exposures (3.1 vs. 1.6); and 
Table 5-4 Workplace recommendation examples 
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those self-employed had more recommendations than those with paid employment 
(3.4 vs. 2.0). Interestingly, patients who reported taking > 1 day off work in the 
previous 12 months had a greater number of recommendations when compared to 





Table 5-5 Relationship between patient characteristics and 
number of recommendations 
Patient characteristics Mean number of recommendations (SD) 
Socio-demographic characteristics 
Male 2.6 (2.1) 
Female 1.8 (1.0) 
Smoking status  
Never 3.0 (1.4) 
Ex-smoker 1.7 (1.5) 
Current smoker 3.8 (1.8) 
Clinical characteristics 
MRC dyspnoea score  
1 2.1 (2.0) 
2 2.0 (1.2) 
3 2.1 (1.7) 
4 2.2 (2.2) 
5 4.7 (2.9) 
Disease severity  
GOLD stage 1 1.8 (2.0) 
GOLD stage 2 2.4 (1.5) 
GOLD stage 3-4 2.7 (1.9) 
CAT score  
0-10 1.5 (1.9) 
11-20 2.4 (1.5) 
21-40 3.0 (2.5) 
Number of co-morbidities  
0 2.8 (2.3) 
1-2 2.9 (2.2) 
3+ 1.7 (1.3) 
Number of exacerbations  
0 2.7 (1.8) 
1-2 1.7 (1.6) 
3+ 3.8 (2.4) 
Occupational characteristics 
Occupational exposures to VGDF  
None 1.6 (1.9) 
Low 2.5 (1.5) 
Medium – high 3.1 (2.2) 
Employment type  
Employed  2.0 (1.4) 
Self-employed 3.4 (2.7) 
Sickness absence (over previous 12 
months)  
None 1.9 (1.7) 
> 1 day 2.5 (1.7) 
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5.6.6 Occupational health assessment feedback 
Among the 28 patients who received recommendations, 25 (89.3%) completed the 
telephone follow-up and three were non-contactable. Amongst the responders, there 
were a total of 75 recommendations (range 1-8).  
22 (88.0%) patients reported that this was their first occupational health assessment. 
Among the 3 who reported having previously visited an OH professional, all reported 
that the COPE assessment was: 1) more detailed and 2) more useful compared to 
their previous OH assessment experience.  
5.6.6.1 Patient satisfaction of the assessment 
16 (64.0%) patients reported that they felt in better control of their work as a result of 
the OH assessment (Table 5-6). The majority (n=20: 71.4%) felt that they understood 
what changes were required and most reported that they would recommend an OH 
assessment to their colleagues (n=21: 75.0%). 
 
Patient satisfaction questions about the OH 
assessment 
Strongly agree or 
agree 




I feel in better control of work 16 (57.1%) 5 (17.9%) 4 (14.3%) 
I now understand the change which need to be 
made 20 (71.4%) 4 (14.3%) 1 (3.6%) 
I would recommend an OH assessment to my 






Table 5-6 Patient satisfaction questionnaire results 
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5.6.6.2 Uptake of recommendations 
Table 5-7 provides a summary of the feedback for each patient interviewed at the 
follow-up. The majority of patients (n=23: 82.1%) reported that all of their individual 
recommendations would help other patients with COPD who have a similar job. 
Twenty (71.4%) patients reported that all or most of their recommendations would 
theoretically help them to manage their COPD at work. The remaining 5 (17.6%) 
patients expressed that the recommendations would not be useful in helping them 
manage their COPD at work.  
Fifteen (53.6%) patients reported that they were likely to implement all or some of the 
OH recommendations, but overall, only 28 (37.3%) of the recommendations were 
reported to be likely to be implemented. Reasons for not implementing 
recommendations were grouped into themes (Table 5-8). Five patients reported more 
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Reasons for not implementing the 
recommendation(s) 
1 6 6 (100%) 6 (100%) 3 (50%) “Already doing this”  n=3 
2 8 8 (100%) 8 (100%) 1 (12.5%) “Already doing this”: n=6 Impractical: n=1 
3 2 2 (100%) 2 (100%) 1 (50%) Need to consult manager 
4 2 2 (100%) 2 (100%) 2 (100%)  
5 2 2 (100%) 2 (100%) 1 (50%) “Already doing this” 
6 5 5 (100%) 5 (100%) 0 (0%) “Already doing before meeting”: n=3. Not practical: n=2 
7 2 2 (100%) 2 (100%) 1 (50%) “Doing before the assessment” 
8 2 2 (100%) 2 (100%) 0 (0%) “Only few year left until retirement, don't want to get involved at work” 
9 2 2 (100%) 0 (0%) 0 (0%) “I already manage myself well” 
10 3 3 (100%) 3 (100%) 3 (100%)  
11 3 3 (100%) 0 (0%) 0 (0%) “Employer will get rid of me”: n=2 Not applicable: n=1 
12 3 3 (100%) 3 (100%) 0 (%) 
“Retiring soon and if I am not capable of 
doing my job, I won't have a job" n=2 
Not practical: n=1 
13 3 2 (66.7%) 0 (0%) 0 (0%) Not applicable: symptoms are not exacerbated at work 
14 4 4 (100%) 3 (75%) 0 (0%) 
“Doing before assessment”: n=2. 
Not practical: n=1. 
Symptoms not affected: n=1 
15 3 3 (100%) 2 (66.7%) 2 (66.7%) Not applicable: does not do this task 
16 2 2 (100%) 2 (100%) 2 (100%)  
17 1 1 (100%) 1 (100%) 1 (100%)  
18 1 0 (0%) 0 (0%) 0 (0%) “OH department not supportive” 
19 4 4 (100%) 4 (100%) 2 (50%) “Already doing this”: n=1 Not practical: n=1 
20 1 1 (100%) 1 (100%) 0 (0%) “Already doing this” 
21 2 2 (100%) 2 (100%) 2 (100%)  
22 2 2 (100%) 0 (0%) 0 (0%) Does not have an OH department - "no one to go to": n=2 
23 5 5 (100%) 5 (100%) 3 (60%) Not practical: n=2 
24 3 3 (100%) 3 (100%) 2 (66.7%) Not practical 
25 4 4 (100%) 2 (50.0%) 2 (50.0%) 
Not applicable: does not do task and 






Table 5-7 Uptake of recommendations 
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Reasons for not implementing recommendations Number of patients (%) 
Patient implemented recommendation prior to assessment 8 (32.0%) 
Recommendation not practical 7 (28.0%) 
Patient concerned about consequences of employer involvement 4 (16.0%) 
No OH department or does not feel supported by OH services 2 (8.0%) 
Recommendation was not applicable 5 (20.0%) 
 
An exploratory analysis was also carried out to compare uptake and type of 
recommendation. Table 5-9 indicated there was a range of recommendations which 
were likely to be implemented. However, when comparing to those less likely to be 
taken up, patterns were more skewed and there was less uptake of the 
recommendations related to modifying job tasks/work methods/physical aspects of 
the job (n=19: 40.4%). These were often described as “not applicable”, “not practical” 
or were already in place prior to the OH assessment. However, due to the small 














of the work 
environment 
Modification 















Patient likely to 
implement 
recommendation 
2 (7.1%) 6 (21.4%) 8 (28.6%) 2 (7.1%) 4 (14.3%) 6 (21.4%) 28 
Patient unlikely to 
implement 
recommendation 
6 (12.8%) 19 (40.4%) 4 (8.5%) 3 (6.4%) 5 (10.6%) 10 (21.2%) 47 
Main reasons for not implementing 
Already in place 
prior to assessment 4 (22.2%) 8 (44.4%) 2 (11.1%) 1 (5.6%) 2 (11.1%) 1 (5.6%) 18 
Not practical 2 (22.2%) 3 (33.3%) - 1 (11.1%) 2 (22.2%) 1 (11.1%) 9 
Not applicable - 6 (66.7%) 1 (11.1%) - - 2 (22.2%) 9 
 
 
Table 5-8 Main reasons for not implementing workplace recommendations 
Table 5-9 Patterns between uptake and type of recommendation 
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5.6.7 Employer involvement  
Of the 35 patients assessed, 9 were self-employed, 5 received no OH 
recommendations, and a further five declined the offer of employer involvement at 
the stage of OH assessment (Figure 5-3).  
Among the 16 patients receiving an employer OH recommendations report, only 2 
agreed that their employer could be contacted. Another two patients expressed to the 
researcher (KK) that they had approached their line manager themselves and the OH 
recommendations had been implemented. 
A study invitation letter was posted to the 2 employers of the consenting participants, 














35 patients seen for occupational 
health assessment 
OH practitioner provided researcher 
with generic OH recommendations for 
employers: n=21 
Employer reports sent to patients: 
n=16 
Patients agreeing to employer 
involvement at follow-up: n=2 
Self-employed: n=9 
Received no OH 
recommendations (employed 
patients): n=5 
Did not consent to employer 
involvement at OH 
assessment: n=5 
Did not consent to employer 
involvement at follow-up: 
n=13 
Loss to follow-up: n=1 
Employers responding to 
study invitation: n=0 
Figure 5-3 Employer participation in the COPE feasibility study flow chart 
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5.6.8 Self-management recommendations 
All COPE feasibility study participants received >1 self-management 
recommendation, ranging from 1 to 6 recommendations per patient (mean=3; 
SD=1.4).  
The most common recommendations were for patients to explore with their GP, 
referral to a dietician (n=26; 74.3%), plan for worsening symptoms (n=22; 62.9%) or 
approaches to managing stress (n=14; 40.0%) (Table 5-10). Other recommendations 
included discussion on smoking cessation (n=13; 37.1%); approaches to support 
doing more physical activity (n=10; 28.6%); referral to pulmonary rehabilitation (n=9; 
25.7%); and uptake of flu vaccination (n=7; 20.0%). Although only 3 patients had a 
recommendation to discuss inhaler usage with their GP, this data was unavailable for 
14 (40.0%) patients. Overall, data completion was high (>90.0%) for all self-
management recommendation data, excluding data on the flu vaccination 









Table 5-10 Self-management recommendations 
Self-management recommendations N (%) N=35 
Smoking cessation advice 13 (37.1%) 
Support on inhaler usage 3 (8.6%) 
Referral to pulmonary rehabilitation 9 (25.7%) 
Flu vaccination 7 (20.0%) 
Plan for worsening symptoms 22 (62.9%) 
Advice on approaches to manage stress 14 (40.0%) 
Referral to a dietician 26 (74.3%) 
Approaches to support increased physical activity 10 (28.6%) 
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5.6.9 Pre and post intervention outcome measures  
Data on outcomes was available for the majority (85.7%) of those assessed. 
Differences were not tested for statistical significance as this was a feasibility study 
and there was insufficient power to do so. Overall, absenteeism rates and quality of 
life measures were higher (indicating poorer QoL) and there was little change in 
presenteeism post-intervention, compared to the pre-assessment period (Table 
5-11). However these were point estimates, and lack of adequate power limits our 
ability to draw any meaningful conclusions.  
 










Mean days off over previous 6 months (SD) 3.0 (6.7) 4.8 (9.8) +2.3 (10.9) 
Median days off over previous 6 months (IQR) 0 (0 to 3.0) 0 (0 to 5.0) 0 (0 to 3.5) 
Mean SPS-6 score (SD)* 23.4 (4.5) 22.7 (5.5) -0.07 (4.8) 
Mean CAT score (SD)** 9.4 (7.0) 11.2 (8.6) +1.1 (4.4) 
Mean SGRQ-C score (SD)** 37.3 (20.8) 39.2 (23.0) +5.3 (17.6) 
SGRQ-C impact score (SD)** 21.9 (20.8) 24.5 (23.6) +4.7 (18.5) 
SGRQ-C activity score (SD)** 44.3 (25.0) 48.0 (31.1) +2.9 (16.0) 
SGRQ-C symptoms score (SD)** 58.8 (21.8) 62.7 (18.6) +4.8 (15.1) 
Outcome measures in those with recommendations 
Mean days off over previous 6 months (SD) 3.8 (7.3) 5.4 (10.3) +2.6 (11.6) 
Median days off over previous 6 months (IQR) 0 (0 to 3.0) 0 (0 to 5.0) 0 (0 to 5.0) 
Mean SPS-6 score (SD)* 23.2 (4.3) 22.4 (5.6) -0.5 (5.1) 
Mean CAT score (SD)** 10.2 (7.3) 11.3 (8.7) +0.8 (4.3) 
Mean SGRQ-C score (SD)** 40.6 (19.9) 39.2 (23.0) -5.3 (17.7) 
SGRQ-C impact score (SD)** 23.8 (21.1) 26.6 (24.0) +4.2 (18.7) 
SGRQ-C activity score (SD)** 46.9 (23.1) 52.3 (30.2) +4.5 (15.3) 
SGRQ-C symptoms score (SD)** 60.7 (19.9) 62.3 (18.9) +5.4 (15.3) 
*SPS-6 questionnaire: lower scores indicate worse work performance 




Table 5-11 Secondary outcome measures pre and post intervention 
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5.6.10 Interviews with GPs of participating patients 
Of the 14 GPs that were contacted, the majority (n=9; 64.3%) refused to take part in 
the telephone interview. Five GPs did not respond to the messages left by the 
researcher (KK). Thus, no GP interviews took place. 
5.6.11 Qualitative interviews with patients 3 months post-
intervention 
A total of 19 semi-structured interviews were carried out: 14 among patients who took 
part in the OH intervention and 5 patients who declined or did not respond to taking 
part in the feasibility study. Interviews were all carried out by the same researcher 
(KK), and lasted between 35 to 80 minutes. Most interviews (n=16) were conducted 
over the telephone and the remaining at the patient’s home (n=3). 
5.6.11.1 Characteristics of the participants 
The characteristics of the interview participants are summarised in Table 5-12. 13 
(65.0%) were male with a mean age of 61.9 years (SD: 7.1) and mean MRC score of 
2.4 (SD: 1.3). The participants were from a range of occupational backgrounds. Of 
those who took part in the feasibility study, participants possessed a range of OH 
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P1 64 Male 2 
Managing director for 
engineering company 
2 Participated 
P2 63 Female 2 Coffee shop manager 1 Participated 
P3 59 Male 5 Bricklayer 8 Participated 
P4 50 Male 1 HGV driver 4 Participated 
P5 55 Male 3 Relief caretaker 5 Participated 
P6 80 Male 2 Technical manager 3 Participated 
P7 59 Male 2 Labourer 2 Participated 
P8 61 Female 2 Secretary for local MP 0 Participated 
P9 65 Male 1 Plumber 5 Participated 
P10 68 Female 3 Museum attendant 2 Participated 
P11 61 Male 1 Visiting lecturer 0 Participated 
P12 64 Male 4 Truck washer 6 Participated 
P13 50 Female 5 Cash officer (supermarket) 3 Participated 
P14 68 Male 4 Cleaner 2 Participated 
P15 57 Female 1 Duty manager n/a Non-participant 
P16 68 Female 2 Hotelier n/a Non-participant 
P17 55 Male - Printer engineer n/a Non-participant 
P18 63 Male 1 Project manager n/a Non-participant 
P19 66 Male 3 Foreman duct erector n/a Non-participant 
 
5.6.11.2 Qualitative findings 
Five themes regarding the acceptability and barriers of the OH intervention were 
identified from the qualitative interviews: 1) motivating factors to take part in the 
feasibility study, 2) factors affecting non-participation, 3) factors influencing 
adjustments for COPD in the workplace, 4) future considerations for occupational 
health assessment, and 5) intervention outcomes. See Table 5-13 for identified 





Table 5-12 Characteristics of those taking part in the qualitative interviews 
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Theme Sub-theme Code 
Theme 1: motivating factors to 
take part in the feasibility study 
Outward incentives: driven by 
altruistic views 
 
Helping other COPD patients 
Increasing COPD knowledgebase 
Supportive of research 
Inward incentives: driven by 
personal gain 
Positive impact on own health 
Improve understanding/knowledge about COPD 
Help with future employment 
Occupational exposures 
Theme 2: factors affecting non-
participation 
 
Work related factors 
Taking time off 
Concerned about employer involvement 
Personal factors 
Perception/attitude towards COPD 
Individual characteristics 
Smoking 
Study related factors 
Information sheet lacked clarity 
Location of the assessment/travel or distance to the 
University 
Participation in other research  
Theme 3: future considerations for 
occupational health assessments 
Content 
Educating and empowering patients 
In-depth health check 
The perspective of other COPD patients 
Practicalities in delivering the 
intervention 
Timing of OH assessment 
Targeted approach to identifying suitable patients 
Professional delivering the 
intervention, their level of 




Practice nurse/COPD nurse 
Personal characteristics 
Employer involvement 
Theme 4: factors influencing 
occupational adjustments for 
COPD 
Control over work 
Flexibility in working hours/days 
Flexibility in work tasks 
Outlook on symptoms at work 
Self-adjustment to manage symptoms at work 
Ignore symptoms 
Denial of symptoms 
Reluctance of sharing health 
issues with the employer 
Separation of work and life  
Impact on self-esteem 
Working relationships 
Positive relationships at work 
Negative working relationships 
View on the impact of the 
working environment 
Awareness of impact of the working environment on 
health 





Adjustments in working practices 
Impact on self-management 
Table 5-13 Summary of the identified themes from the qualitative interviews 
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5.6.11.2.1 Theme 1: motivating factors to take part in the feasibility study  
Two main factors were identified which motivated patients to take part in the COPE 
feasibility study: altruism and personal gain. 
Outward incentives: driven by altruistic views 
Altruism motivated the majority of patients to participate in the study. For a few, it was 
the only motivating factor as it was thought that there would be little or no personal 
benefit from participating. Many patients proposed the beneficial impact for other 
COPD patients by their participation.  
[P18: male, 63 years, project manager] “Well if it can help your research and 
other people to improve their lives then I am happy to participate in something 
like that. It is all part of trying to be a good citizen.” 
A few patients expressed the importance of developing and increasing the 
knowledge base on COPD, with one patient emphasising the importance of achieving 
this through participating in qualitative research as opposed to quantitative research: 
[P10: female, 68 years, museum attendant] “To get feedback from people who 
are actually suffering from the disease, rather than do a thing called statistical 
research, and anything that can be given that informs about living with COPD 
has got to be a good thing.” 
A few patients were generally supportive of research, and either previously or 
concurrently, were involved in other health research. Thus, being accustomed to 
research processes may have encouraged participation.  
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[P14: male, 68 years, cleaner] “I am doing a test now with ***** University to 
see if they can deal with degenerative eye problems, so I am doing one for 
you and one for ***** University.” 
Inward incentives: driven by personal gain 
In some patients participation was incentivised by the various perceived personal 
benefits. One consideration was the beneficial impact on the patient’s own health. In 
fact, a few patients believed this was to be achieved through the monitoring of their 
health/health check or help with COPD symptom management at the OH 
assessment.  
[P1: male, 64 years, managing director] "A bit selfishly because if there is any 
possibility of me personally getting an improvement then I will try and assist in 
whatever way I can." 
Importantly however, many participants demonstrated or even articulated their lack of 
understanding about COPD and consequently, a number of patients cited that by 
participating they sought to improve their knowledge and therefore develop a better 
understanding of the condition. For example, one patient was extremely concerned 
about definition of the term ‘COPD’, insisting that his condition was not chronic. As a 
result, he attended the occupational health assessment to seek answers:  
[P14: male, 68 years, cleaner] “…people are saying COPD, now that means 
the “C” means chronic. Now there is obviously a lot of more people out there 
with a condition that is in the chronic situation, whereas mine is not chronic, 
but I have got COPD probably.” 
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One patient attended the assessment with the belief it would help with securing 
future employment, and was the only patient with a work-related reason for taking 
part. 
[P11: male, 61 years, visiting lecturer] “If I had got a potential employer what 
they could do to help me, just getting employment.” 
One patient (non-responder) expressed keenness to take part in the study due to the 
workplace exposures; commenting that his environment at work had negatively 
affected his health. However, due to his late expression of interest, he was unable to 
receive an OH assessment: 
[P19: male, 66 years, foreman duct erector] “I think it is a really good idea 
because I do work in a nasty environment which I think has affected my 
health. I do think it is a very good idea that’s why I am okay to carry on now…” 
5.6.11.2.2 Theme 2: factors affecting non-participation 
Work, personal and study related factors were seen as important barriers affecting 
participation in the COPE feasibility study. 
Work related factors 
Many patients suggested ‘time’ as one of the main barriers to participation; 
commenting on difficulties in taking time off work. A few mentioned this may be a 
particular issue for those in full time employment (compared part-time workers), or 
those with rigid working hours. In fact, one of the non-participating patients stated 
that his “strange working hours” prevented study participation, and otherwise, was 
very interested in taking part.  
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[P10: female, 68 years, museum attendant] “Time is a big factor if somebody 
is working full-time.” 
Suggestions such as, offering an out of hours service as well as altering the invitation 
letter to emphasise the limited burden on the patient’s time, were made to address 
this issue. Although for self-employed or small business owners it was seen that time 
is of the essence; implying that work may be prioritised differently for such patients 
compared to those employed for wages. 
The negative financial consequences of taking time off work were also raised, with 
provision of financial incentives for participation suggested as a potential solution. 
Time barriers were also discussed in relation to a general lack of time in today’s 
climate; disruption of cancelling and rearranging prior commitments; and the various 
other priorities an individual may have and therefore difficulties in committing to the 
study. 
Some patients stressed the concern (their own, or that of other patients) about 
reading the potential for employer involvement within the invitation letter; feeling 
uncomfortable or even fearful of the employer’s reaction, and therefore the potential 
targeting for dismissal. Furthermore, a few raised concerns about the stigma 
associated with having COPD and it negatively affecting the employer’s opinion of 
their work capacity. In fact, the fear of employer involvement was the main reason for 
not taking part for one of the five non-participants:  
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[P17: male, 55 years, printer engineer] “I could be putting my job on the line 
…. because of knowledge of my health condition and that is why I imagine 
other people, erm, other patients have declined the offer because of that 
reason also.” 
It was suggested for future studies to exclude employer involvement as a method to 
improve the uptake rate. 
Personal factors 
Negative attitudes towards COPD were suggested as a reason for non-participation 
by some patients; these included views such as feeling embarrassed about having 
COPD, in denial or frightened to find out more about COPD – this included the 
implications of having the disease, its progressive nature and therefore how to best 
manage the condition. Although one patient identified this may be a reason for non-
participation, s/he strongly stressed the importance of accepting the diagnosis:  
[P3: male, 59 years, bricklayer] “If you've got COPD, you've got it and it's no 
good trying to hide it or being ashamed of it…it's a lot better to talk to people 
about what you have got rather than just curl up in a ball and feel sorry for 
yourself…or just not do anything.” 
For one patient, this negative view was precipitated by past difficult health 
experiences and therefore did not want to remember his/her childhood by focussing 
on ill health as a result of taking part in the study. 
Some patients discussed the recognition of having a ‘health condition’ but not having 
a ‘health problem’. Therefore through self-adjustment and learning to function well 
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with the condition or believing they did not have ill health, patients may have felt it 
was unnecessary to attend the OH assessment. 
Another important point raised by a few patients was related to current lifestyle 
behaviours, particularly smoking. For the fear of being judged, smokers may have 
preferred not to participate. It was also implied that some smokers may be unwilling 
to abstain from smoking and hence, would be reluctant to meet a professional about 
their health for the fear of hearing they are not managing their own health 
appropriately.  
[P10: female, 68 years, museum attendant] “I am particularly thinking of 
people who perhaps still smoke. Smoking at one time was ... people got angry 
with you for smoking and not giving up and I think perhaps it might be 
something to do with that.” 
Individual personality characteristics could also have influenced patients. Intrigue 
encouraged one patient to participate, whereas suspicion (about the handling of 
personal information), shyness and lack of self-confidence were identified as reasons 
to deter patients. It was suggested to soften the invitation letter for the more introvert 
patient, however, the practicalities of how this could be achieved were not discussed. 
A few patients suggested that some patients are not interested or curious to find out 
more about COPD or their health, and thus little can be done for such cases: 
[P14: male, 68 years, cleaner] “It’s like taking a horse to water, you can’t make 
him drink it. You can take him there but you ain’t going to make him drink it, so 
it’s the same with information on breathing.” 
 
CHAPTER 5: FEASIBILITY OF DELIVERING AN OCCUPATIONAL HEALTH INTERVENTION AIMED AT IMPROVING WORK 




Study related factors 
The travel to the University, albeit via a taxi offered by the study, was raised as a 
potential barrier by a few patients. The distance may have deterred patients, 
particularly women. It was also suggested that some patients may feel uncomfortable 
about visiting unfamiliar areas or a large city, such as Birmingham. For one patient, 
this was the only shortcoming of the study; describing the drive to the University as 
stressful.  
[P12: male, 64 years, truck washer] “Travelling bit could be something which 
would put people off… females do not like travelling into city centres and going 
into strange areas where they don’t know.” 
Additionally, the room in which the assessment was carried out was described as not 
conducive or relaxing; which was thought to possibly arouse suspicion amongst 
study participants. A remedial proposal was a familiar environment; a few patients 
suggested for the assessments to be conducted locally: the patient’s home or their 
local GP practice. 
A few patients conveyed that the invitation letter lacked clarity in the following areas: 
the purpose of the study, the length of the OH assessment and the proposed 
questions or information required from the patient at the assessment.  
[P9: male, 65 years, plumber] “I was a bit apprehensive thinking about how 
much time it was going to take and exactly how it was going to pan out.” 
A number of suggestions were provided to improve the letter: use of lay terms, as 
some patients may have found the letter “too medical”; to clearly state that the study 
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is about COPD and to specify the purpose of the interview, its direct relevance to the 
patient and the benefits of participating. One patient mentioned that it would be 
beneficial to know that the issues related to COPD are not unique to the patient 
alone. One self-employed patient (non-participant) suggested omitting the word 
“employed” from the patient information sheet; believing that he would not reflect a 
working COPD patient, and therefore felt discouraged from participating.  
Conversely, a few patients found the information simple and easy to understand, and 
questioned why patients chose not to participate, suggesting an assumed obligation 
to participate in the related studies.  
One patient found the regular patient contact from the main research study (cohort 6 
monthly questionnaires) onerous and believed this may have discouraged 
participation in any related studies: 
[P14: male, 68 years, cleaner] “Oh, ***** ****, not again, I have got to fill that 
form in again”, you know, and people do get cheesed off, although it is for their 
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5.6.11.2.3 Theme 3: future considerations for occupational health 
assessments 
 
Patients discussed their views on a number of aspects which should be considered 
when designing and delivering future occupational health interventions. This included 
views on: the content of the OH intervention; the practical aspects to consider when 
delivering such an intervention; the importance of involving the employer and the 
expertise and characteristics of the individual delivering the intervention. 
Assessment content 
Many participants believed that COPD patients could benefit from a modified OH 
assessment, by incorporating other features as part of the intervention. One feature, 
highlighted by a number of patients, was educating and empowering COPD patients 
through providing guidance on the management of their condition.  
[P6: male, 80 years, technical manager] “How to deal with it [COPD] and how 
do I limit its advancement... Well now I've got it, what do I do about it?... I 
expected to be given a little more guidance on how to manage my condition...” 
An option, discussed with a subset of patients, was to include an abbreviated OH 
assessment as part of the COPD annual review: a COPD management review 
conducted at the patient’s GP practice.  Patients cited that this potential incorporation 
would be beneficial by: helping patients develop a better understanding of their 
COPD; encourage a regular assessment of the impact of COPD on work (and vice 
versa); facilitate in fostering a better relationship with the GP/nurse and help foresee 
any potential work related issues due to ill health. Although, one patient suggested 
an annual assessment would be too frequent and to alternate the year of 
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assessment. A few patients, with milder disease, appreciated the benefits of such an 
assessment for other COPD patients, but believed it would not be personally 
applicable because of their good health.  
A few favoured extending the OH assessment into a detailed health check, to help 
patients develop a better understanding of their overall health:  
[P11: male, 61 years, visiting lecturer] “I thought there would be some more 
breathing tests with regards to myself…or on physically what I could do” 
Another important feature, raised by a few patients, was the importance of discussing 
or hearing the perspective(s) of other COPD patients. It was thought that this would: 
create greater awareness that the condition/situation is not unique to the individual; 
guidance on managing life with COPD from those with experience and to learn the 
truth about the prognosis of COPD.  
[P3: male, 59 years, bricklayer] “Have a good talk to somebody about it, 
preferably somebody who's got it...somebody who is more advanced than you 
are, they can actually tell you what is going to happen or what can happen.” 
Professional delivering the OH assessment, their level of expertise and personal 
characteristics  
Some thoughts were shared on the various professionals that may be best placed to 
conduct an OH assessment. The type and expertise of the professional conducting 
the OH assessment were discussed in relation to the feasibility of wider 
implementation, the patient’s own confidence in the findings, and likely impact on 
employers.  Although some patients expressed the importance of seeing a 
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professional with OH experience, a number of patients favoured an external OH 
service; finding an internal OH service (linked to the employer) impersonal. Patients 
were cautious about OH services that are related to the employer and expressed 
concerns about personal information filtering to the line manager. Indeed, one 
patient’s views on the use of an external OH service were influenced by the lack of 
confidentiality displayed by the employer’s recommended OH service:  
[P17: male, 55 years, printer engineer] “The company and releasing 
information that it may get into the wrong hands...information, with it being 
duplicated, for me, is not a show of confidence in information being, err, 
basically sent around… It certainly became knowledge in verbal conversation 
between managers and workforce… managers knew of the conditions, yes. 
So I felt, err, it was compromised …into the employer’s hand which then 
throws a lack of confidence in the, erm, the erm, general assessments.” 
 
As an alternative, a number of patients identified the GP as a promising candidate to 
carry out an OH assessment, with the aim of providing this feedback to the employer.  
[P3: male, 59 years, bricklayer] “So this is something for the doctors to do, 
look at the patients as a patient, what's up with them.” 
It was believed that a letter from the ‘doctor’ would carry greater weight. However, a 
few patients believed that information from the GP would not be easily received by 
the employer. Furthermore, concerns were raised about the GP’s limited capacity to 
conduct such an assessment due to their limited time and significant workload. One 
patient’s reluctance of sharing her real concerns was due to her apathetic GP. 
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Some patients identified the nurse as a potential candidate. The ease of discussing 
health information with the nurse largely influenced this choice. Other reasons 
included reducing the GP’s burden and it was thought that it would be more efficient 
to visit the nurse than the GP.  
[P5: male, 55 years, relief caretaker] “The nurse… when you talk to her and 
she does your breathing test, she could go through it. That would free up the 
doctor then, wouldn’t it?” 
However it was raised that a nurse may be inexperienced to perform this role.  
A number of patients lacked trust or confidence in their GP practice, however the 
need for the potential candidate to possess comprehensive knowledge of COPD was 
clear. It was suggested that a medical professional either delivered the assessment 
or worked alongside an OH professional. One patient was reassured about the OH 
assessment and recommendations by mistakenly considering the OH practitioner to 
be a medical practitioner. However, a few patients were pessimistic about employers 
acting on feedback from medical expertise. In fact, one patient was doubtful about 
the employer actively engaging with any professional for OH advice: 
[P13: female, 50 years, supermarket cash officer] “I am not sure because they 
have ignored my doctor and now they have ignored an Occupational Health 
Therapist so I don’t know what would make them sit up and take notice. I 
couldn’t tell you. I mean that’s two that’s in a profession, you know, they have 
ignored, so I can’t answer. I don’t know who they would take notice of, no.” 
A few patients described the positive impact of certain personal characteristics of the 
professional delivering the OH assessment on their overall experience. A few 
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patients appreciated the OH professional’s positive demeanour, with another patient 
describing the conduct of the assessment as casual and hence did not feel 
pressurised to share personal information; demonstrating the contribution of good 
communication to a positive patient experience. 
[P7: male, 59 years, labourer] “I thought it was very good. You can talk to him 
easily, I find him quite easy to talk to and get on with and yourself.” 
Practical considerations in delivering the intervention 
Some patients felt that an OH assessment was suitable for only certain 
circumstances among those with COPD, or that it was more helpful at particular 
periods in the course of the disease.  Some patients suggested adopting a targeted 
approach to identifying suitable patients for OH assessment. One approach was 
based on disease severity and the aggravation of symptoms in the workplace. 
Another suggestion was based on the work environment; proposing that an 
assessment might be more appropriate for those in a large working environment or 
certain industries: 
[P15: female, 57 years, duty manager] “…it is mainly environment really. What 
kind of environment they are working. Like I say, if factory… extractor fans and 
stuff like that. Even down to posture really…”  
Many patients discussed the ideal timing of conducting an assessment; indicating 
that it would be beneficial “early on”. Some patient felt this was based on the patient’s 
age, whereas other patients described this “early on” period in-line with the time of 
diagnosis: 
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[P13: female, 50 years, supermarket cash officer] “When you are first 
diagnosed, because you can learn things, erm, what rights you have got at 
work and how you can go about things… rather than wait until you are 
struggling and then have to work for years like I did without finding out 
anything about work.” 
Importantly, a few patients stated the importance of considering the acceptance 
period – “coming to terms” with COPD – prior to offering patients an OH assessment.  
In contrast, one patient suggested that an assessment would be most beneficial in 
those who are significantly affected by their COPD: 
[P8: female, 61 years, secretary for local MP] “Wait until you [COPD patient] is 
struggling and then take part and that helps.” 
Employer involvement 
Although many patients discussed the issues related to the fear of employer 
involvement, a number of patients recognised the importance of involving the 
employer and informing them of an employee’s COPD status to encourage 1) 
appropriate workplace adjustments, 2) educate the employer about the employees’ 
health and 3) for the safety of other employees. One patient’s view on withholding 
health information from the employer was altered after a negative health experience. 
He later realised the advantages of informing the employer:  
[P19: male, 66 years, foreman duct erector] “I did try to hide my symptoms for 
some time, mainly for fear of losing my job, you know what I mean. But then 
eventually I had to tell them anyway because I, erm, ended up in hospital. I 
couldn’t breathe like, I had to go back and explain to them [employer] but they 
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was nice, you know, really good to me afterwards, so probably it was just a 
silly thing not to tell them, you know… He [employer] makes sure I have got 
the right equipment and makes sure that I don’t have to do heavy work. If I 
don’t feel well I can go home any time. If it’s cold I don’t hang around outside I 
can go in the office and do work in the office.” 
5.6.11.2.4 Theme 4: factors influencing adjustments for COPD in the 
workplace 
A number of issues were raised by the interviewed patients, which impacted on their 
ability to influence workplace adjustments or discuss the impact of work on their 
health with the employer. These included the employee’s: control over their work; 
attitude towards sharing health information with their employer; relationship with 
employer and other employees; outlook on their own symptoms at work and 
awareness of the impact of the working environment on their health. 
Control over work 
Flexibility in working hours or work tasks was important in helping patients manage 
their COPD symptoms. This was most prevalent among the self-employed or small 
business owners, who displayed greater autonomy in selecting and delegating 
certain work tasks: 
[P18: male, 63 years, project manager] “Driving late at night makes me 
fatigued because I get tired….. so I get somebody else to do that, I pay 
somebody to do that.” 
Attitudes towards sharing health information with the employer 
Many patients were reluctant to disclose personal information with their employer or 
colleagues for additional reasons other than those discussed in theme 2 (e.g. fear of 
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job loss). One reason cited was the importance of maintaining a division between 
work and life and keeping health matters private, for example:  
[P5: male, 55 years, relief caretaker] “I work with them, I don’t want to socialise 
with them. Things like that [COPD] I keep to myself”.  
Another reason, expressed by a few patients, was the detrimental impact on self-
esteem, and that sharing information about their health condition with the employer 
may be interpreted as a weakness, particularly among the older workers who may 
have a different approach to working with health problems. 
[P10: female, 68 years, museum attendant] “It might be a question of pride as 
well, I don’t know, you know, as I say I don’t think it is just the COPD, I think it 
might be anything, you know. Particularly the old people, we have kind of been 
brought up to that you just get on with it sort of thing.” 
Although, it was clear from the interviews that this lack of discussion did not always 
mask the health issue(s). 
Working relationships 
Positive working relationships were associated with better engagement with the 
employee’s health needs. For example, working as a team made it easier to 
influence change in the working environment, particularly if the management 
demonstrated reluctance to workplace change. Some employers were described as 
very helpful, sympathetic and supportive which were favourable for working 
adjustments. For one patient, this was due to his 20 year service with the company. It 
was also found that positive working relationships as well as team work made it 
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easier to put forward workplace suggestions to the management in the event of poor 
health.   
[P4: male, 50 years, HGV driver] “They have changed one or two things but 
we keep complaining about it and there are times we wouldn’t stand down.” 
Small company owners (including some self-employed participants) displayed 
empathy and understanding of their employees’ health due to their own health 
condition; providing occupational adjustments without hesitation for those with a 
general or similar health issue, as the health experiences of colleagues were 
appreciated and better understood.  
Conversely, patients with negative or passive working relationships reported 
employers to be less likely to focus on their health needs and workplace adjustments: 
[P3: male, 59 years, bricklayer] “All they want is work going out of the door and 
they aren’t bothered about your health.” 
Outlook on symptoms at work 
Some patients were conscious of their symptoms at work and were proactive in 
independently making workplace adjustments without the employer’s input e.g. 
avoidance of certain tasks.  
[P17: male, 55 years, printer engineer] “I think if I come to manual lifting…and 
carrying heavy components ….then I find I can sometimes be out of breath… if 
I stand in that dust cloud then it will obviously bring worse conditions for 
me…so I tend to stay away from hands on and handling 
of…erm…equipment.” 
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Interestingly, one patient (small company owner) observed that his smoking 
employee was more responsive to the impact of workplace exposures on symptoms 
and was more malleable to the suggested occupational recommendations than the 
non-smoker. 
Some patients, however, ignored their symptoms at work, occasionally reporting their 
reasons. These included beliefs that symptoms will self-correct; assumption there 
were no suitable intervention(s) available to treat symptoms; infrequency of 
symptoms or the infrequency of demanding job tasks which were thought to 
aggravate symptoms; fear of the implications of involving the employer if symptoms 
were reported, and not wanting to take time off work because of symptoms among 
those who were self-employed. One patient attributed his symptoms to the work 
environment and his smoking, and not an aggravation of his health condition: 
[P9: male, 65 years, plumber] “I used to have coughs and wheezing and I 
never really took much notice to it and I just put it down to the job and that I 
used to smoke.” 
Conversely, a few patients rejected the notion that their COPD symptoms were 
affected in the working environment, even though they were contradictory in their 
interviews by discussing the minor workplace adjustments that had been made.  
[P5: male, 59 years, relief caretaker] “It hasn't affected me so far and because 
it hasn’t affected me I don't see why they should know. Once it does start 
affecting my work, then obviously I would tell them…Some things I am limited 
on... So I try and avoid those as much as possible.” 
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Awareness of the implications of the working environment on health 
Some patients alluded to their own or their employer’s lack of awareness or 
knowledge of workplace exposures and its subsequent impact on health; providing a 
further explanation for the absence of seeking OH advice. 
In contrast, a few patients discussed the importance of health and safety procedures 
and protocols in the workplace as a means of identifying occupational hazards. In 
fact, one patient was convinced that any problems associated with occupational 
exposures were avoided as a result of receiving training for health and safety in the 
workplace: 
[P15: female, 57 years, duty manager] “There is only certain cleaning agents 
we use because of health and safety…so, I have done health and safety 
courses… been on them. Yes, that’s why I have not had any problems with 
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5.6.11.2.5 Theme 5: intervention outcomes 
Many patients discussed the various benefits of taking part in the COPE feasibility 
study. This included personal changes, such as feelings of reassurance about their 
COPD, as well as changes to practices and behaviour, such as implementing 
changes to their working and self-management practices. Very few patients reported 
no benefit from taking part in the study.  
Personal (internal) changes 
As a result of participating in the study, many patients developed a greater 
awareness of the relationship between COPD and work. This included: an increased 
awareness of the impact of the workplace on COPD symptoms; consolidating 
previous knowledge; and becoming generally better informed. Consequently, patients 
cited that they were “thinking a lot more” about their COPD at work. 
[P2: female, 63 years, coffee shop manager] “It helped me a lot. I realise it 
wasn't old age creeping on, that there was actually something wrong and that 
it is just not case of having to manage it” 
The OH assessment provided an outlet for patients to discuss their health status and 
work. The various positive benefits of this were discussed: helped to alleviate 
anxiety; helped to provide answers about the condition; reduced agitation and just 
generally helped patients feel better about themselves and their COPD.  
Consequently, this helped to provide reassurance to a number of patients in a few of 
ways: 1) other working COPD patients experience similar problems, 2) their current 
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working practices and any self-adjustments previously made in the workplace were 
appropriate, and 3) the implications and prognosis of COPD. 
[P10: female, 68 years, museum attendant] “I have realised that my problems 
aren’t unique to me, and when you are part of a big club it makes you feel 
better.” 
External changes 
As a result of the intervention, some workers initiated changes in the work 
environment or their working practices, for example using safer equipment and 
implementing regular breaks between work tasks. In fact, a few self-employed 
patients/small business owners extended the OH recommendations to benefit their 
employees. 
[P12: male, 64 years, truck washer] “It made me conscious of giving the guys 
a little bit more of a break…erm…and saying, yes okay we will get stuck in for 
an hour and then we will have a cup of coffee” 
Another workplace change included some patients adjusting their exposures to 
vapours, gases, dusts and fumes by reducing or avoiding certain workplace 
exposures.  
However, some patients either made no changes or rejected some of the 
recommendations. One reason included the lack of use or applicability of the 
recommendation(s). Patients generally found PPE unsuitable in the work 
environment; with one patient rejecting the recommendation of using goggles in the 
workplace due to the lack of practicality. 
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Interestingly, a few expressed much of the recommendations provided in the OH 
feedback report were a repetition of the information they had shared about their 
current work practices at the assessment with the OH practitioner. 
A number of patients cited the personalised self-management recommendations 
useful and took steps to achieve the self-management recommendations; of which a 
few discussed the report with the GP. The information encouraged one patient to feel 
“enlightened” about their condition. It was also found to be more detailed than the 
information previously provided by the GP. The patients also positively commented 
on the BLF self-management booklet, particularly finding the advice on managing 
breathlessness useful. 
[P6: male, 80 years, technical manager] “I have never had one of those...best 
bit of information I have received since I’ve been aware of my condition…I do 
a lot of the recommendations based in this publication…breathing aspects. I 
certainly do try to and keep the airways clear.”  
Conversely, many patients were indifferent about the self-management information. 
Some reasons discussed included idleness, lack of time/opportunity to read the 
information and the view that self-management could only be confronted once ‘the 
other things are under control’. Furthermore, those with less severe disease felt that 
the self-management recommendations or BLF booklet were not currently 
appropriate or applicable.  
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This is the first study to assess the feasibility of delivering a standardised 
occupational health intervention to a heterogeneous sample of patients with COPD 
with varying disease severity and working in diverse occupations.  
5.7.1 Uptake of intervention 
Patient uptake rates to the COPE feasibility study were very low (11.3% of those 
invited), with younger patients, females, current smokers, those with milder disease 
and better work productivity more likely to decline or to not respond to taking part. 
Targeting those with lower work productivity using historic data on absenteeism and 
presenteeism was not successful, although there was a limited sample to draw from. 
These findings are in keeping with evidence that there is reluctance for COPD 
patients to undertake rehabilitation. Non-participation rates for pulmonary 
rehabilitation (PR) have been cited up to 50%,230 despite the clinical benefits of 
attending such programmes, such as improving quality of life in those with COPD.231  
Similar to this study, there is evidence that smokers are also less likely to attend PR 
than non-smokers (OR=0.3; 95% CI 0.1 – 0.9).232 This may be a consequence of the 
self-blame that some COPD patients experience, by attributing the cause of their 
COPD to smoking. Patients may therefore feel discouraged to take up health-related 
interventions due to their low expectations of the care provided to manage their 
condition as well as the fear of hearing “it’s your own fault”.233 
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5.7.2 Facilitators and barriers to uptake  
Two main factors were identified to influence the patients’ decision to participate in 
the study: 1) altruistic views, such as helping other COPD patients, increasing the 
COPD knowledgebase and being supportive of research and, 2) personal benefit, 
such as anticipating a positive impact on one’s own health and developing a better 
understanding of the condition. Only two patients provided an occupational reason as 
a motivating factor to take part. These findings – personal benefit and hoping to help 
others – are consistent with studies in other areas.234-236 However, these reasons 
relate to participation in a research study, and do not translate to view on the uptake 
of an OH assessment intervention. 
In terms of intervention uptake, most decliners did not see the relevance of the 
intervention, as they did not perceive they had a problem that needed to be 
addressed. This was either that they did not perceive having a health problem, or that 
they did not recognise problems with work, sometimes because they felt workplace 
adjustments were already in place. Occasionally they were concerned about 
employer involvement.  
However, employer involvement was raised as a significant concern among the 
interviewed participants, with patients citing employers’ main concern being work 
productivity rather than employee health, and job loss as one of the feared 
consequences of involving the employer. This was despite employer involvement 
being considered important for workplace adjustments to be implemented. These 
views are consistent with those of the general population, where there is generally 
reluctance among employees to disclose health information to employers.237 
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Similarly, among a population with work-related asthma symptoms, patients preferred 
to persist with respiratory symptoms at work out of fear of the financial consequences 
(e.g. job loss) associated with sharing health matters.238 
Practical issues related to lack of time or inconvenience of the venue were also cited 
as reasons for non-attendance, reflecting low motivation to attend, which is similar to 
the situation for many other predominantly lifestyle focused interventions.230;239;240 
Many participants suggested that negative perceptions or attitudes towards COPD 
(e.g. difficulty in accepting COPD) may contribute to non-participation. As COPD 
progresses, patients’ lives are increasingly affected; with symptoms and functionality 
worsening over time and resulting in poorer health, reduced quality of life and loss of 
independence.24 These changes are thought to trigger a grieving process 
characterised by: denial (“I have no problem”); resistance (“I want my life back”); 
sorrow (“all is hopeless”) and acceptance (“if I adapt to my disease I will have less 
symptoms and a better quality of life”).241 In fact, the denial stage can last many 
years in patients with COPD,242 especially as functionality losses and impairments 
start mildly and gradually worsen over time.24 Patients’ views of engaging with health 
interventions and how they view managing their disease may therefore be partly 
driven by their position in the grieving process. For example, at the initial denial 
stage, patients may experience having ‘no problem’, irrespective of whether a 
problem exists, and may therefore be unwilling to adopt behaviour changes for ‘non-
existing’ issues.  
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The grieving process resonated with views of some of the interviewed patients, who 
mentioned the importance of accounting for the acceptance stage when delivering 
interventions in patients with COPD. The stage of the grieving process may therefore 
provide insight into patients declining to take part in the intervention (possibly 
explaining the high “I am fine at work” response). It may also explain why some 
patients may ignore their symptoms whilst others are able to implement self-
adjustments to manage their symptoms in the workplace. Knowledge about the 
patient’s psychological barriers prior to initiating behaviour change through an OH 
intervention could therefore be beneficial.  
5.7.3 OH recommendations and uptake of OH recommendations  
The majority (80.0%) of patients who attended the assessment received some 
occupational recommendations. Although a range of recommendations were made, 
modifications to job tasks/work methods/physical aspects of the job and referral to 
OH services and education were recommended the most. This suggests that OH 
assessments are likely to identify potential modifications for most patients with COPD 
who are in work. Whilst the exploratory analysis suggested that the likelihood to 
benefit may be maximised by targeting those with certain characteristics (more 
severe disease, smokers and those working in occupations with high VGDF 
exposure), this needs further verification as the limited sample size in this study 
precludes drawing firm conclusions. 
However, whilst many recommendations were made, only 37% of these were 
reported to be implementable by patients, either because the suggested 
modifications were already in place, or the recommendations were perceived to be 
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impractical or not applicable. The impractical nature of recommendations, particularly 
in relation to use of personal protective equipment (PPE), has been cited as a 
general problem among workers243; with a lack of training in using PPE and good 
safety within the organisation identified as factors associated with reduced PPE 
compliance.244 Training on the importance of using PPE has been shown to impact 
positively on regulating health and safety.245 However, only a few participants alluded 
to the awareness of health and safety regulations in the workplace; possibly 
influencing their attitude towards such OH recommendations. 
This study found that the ideal workplace adjustment (as recommended by OH) may 
not align with patient preference or practicality, which is in keeping with other 
evidence focusing on adjusting behaviours in the workplace.246 This highlights the 
importance of patient feedback and possible workplace or on-site visits (if feasible) 
prior to providing OH recommendations, as methods of improving recommendation 
uptake.  
5.7.4 Self-management recommendations 
Unlike the OH recommendations, all participating patients received a minimum of one 
self-management recommendation. Nevertheless, similarly to the OH 
recommendations, over half of the interviewed patients did not use these 
recommendations, either because they lacked motivation or did not perceive they 
would benefit.  
The ability to self-manage COPD is important; interventions focussing on helping 
patients better self-manage their disease have shown positive patient outcomes, 
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which in turn translate to better work related outcomes. For example, a recent 
systematic review found highly supportive self-management interventions led to a 
significant reduction in hospital admissions compared to those receiving usual care 
among those with COPD (OR=0.60; 95% CI 0.40-0.89).63 Nevertheless, poor 
adherence to a therapeutic regimen is common among COPD patients for various 
reasons such as illness perceptions, depression and lack of social support.247 In fact, 
COPD patients often have a poor understanding of their symptoms.248 All of which 
may explain why some interviewed patients reported that their COPD did not require 
enhanced self-management. Additionally, COPD patients are often affected by other 
co-morbidities; adding further complexity to their therapeutic regimens.247   
5.7.5 The psychological impact: an outcome of participating in the 
COPE feasibility study 
It is known that patients often seek reassurance 249 and more information about their 
condition from healthcare professionals,250 and some of the motivating factors to 
participate in this study suggest that this was also true amongst this patient group. 
Even among those who did not plan to implement any of the recommendations 
following the intervention, many expressed benefits such as increased awareness of 
the relationship between COPD and work as well as feelings of reassurance about 
the condition and current practices to manage their COPD in the work environment. 
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5.7.6 Other measures and their feasibility 
As patients were not randomly allocated to receive the intervention and there was no 
control group, no conclusion can be drawn in terms of intervention effect, and the 
possible effect size. Nevertheless, this study has demonstrated the feasibility and 
acceptability of undertaking relevant measures in a definitive trial. 
 
5.7.7 Future considerations for OH assessments in COPD patients 
The findings from the qualitative interviews suggest that COPD is a complex 
experience among working individuals. The findings demonstrate that a study of this 
approach may not be successful as only a small number of patients wanted to take 
part. However, a number of factors were identified which may be useful when 
considering to deliver an OH intervention among COPD patients in the future, such 
as OH content, expertise and characteristics of individual(s) delivering the 
intervention, employer involvement and changes in current UK policy. 
OH intervention content to include patient empowerment and education 
Education on the management of COPD was important for the participants, and was 
seen as a key factor in patient empowerment. A number of patients expected a self-
management assessment or feedback at the face-to-face OH visit. Some patients 
also recommended incorporating a COPD self-management and/or health check 
component to the intervention as a means of improving the OH assessment. In fact, 
a number of patients described their struggles with managing their breathlessness 
during the qualitative interviews, and some expressed their appreciation of the ‘tips 
for managing breathlessness’ highlighted in the COPD self-management leaflet. 
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These findings are in keeping with the literature, related to COPD patients often 
feeling the need for more information about their condition.23 However, they do not 
necessarily receive accurate information about the disease and its management and 
there is evidence of the ineffective transfer of knowledge about COPD from 
healthcare professional to patient.233  
Expertise and characteristics of individual(s) delivering an OH intervention 
Whilst there were mixed views on the most appropriate professional to conduct an 
OH assessment, there were some constructive suggestions for future testing and 
implementation. The incorporation of an abbreviated OH assessment as part of the 
COPD annual review was welcomed by a number of participants, and might help 
overcome the low uptake rates and incorporate both OH assessment and self-
management advice delivered by the same professional in one visit. Recent data 
(2013/2014) shows that approximately 80% of COPD patients had an annual review 
in the previous 12 months.251 However, concerns about poor patient-GP 
communication and relationships, limited time and the lack of experience and 
expertise of practice staff all need to be considered and addressed.252-254  
Furthermore, participants articulated the desired skill set required for the professional 
that should ideally deliver an OH assessment intervention. These include possession 
of comprehensive COPD knowledge, OH background and good communication 
skills, and preferably someone external and unrelated to their employer.  
A plausible alternative proposal for delivery of an OH assessment, I suggest, is to 
incorporate this as part of a pulmonary rehabilitation programme, encouraging a 
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holistic assessment of the patient with a focus on their COPD related health needs. 
By improving self-efficacy, patients are empowered to modify their behaviours255 and 
respond effectively to particular events, for example the management of 
exacerbations.256 Therefore, this incorporation may encourage successful workplace 
behaviour adjustments. Incorporating an OH aspect to PR may also promote a 
targeted approach (as suggested by a number of patients) to identifying those more 
affected by their disease – UK NICE guidance recommends referral to pulmonary 
rehabilitation in those with a recent hospitalisation due to an acute COPD 
exacerbation or those with a MRC score >3.25 However, it would first be necessary to 
overcome the low uptakes to PR. Although one economical method, shown to 
improve attendance to health appointments, includes shifting the patient’s role from a 
passive to an active recipient through commitment. Examples include verbal 
commitment, with patients repeating the date and time of their appointment, and 
written commitment, with patients writing the details of their future appointments 
instead of a professional.257 
Employer involvement in future interventions 
The study findings indicate that employer involvement through a patient-driven 
approach may not be successful, despite a few patients reporting independently 
discussing the OH recommendations with employers. Future interventions may 
therefore wish to consider excluding direct employer involvement, leaving the 
dissemination of any recommendations at the discretion of the patient. However, 
issues related to the reluctance of informing the employer of health conditions still 
remain.  
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Managerial support is recognised as important for successful workplace adjustments 
in those with chronic health conditions.145 However, employers often lack 
understanding about disabilities and therefore may associate disability with physical 
impairments instead of those with a chronic or mental health condition.258 From the 
employer’s perspective, there is a need to address a number of factors for the 
adequate management of health conditions in the workplace: trust between the 
employee and employer; knowledge of the health condition and its impact on work 
and the need for employees to be open and take responsibility of their condition 
within workplace.259  
Direction for future policy 
Future policies need to focus on raising awareness of long term conditions, including 
COPD, in the workplace, and their impacts on work ability and work productivity. The 
needs and concerns of both patients (e.g. fear of job loss) and employers (e.g. lack 
of understanding about the impact of chronic conditions on work) need to be taken 
into account if we are to find solutions to managing COPD at work and gaining the 
best out of the workforce. 
5.7.8 Study limitations 
The main limitation of this study was the small sample size. Therefore, any patterns 
assessed among those who received recommendations should be interpreted with 
caution. Furthermore, we observed a possible non-response bias; for example, non-
participants were more likely to be female, current smokers and have milder disease 
than those participating in the study. Although the absence of randomisation and a 
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control group makes it difficult to draw conclusions about the impact of the 
intervention on patients, the purpose of this study was to explore the feasibility of 
such an OH intervention. There was no employer involvement in the study and 
therefore, the facilitators and barriers of the OH recommendations from the 
employer’s perspective are unknown. It would have been useful to collect quantitative 
outcome data on the usefulness of the self-management recommendations among 
all the participating patients. Although a few qualitative transcripts were assessed by 
other academics (including an experienced qualitative researcher), a more rigorous 
method would involve two data analysts independently assessing all transcripts. 
Lastly, although the main researcher (KK) consistently considered reflexivity during 
the interviews, interviewed patients may have felt reluctance to express their views 
openly due to the researcher’s role and commitment in the study. 
5.8 Conclusions 
This is the first study to assess the feasibility and acceptability of a standardised 
occupational health assessment in those with COPD. Uptake rates were very low, 
with younger individuals, smokers and those with milder disease declining or not 
responding. Although the majority of the patients who were seen received some OH 
recommendations, only half took up some or all of the recommendations. 
Modifications to job tasks/work methods/physical aspects of the job and to seek OH 
input and education were recommended the most. All patients received self-
management recommendations, although not all were willing to take these up. 
However, many patients reported benefits of an increased awareness and 
reassurance about COPD and the interaction between COPD and work due to the 
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OH intervention. Future interventions may wish to consider the patient’s position in 
the grieving process to understand whether patients have accepted their COPD 
diagnosis before initiating behavior change. Attaching the OH assessment as part of 
a pulmonary rehabilitation programme or embedding it within routine annual reviews 
are potential options that could be further explored. We found that employer 
involvement in this format is not feasible, although there is a need to raise awareness 
of the impact of COPD among employers. There is now a need for future 
interventions to develop on this work, and test the effectiveness of including OH 




   
6. DISCUSSION 
The overall aim of this work was to investigate the relationship between COPD, 
employment and work productivity. To achieve this, four research studies were 
carried out, detailed in chapters 2 to 5. First, a systematic review of the literature was 
conducted to collate the current evidence and assess how COPD and its associated 
severity impacts on employment, absenteeism and presenteeism. Subsequently, two 
cross-sectional analyses were conducted, assessing which socio-demographic, 
clinical and occupational factors contribute to the lower employment rates and 
reduced work productivity among those with COPD. Finally, these findings were used 
to inform an experimental study outlined in chapter 5. This involved investigating the 
feasibility and acceptability of a novel intervention, aimed at improving the 
management of COPD within and outside the work environment, with the ultimate 
intention to impact on work productivity. 
This final chapter aims to summarise the work within this thesis, discuss the main 
findings, and provide direction for clinical practice and future research in this field.  
6.1 Summary of the evidence 
6.1.1 Chapter 2: A systematic review assessing the effect of COPD 
on employment, absenteeism and presenteeism 
Prior to the work presented in this thesis, evidence on the impact of COPD on 
employment and work productivity was limited and conflicting. The systematic review 
has clarified some of these issues and highlighted areas for further work. There was 
clear evidence of lower employment rates among those with COPD compared to 
similar populations without COPD. Among those in paid employment, patients with 




COPD were found to take more time off compared to those without COPD, although 
there was inconclusive evidence as to whether sickness absence prevalence rates 
(episodes) differed significantly between COPD and non-COPD patients. Fewer 
studies were found assessing the impact of COPD on work performance, but 
available evidence suggests that COPD patients face greater impairment at work 
compared to those without COPD. The small volume of literature and inconsistencies 
in the measurement and reporting of this outcome did not allow quantification of 
these results.  
The review also indicated that among those with COPD, increased disease severity 
was associated with a reduced probability of being in work. However, there was 
inconclusive evidence on the impact of disease severity on work productivity. 
Methodological weaknesses, mainly the lack of adjustment for relevant confounders, 
limited firm conclusions being drawn. The paucity of evidence among a UK working 
COPD population was also highlighted by the review. 
6.1.2 Chapter 3: The association between COPD and employment; 
cross-sectional analysis of data from the Birmingham COPD Cohort 
I used data from the Birmingham COPD Cohort to report employment rates among 
COPD patients of working age (40.0%), which is lower than those reported in the 
general population (73.5%), those with a long-term condition (59.6%) and those with 
a disability (46.1%).179 I also found that being older (p for trend<0.01), having a lower 
educational level (p for trend<0.05), worse reported breathlessness (mMRC score 0-
1 vs. mMRC score 4: OR=0.36; 95% CI 0.15 – 0.85) and high workplace exposures 




to VGDF (none vs. high JEM derived VGDF: OR=0.32; 95% CI 0.12 – 0.85) were 
independently associated with a reduced probability of being in work.  
Whilst previous studies have suggested that disease severity may be an important 
contributor to unemployment among COPD patients,22;101;103;158 this is the first study 
to report the significant impact of reported breathlessness (a subjective measure of 
disease severity) on unemployment after adjusting for a range of relevant 
confounders. Other measures of disease severity, including increasing airflow 
obstruction and the presence of comorbidities, were not significant independent 
predictors of being employed. These results therefore clarify the inconsistencies 
noted in previous research,22;100-103;119;152;158 and suggest that reported 
breathlessness is a better indicator of being out of work compared to other 
measures.  
6.1.3 Chapter 4: The association between COPD and work 
performance; a cross-sectional analysis of data from the 
Birmingham COPD Cohort 
In this chapter I found that in the COPD cohort population who were employed, 
sickness absence prevalence (proportion of the working population reporting >1 day 
in 12 months) was lower (44%) compared to data from the general population 
(48%)260 and those with long-term conditions (55%).261 However, on average, 
patients with COPD took more time off work annually (10.4 days) compared to the 
UK national average (4.4 days)125; concurring with the findings from the systematic 
review.  




Using a multivariable logistic regression analysis, I assessed which characteristics 
were associated with high sickness absence durations (defining high sickness 
absence as > 6 days off work). Increasing breathlessness (MRC score 1 vs. MRC 
score 4-5: OR=9.04; 95% CI 2.85 – 28.68) was the only independent relevant factor 
identified, although increasing airflow obstruction and being female were also 
important factors when analyses were restricted to those with COPD-specific 
sickness absence. The findings help clarify the inconsistencies between disease 
severity and absenteeism noted in previous literature.22;118;152;158;160-162;165 
In contrast to the findings of the systematic review suggesting poorer work 
performance among those with, than those without COPD, the average presenteeism 
scores in our study population were similar to those reported in populations with no 
disability93 and better than those with arthritis,191 indicating that when at work, COPD 
patients are generally functioning well. However, our analysis did not contain a non-
COPD comparator population to allow adjustment for potential confounding factors. 
One of the unique features of this study was that we were able to examine 
presenteeism and absenteeism within the same population, and in this chapter I 
demonstrated that these measures are not interchangeable. One in five patients with 
presenteeism scores indicative of poor work performance had little or no recent 
absenteeism.  
Another novel aspect of this study was identification of factors associated with poor 
work performance, including increasing reported breathlessness, and high workplace 




exposures to VGDF (none vs. high JEM derived VGDF: OR=4.34; 95% CI 1.26 – 
14.93).  
Evidence from previous research suggested a trend between increasing 
breathlessness and presenteeism,22 however, this is the first study to confirm the 
association among COPD patients. Previous studies among COPD patients were 
small and methodologically limited, with contradictory findings of the impact of airflow 
obstruction on work performance.22;158;165 However using a validated presenteeism 
instrument and adjusting for important confounding factors, I found that airflow 
obstruction was not associated with poor work performance. 
6.1.4 Chapter 5: Feasibility of delivering an occupational health 
intervention aimed at improving work productivity, among working 
COPD patients  
Finally, these findings were used to inform the development of a feasibility study (OH 
intervention consisting of an OH assessment and feedback on improving current self-
management practices), with the aim of helping patients to manage their COPD 
better at work.  
Intervention uptake was low (11.3%). A range of physical, psychological and practical 
barriers affecting non-participation were identified. Participating patients viewed 
employer involvement negatively; >90% declined permission to involve the employer 
in the study (with the aim to improve the working environment), even with 
reassurance about anonymity. 
Nevertheless, amongst those who did participate, a number of potential benefits were 
observed. Everyone received recommendations for either workplace modifications or 




for improving their disease self-management, suggesting that their management 
could be further optimised. However, only half of these were perceived to be 
implementable. Many also gained in other ways, including reassurance, feeling of 
empowerment and gaining greater awareness. Patient empowerment is considered 
important for behaviour change262 and improving the quality of life and other health 
outcomes among those with a chronic condition.263-265 It involves equipping patients 
with the knowledge, skills and self-awareness of identifying and achieving their own 
goals,262 and thus, positively influence their own health.266 Group sessions or face-to-
face interventions have been found to be effective in increasing patient 
empowerment.267;268 Some of these elements were also part of the OH intervention 
(e.g. face-to-face interaction and educating patients on COPD and the relationship 
between COPD and work), which may partly explain the findings of the positive 
psychological impact among the majority of the participating patients.  
Whilst the intervention tested was not found to be feasible, the study provided 
important information to inform the development of future OH interventions, including 
insights into the content, groups who should be targeted, timing of such interventions 
in relation to the course of the disease, type of occupation and pattern of work, and 
characteristics of those who could deliver such interventions, seeking opportunities to 
embed the intervention within existing structures.   
 
 




6.2 Measures of disease severity in predicting 
occupational outcomes among those with COPD 
The findings of these analyses consistently demonstrate that reported 
breathlessness is a better measure of the impact of COPD on employment and work 
productivity than any other single measure of disease severity. 
Historically, airflow obstruction (predominately measured by FEV1) was used to 
define the overall severity of COPD. However over the years, there has been an 
increasing recognition of the unclear or weak correlations between airflow obstruction 
and the various aspects of health, such as health related quality of life and 
prognosis.47;269 Furthermore , there is evidence that other single measures, such as 
exercise capacity, may better assess the impact on health than FEV1.270  
Consequently, there has been a rise in the development of multi-dimensional 
prognostic indices as a means of capturing the various aspects of disease severity 
into one measure,271 for a better assessment of the impact of COPD on the 
individual. The testing of these indices, combined with the known heterogeneity of 
COPD, has led to the acceptance that such multi-dimensional instruments better 
predict important clinical outcomes (e.g. mortality,48 hospitalisations272 and COPD 
exacerbations273) and thus COPD prognosis, than FEV1 alone. Many of these 
measures include breathlessness as one of the components. Furthermore, over the 
recent few years it has been recognised that the degree of reported breathlessness 
is a better predictor of mortality than airflow obstruction.47 




The findings in chapter 3 were in keeping with this; the modified BODE index better 
measured the impact of COPD on the likelihood of being in paid employment than 
airflow obstruction. Subsequently, various components of the modified BODE index 
were explored. Although there was a non-significant trend associated with increasing 
airflow obstruction, the breathlessness component was the main driver of the effect 
on employment. Furthermore, this was validated by the consistent evidence across 
all three outcome measures (employment, absenteeism and presenteeism) assessed 
in this thesis. 
However, research in this field is lagging; although a few studies have incorporated 
measures of dyspnoea into their assessment of COPD and statistical 
modelling,22;100;118 airflow obstruction has been the main measure of disease severity 
among the majority of studies.  
Due to the clear evidence presented in this thesis, a strong suggestion is that future 
statistical models should consider including other important measures of disease 
severity, particularly breathlessness, in addition to airflow obstruction. An alternative 
suggestion is the use of a multi-component prognostic index (instead of individual 
factors depicting aspects of disease severity), which contains breathlessness, such 
as the BODE index48 or the ADO score49 which has been validated in primary care 
populations. This may be more suited to models requiring adjustment for COPD 
prognosis, as the use of a composite index should help avoid the problems of 
reduced statistical power occurring with adjustment for a number of individual 
covariates.  




6.3 The importance of exposure to vapours, gases, dusts 
and fumes in COPD  
The causal role of occupational exposures in the development of COPD is well 
documented71;72; although the effect of such exposures on employment and work 
productivity among those with diagnosed COPD was less clear.101;102;118;274 This is 
due to the paucity of evidence in this area, as well as the lack of reliable 
measurements of occupational exposures. 
A few previous studies did suggest that occupational exposures to VGDF are 
associated with adverse working outcomes. For example, such exposure has been 
shown to increase the risk of respiratory related work disability (mainly defined as 
changing or leaving job due to lung disease) in those with COPD (low risk VGDF vs. 
high risk VGDF: adjusted OR=1.6; 95% CI 0.8 – 3.0),275 asthma (none vs. high VGDF 
exposure: adjusted OR=3.5; 95% CI 1.4 – 9.0)276 and the general population (none 
vs. high VGDF exposure: adjusted OR=3.4; 95% CI 1.8 – 6.6)276 as well as 
respiratory related sickness absence among those with asthma (none vs. high VGDF 
exposure: adjusted OR=1.96; 95% CI 1.06 – 3.64) and respiratory symptoms (none 
vs. high VGDF exposure: adjusted OR=2.20; 95% CI 1.01 – 4.77).201 These 
highlighted studies include prospective longitudinal studies,275;276 with large,201;276;277 
randomly selected participants from the general population (reducing the risk of 
selection bias),201;275-277 all of which have used a standardised method of assessing 
the risk of occupational exposures to VGDF (although varying job exposure matrices 
were used).201;275-277 However, these studies were based on self-report of respiratory 
disease, and therefore at risk of misclassification.201;275-277 Furthermore, important 




socio-demographic (e.g. education or socio-economic status), co-morbidities and 
clinical characteristics among those with respiratory disease (e.g. disease severity 
distribution) were often unreported; thus, lacking clarity in the generalisability of the 
sample population to those with respiratory disease. Some studies included younger 
participants (aged<45 years),201;276;277 which may preclude generalisability of the 
impact on work disability to those of working age (<65 years). They also suffered 
from methodological limitations related to the lack of adjustment of all important 
confounders, such as co-morbidities, educational level and disease specific 
characteristics (although one study adjusted for asthma symptom score276). 
Although the cross-sectional nature of this work precludes inferences on the causal 
role of VGDF on work ability and work productivity, many of these limitations 
(adjusting for all important confounders, spirometry defined COPD or based on GP 
records, range of socio-demographic, clinical and occupational characteristics within 
study sample) were addressed in this thesis. Furthermore, given that the majority of 
participants had been in their job roles for many years, whereas the measures of 
work productivity were recent, a temporal relationship was likely. Additionally, the 4 
level job exposure matrix within this thesis included an additional level (medium 
exposure level to VGDF), which was deficient in the exposure matrices in the other 
studies (mainly based on 3 levels, such as, none, low and high or, low, intermediate 
and high),201;275-277 and therefore may be considered as potentially more 
discriminatory to VGDF exposures in the workplace than other matrices, as well as 
providing evidence of a dose response relationship.   




The findings in this thesis (using lung function data, a standardised job exposure 
matrix and adjusting for all relevant confounders) that high exposures to VGDF were 
associated with the reduced probability of being in work and an increased risk of poor 
work performance, were in keeping with the emerging body of literature as well as 
addressing the gap in knowledge of the impact among COPD patients. Weak trends 
were also associated with high rates of sickness absence, but the study lacked 
power to detect significant differences, should they exist. 
With occupational exposures to VGDF identified as a significant factor associated 
with unemployment (chapter 3), poor work productivity (chapter 4) and increased risk 
of work disability275 in patients with COPD, it is important that this is considered in 
future studies to take account of the potential adverse impact of occupational 
exposures on working patients with COPD.  
6.4 A model for other chronic diseases  
Poorer working outcomes are not observed in COPD patients alone. Chapter 1 and 
the systematic review in chapter 2 highlighted that having any long-term health 
condition is associated with adverse working outcomes compared to those with no 
chronic conditions. With an ageing UK population and an ageing workforce, chronic 
disease, is likely to become more prevalent in the labour market,278 and as a 
consequence, lower employment rates and reduced productivity are likely to increase 
among these patients. To address this projected increase in poor working outcomes, 
interventions among those with chronic disease should be underpinned by the factors 
affecting these individuals. 




Although the work presented in this thesis is in relation to one particular chronic 
disease – COPD – it demonstrated the assessment of factors (socio-demographic, 
clinical and occupational) which are also relevant to those with other chronic health 
conditions. Therefore, this work could be used as a model for research into the 
effects of other chronic conditions on work, with the assessment of similar clinical and 
occupational factors, particularly characteristics which are specific and relevant to the 
disease. This should account for patients’ perceived limitations (e.g. subjective 
markers of disease severity) in relation to their condition in addition to clinically 
measured outcomes depicting disease severity. As observed in this work, a 
subjective measure of disease severity (patient reported breathlessness) better 
predicted the impact on work than an objective measurement (airflow obstruction, 
measured by spirometry). This suggests the importance of assessing commonly 
reported symptoms, such as pain,279 physical limitations280;281 or fatigue,282 among 
chronically ill patients, as potential indicators of occupational or disease outcomes.  
It is also important to consider the impact of multimorbidity on occupational 
outcomes. Workers are likely to be affected by more than one health condition,145 
and multimorbidity is  projected to increase among the UK population.279 In the 
working population in this study, 83% reported having at least one co-morbidity in 
addition to COPD. There is much evidence that multimorbidity is associated with 
adverse occupational outcomes145;283 as well as increased functional difficulties and 
poorer quality of life.284 Therefore, in addition to disease-specific measures, 
assessment of multimorbidity should also be incorporated within future studies that 
assess factors impacting on work productivity.   




6.5 Future interventions aimed at improving work-related 
outcomes among those with COPD 
There are two main approaches that could be used for improving work-related 
outcomes among those with COPD: disease-focused or workplace-focused 
approach. More commonly, the latter approach has been used, whereby 
interventions targeting either the whole workforce, or those with chronic conditions 
are evaluated in larger workplaces. These interventions have the potential to be 
rolled out to other large employers, and often use systems and processes that are 
more commonly available in such workplaces. For example, collaboration between 
the employer, employee and occupational health services for a worksite assessment, 
workplace modifications and a return to work plan for the patient (in those taking time 
off work), including an expected return date.211  Among those with chronic health 
conditions, this may also include health promotion advice such as smoking cessation 
and physical activity.210 Disease focused interventions have mainly been used for 
chronic diseases such as cancer or heart disease, where people with these 
conditions are supported to return to work after recovery from an “event”.  For 
example, important intervention components among those returning to work after a 
myocardial infarction (MI) include: knowledge about MI and its associated symptoms, 
addressing patient perceptions of MI and discussing the importance of medication 
and lifestyle behaviours (e.g. physical activity).213 Among cancer patients returning to 
work after their diagnosis, interventions may include education (e.g. about the 
condition and nutrition) coping strategies (for managing stress and fatigue), 
counselling, physical activity and a multidisciplinary endeavour to support the patient 
to return to work.215 




It could be argued that both approaches possess strengths as well as weaknesses; 
these are discussed further below.  However, in this thesis, a disease-focused 
approach has been used and was more appropriate given the population studied. 
Reported breathlessness, which is potentially modifiable with interventions such as 
pulmonary rehabilitation, was identified as a risk factor for all occupational outcomes. 
Furthermore, all patients who took part in the occupational feasibility study had at 
least one area of their care that could have been improved (self-management 
recommendations), and most had workplace modifications that if implemented, could 
have impacted on their disease.  Therefore a disease-focused intervention, delivered 
by an external professional (independent of the employer), seems viable and could 
be explored further. Whilst the approach used in this thesis was not feasible, other 
ways of delivering such an intervention are worth pursuing. This would encourage a 
targeted approach to symptom management, tailored to the needs of COPD patients, 
as well as the use of clinical expertise to encourage behaviour change. Patients may 
also feel more confident to discuss their individual health needs and the associated 
problems encountered in the working environment, without fear of the repercussions 
on their employment. Furthermore, the multi-component nature of the disease would 
benefit from specialist expertise and supported management in the overall 
management of COPD patients for improved health outcomes, such as quality of 
life.63  
However, specific workplace adaptations, such as the reduction of occupational 
exposures, may be more challenging to implement using this approach. For this, a 
workplace-focused approach might be more suitable. Such an approach could 




potentially encourage the entire workforce to benefit. However, a workplace-focused 
approach is unlikely to be individualised (e.g. a generalised and non-specific 
assessment of the patient’s condition) due to the differing health conditions, lifestyles 
and risks of disease within the workforce,1;179 and therefore the approach could be 
less effective in improving specific disease related issues associated with adverse 
working outcomes (such as breathlessness). However, individuals may benefit from 
broader health promotion or occupational advice such as smoking cessation, or the 
use of personal protective equipment in the work environment.  
It could be debated whether workplace occupational health services could deliver 
disease-specific assessment and recommendations for the workplace. However, as 
supported from evidence presented in this thesis, patients may be reluctant or 
unwilling to discuss their disease as well as their lifestyle behaviours in this format. 
Therefore, the targeting of particular patient groups (e.g. those with more severe 
disease) and the timing of the intervention (e.g. subsequent to acceptance of the 
diagnosis of COPD) could be challenging factors to address in a workplace-focused 
approach. From the employer’s perspective, this may involve greater resources and 
therefore greater costs to the organisation in the short-term. Although benefits may 
be observed in the long-term, such as reduced absenteeism, increased work 








6.6 Strengths and limitations of the thesis 
Few studies have examined the effects of COPD on occupational outcomes within a 
primary care population assessing a range of socio-demographic, clinical and 
occupational characteristics, accounting for a wide range of potential confounders 
with objective measures of disease severity (particularly spirometry defined COPD). 
Furthermore, this is the first UK study to assess these effects. However, there are a 
number of limitations. Sickness absence rates were not verified and may not 
accurately reflect the true prevalence. Participation in the Birmingham COPD Cohort 
was low (26.3% uptake), and therefore some findings may be affected by responder 
bias. It is known that those participating in research are likely to be different from 
non-participants, for example, they are likely to be healthier and hold differing views 
on health compared to non-participants (e.g. current smokers are less likely to 
participate in research).286 Those taking part in the cohort study were more likely to 
be male and of White ethnicity compared to non-participants. Therefore, those with 
COPD and in employment might be under-represented within this cohort; with the 
sub-cohort containing a biased sub-set of working patients with COPD. This may limit 
the generalisability of the study results to male COPD patients, specific occupations 
which are more common among men, as well as healthier COPD patients. Although 
these weaknesses may affect prevalence rate estimates, the associations observed 
with this work remain valid.  
A novel element of the Birmingham COPD Cohort, and a strength of this work, is the 
addition of the newly identified COPD patients; allowing for the inclusion of those with 
milder disease (GOLD stage 1 prevalence rates in those newly identified vs. existing 




COPD patients: 61.8% vs. 24.5%; MRC score 1-2 prevalence rates in those newly 
identified vs. existing COPD patients: 64.8% vs. 37.8%). However, as baseline 
research visits were carried out at the patient’s GP practice, housebound patients 
were excluded. These patients may have more severe COPD, and therefore may be 
under-represented in this cohort.  
Of the patients with an existing COPD diagnosis (from the GP register) who were in 
work at baseline, airflow obstruction was confirmed in only 283 (84.2%) patients 
(according to the fixed ratio definition in UK guidelines: FEV1/FVC<70%). Although 
this may be partly explained by variation in lung function measurements due to 
issues related to repeatability of lung function measures287 and variations in 
bronchodilator response (reversibility) between spirometry tests,288 it may also 
suggest misdiagnosis among some of the patients. Therefore, some of the included 
patients may not have COPD according to the clinical definition within UK guidelines. 
However, as these patients have been labelled with a diagnosis, and are potentially 
receiving treatment and self-management guidance for COPD, they were included in 
the final analysis.  
Lastly, the cross-sectional nature of the analyses in this work precludes causal 
associations to be established. This limitation could be addressed once the 
Birmingham COPD Cohort three year follow-up is complete. Furthermore, this work 
lacked a comparator group (non-COPD patients). Nevertheless, the work presented 
in this thesis has revealed some important findings with relevance for future policy, 
clinical practice and future research. 




6.7 Considerations for the overall management of COPD 
patients 
In the UK, NICE provide evidence based guidance for the management of COPD.25 
The main aim of promoting COPD self-management is to “prevent exacerbations 
through lifestyle adaption and to allow patients to acquire the skills to treat their 
exacerbation at an early stage”.39 Hence, the guidance recommends a number of 
strategies, some of which include smoking cessation, medication management and 
an action plan for worsening symptoms (recommendation areas are highlighted in 
chapter 5).25 However, evidence from the feasibility study highlighted that there was 
suboptimal management of COPD among all participating patients, as each patient 
was provided with at least one additional self-management recommendation (with 
several recommendations provided to many patients). It can be argued due to the 
small study sample size (n=35) it is difficult to extrapolate and generalise the findings 
to the wider COPD population. However, findings from chapter 4 concur with these 
results. It is also likely that those who agreed to take part in the feasibility study 
represent a more motivated group that attend annual reviews, suggesting that the 
findings are more likely to underestimate the problem of sub-optimal management. 
Smoking cessation is the single most cost effective method in improving the adverse 
outcomes in patients with COPD, irrespective of disease severity and has also been 
demonstrated to slow the progression of COPD by preventing lung function from 
worsening.60;289 Yet, a high proportion (n=133; 41.3%) of those in work remained 
current smokers. Furthermore, as highlighted in chapter 1, increased exacerbations 
are associated with poorer health outcomes, such as increased mortality, increased 




morbidity and a poorer quality of life.55;57 Self-management guidance focuses on the 
importance of preventing exacerbations. However, among this working population, 
approximately 14% of patients experienced >3 exacerbations in the previous 12 
months requiring treatment with antibiotics or steroids. These results suggest that 
better COPD management is required amongst these patients. 
Self-management has been defined as “the patient’s ability to manage the 
symptoms, treatment, physical and social consequences and lifestyle changes 
inherent in living with a chronic condition”290; a shared definition among all chronic 
conditions. For which a collaborative endeavour between patients and healthcare 
professionals is necessary to ultimately encourage behaviour change within 
patients.1;291 
However, findings from chapter 5 indicated patients were actively seeking to find out 
further information about the disease and its management, demonstrating potential 
knowledge deficiencies. Some patients also expressed their concerns about their 
passive relationships with their GPs, and the lack of concern displayed by their GP 
towards their condition. However, knowledge about COPD is important for behaviour 
change and the management of the disease among patients; highlighting the 
importance of the healthcare professional’s role in helping patients achieve positive 
health outcomes.255 
It appears much work is still needed to improve the overall self-management and 
health of patients with COPD, particularly among the working population. There is a 
need for healthcare professionals to focus on the recommended strategies 




highlighted in the NICE guidelines to improve self-efficacy of patients, particularly 
guidance for smoking cessation.  
6.8 Recommendations for policy 
The relationship between COPD and work outcomes merits greater attention and 
should be considered as a matter of concern for all stakeholders. Patients, 
healthcare professionals and employers need to be informed of the adverse impact 
of COPD on work ability and work productivity. This is in preparation to help patients 
to remain in or return to work as well as supporting patients to manage their 
breathlessness and promote the reduction of exposures to VGDF in the workplace. 
Whilst policy to restrict or reduce workplace exposures would be important for those 
with an existing COPD diagnosis, it could potentially have wider beneficial effects on 
the workforce e.g. among those with other respiratory diseases, respiratory 
symptoms as well as in those with undiagnosed COPD. 
Part of the UK government’s strategy to help those with health conditions and 
disabilities remain in or return to work is to educate healthcare professionals, so they 
are better informed and confident to provide advice to patients.10;292 One 
recommendation from this thesis, is that these strategies also incorporate informing 
healthcare professionals of the impact of COPD on work, and the importance of 
improving the management of breathlessness among these patients.  
I also recommend that the UK government should raise awareness among 
employers about COPD, and the impact of occupational exposures on employment 
and work productivity, to encourage workplace accommodations. This could 




potentially be carried out and tested alongside the government’s COPD public health 
initiative – a proposed strategy aiming to raise the awareness among employers of 
the risks associated with smoking and VGDF in lung damage and the development of 
COPD.10 
Lastly, the GP’s role is considered “pivotal” in ’health and work’, as they are usually 
the first healthcare professional patients meet when taking sickness absence from 
work, and are in an influential position to provide guidance about remaining in or 
returning to work.1;10 Therefore, GPs should be encouraged to discuss with patients 
the effects of COPD on work, to increase the awareness among patients of the 
potential adverse outcomes of the disease.  
Activities for increased awareness should also include embedding such information 
within the current literature provided to COPD patients e.g. leaflets related to living 
with COPD, and patient friendly websites. Although leaflets, such as those from the 
British Lung Foundation (BLF) (appendix 6), may contain limited information on the 
impact of work on COPD (occupational exposures contributing to further lung 
damage), this could be modified to include information on the consequences of 









6.9 Recommendations for practice 
Reported breathlessness was identified as a consistent clinical factor affecting work 
related outcomes in all analyses presented in this thesis. This suggests that there are 
potential opportunities to modify work ability and work productivity among those with 
COPD. The UK NICE guidelines for COPD provide guidance for healthcare 
professionals on the management of breathlessness, such as better medication 
management, smoking cessation, referral to pulmonary rehabilitation and oxygen 
therapy.25 Healthcare professionals, particularly those within primary care, should 
therefore identify breathless working patients (preferably using the MRC 
questionnaire), and work alongside these patients to encourage better management 
of their symptoms. Additionally, as identified in the feasibility study, some patients 
may benefit from written information on the management of breathlessness, which 
should also be considered by healthcare professionals.  
Occupational exposure to VGDF was also identified as a modifiable factor that 
impacts on work ability and work productivity among COPD patients. This suggests 
the importance for COPD patients to undergo occupational health (OH) assessment 
to determine the level of exposure to VGDF in their working environment. OH 
services may be able to suggest modifications or workplace accommodations among 
those identified with high exposure jobs. In practice, such assessment may not be 
feasible for all working COPD patients due to the low provision of OH services; an 
estimated 3% – 15% of all UK companies provide OH support (dependent on 
definition of OH support).293 Furthermore, the approach taken in the feasibility study 
to assess and intervene to reduce exposures to VGDF in the work place did not 




appear to be feasible. However, exposures to VGDF remains a clear issue among 
working COPD patients and therefore other approaches should be considered to 
assess and reduce such occupational exposures. 
One potential solution may include providing all stakeholders (patients, employers 
and GPs) access to information on the level of exposure to VGDF for the patient’s job 
role (as an alternative to a risk assessment by OH services). For this, a validated job 
exposure matrix could be linked to the CASCOT software (freely accessible online), 
and a VGDF occupational risk (none, low, medium or high) could therefore be 
presented alongside each job title. This may facilitate employees, employers or GPs 
to initiate or seek advice for the appropriate modifications required to patients’ job 
role, job tasks or working environment to reduce exposure. 
A formal assessment of workplace exposures to VGDF could also be incorporated as 
part of the workplace risk assessment, which currently all employers are legally 
required to carry out.294 This may be a feasible solution, particularly amongst 










6.10 Recommendations for research 
Although recommendations for future research were made in relation to each study, 
this is a summary of the main points to be considered for future research. 
Much of the evidence assessing the relationship between COPD and work (including 
chapters 3 and 4) is limited to cross-sectional studies, which precludes drawing 
inferences on causality. Of the small number of longitudinal studies, the majority 
assessed the impact on absenteeism, and consisted of methodological limitations, 
such as diagnosing COPD based on self-report. There is therefore a need for robust 
prospective longitudinal studies to establish the temporal relationships between 
disease severity, occupational exposures to VGDF and employment/work 
productivity. 
Although the findings (e.g. time off work) were compared to other studies and 
national datasets, this study did not contain a comparator population. Future 
observational studies should contain a non-COPD population to allow for a better 
comparison of outcome measures between those with COPD and those without; 
allowing for consistency in the measurement of exposures and outcome measures, 
statistical adjustment and subsequent statistical significance of any group 
differences.  
In the cross-sectional studies (chapter 3 and 4) there was a low level of data 
completeness for some of the measures; a known issue in observational research. 
Data from health records, where possible and relevant, might also improve data 
accuracy (e.g. co-morbidities and exacerbations).  




The systematic review identified the use of varying presenteeism instruments in this 
field of research, as well as the inconsistency in the reporting of results. Such 
heterogeneity led to difficulties in quantifying and comparing the results between 
studies, as well as assessing the true impact of COPD on work performance – which 
was also true for the studies reporting the impact on absenteeism. There should be 
an agreement on consistent measurements and reporting methods of these 
measures, to allow for comparison between studies 
Due to the consistent significant findings of the importance of breathlessness, I 
recommend that future statistical models should consider including other measures 
of disease severity, particularly breathlessness, or the use of a prognostic index 
instead of assessing airflow obstruction alone. Statistical models may also consider 
testing for the confounding impact of VGDF. 
Lastly, I recommend further research to determine the effectiveness of managing 
breathlessness and reducing workplace exposures on work ability and work 
productivity among patients with COPD. One possible approach is to investigate the 
impact of an OH component as part of a pulmonary rehabilitation programme, where 
patients are referred because of their breathlessness. However, inconvenient timings 
and venue locations have been identified as barriers to the uptake of such 
programmes. To increase accessibility and uptake, future programmes should 
consider providing weekend options, particularly for working patients, and venues 
local to the patients. 
 





There is a need to help patients with COPD remain in or return to work and among 
those in work, to help improve their work productivity. With the state pension age 
rising, there is a need to hasten the response of addressing these issues. The 
studies presented in this thesis provide valuable information for developing a strategy 
to help improve the low employment and high sickness absence rates in those with 
COPD: 
 Breathlessness is the single most important clinical factor associated with 
unemployment and poor work productivity. 
 High exposure to VGDF is the key occupational factor associated with 
unemployment and poor work productivity. 
 It is important to raise the awareness of these two issues amongst patients, 
clinicians and employers. 
 Findings from the feasibility study, particularly the low uptake rates suggest 
that the study was unsuccessful in its current format. However, patients 
identified self-management as an essential element for the general 
management of COPD. 
 Future interventions could test the impact of an OH assessment as part of a 
pulmonary rehabilitation programme on working outcomes, to encourage a 
holistic approach to the management of the multidimensional nature of COPD. 
 The thesis also provides important insights into an important chronic disease 
in relation to work, which could be the basis for the study of other common 





APPENDIX 1. COPE FEASIBILITY STUDY: 









































APPENDIX 2. COPE FEASIBILITY STUDY: 






APPENDIX 3. COPE FEASIBILITY STUDY: 











Current symptoms and 
work 
At work do you experience any symptoms due to your COPD? 
Does your work affect these lung symptoms? 
Do your lung symptoms affect your work? 
Symptom management 
at work Do you do anything in the workplace to manage your symptoms or your COPD? 
Current workplace 
triggers Are you exposed to any vapours, gases, dusts or fumes in your current work? 
 Do any exposures/substances/materials at work worsen your symptoms e.g. leave you feeling short of breath, make you cough or make you feel tired at work? 
 Do any job tasks/work methods/tools at work worsen your symptoms e.g. leave you feeling short of breath, make you cough or make you feel tired at work? 
 Are there any physical aspects of your job which worsen your symptoms e.g. leave you feeling short of breath, make you cough or make you feel tired at work? 
 Are there any other factors at work which can make your COPD worse?  
Working 
demand/pattern Do you work shifts? 
 How many hours do you work per week? 
 Does your shift pattern or working hours affect your health? 
 
In your job, has the work demand or shift patterns worsened your COPD symptoms 
(leave you feeling short of breathe, make you persistently cough or make you feel 
tired?) 
Work environment Is the work environment generally dust-free? 
 Do you work in a cold environment or exposed to draughts? 
 Is your work mainly outdoors? 
 In your job, has the work environment worsened your COPD symptoms (leave you feeling short of breathe, make you persistently cough or make you feel tired?) 
 In your view, can any changes or modifications to your work or work environment be made to improve your COPD at work? 
Equipment and training 
Has your employer suggested you work any personal protective equipment (PPE) 
for certain work tasks? (for example masks)  
IF YES: do you use them? 
IF NO: do you feel the need for PPE for certain work tasks? 
Working relationships Does your line manager know about your COPD?  IF NO: Why not?  
 IF YES: Have with spoken with your employer about work how work affects your COPD 
 
Have any changes been made to your work or working environment because of your 
COPD? 
IF YES: What are they? 
Occupational support 
from work 
Does your current workplace have an occupational health service? 
IF YES: have you received any occupational health services support for your COPD 
at your current workplace? 
 Does your employer give you advice on how work may affect lung health? 





APPENDIX 5. COPE FEASIBILITY STUDY: 


















































APPENDIX 7. COPE FEASIBILITY STUDY: 











APPENDIX 8. COPE FEASIBILITY STUDY: 


































APPENDIX 9. SEMI-STRUCTURED PATIENT 
SATISFACTION QUESTIONNAIRE 
We would like to know your views on the occupational health assessment that you had on 
<XX/XX/2014> 
Was this the first occupational health assessment that you have had? Yes/No 
If yes, in what way did this assessment differ from your previous experience? 
Similar detail to previous experience/ more detailed than previous experience / less intensive or 
detailed than previous experience 
Similar in terms of usefulness to previous experience / more useful than previous experience / less 
useful than previous experience 
























































Your satisfaction of the outcome of the assessment 
I feel in better control of my health at work       
I now understand the changes which need to be 
made to improve my health and wellbeing at work 
      
I would recommend an occupational health 
assessment to my colleagues  















*If you have 




explain why  
Implementing the OH practitioner’s suggestions at work 
<<SPECIFIC RECOMMENDATIONS FOR EACH 
INDIVIDUAL PATIENT WILL BE STATED>> 
    







APPENDIX 10. QUALITATIVE INTERVIEW 






















APPENDIX 11. QUALITATIVE INTERVIEW SCHEDULE 












APPENDIX 12. SEMI-STRUCTURED INTERVIEW 













APPENDIX 14. QUALITATIVE INTERVIEW: PATIENT 
INFORMATION SHEET FOR THOSE 










APPENDIX 15. QUALITATIVE INTERVIEW: PATIENT 
INFORMATION SHEET FOR THOSE NOT TAKING 
































1 Truck washer 6 
Substances/materials 
 Handling (diluting, mixing and use) of strong acidic cleaning solution e.g. cleaning 
using aluminium oxide (spray), should be prevented or minimised as this is a 
respiratory irritant 
Job tasks/work methods/physical aspects of the job 
 Cleaning in confined spaces with poor ventilation can generate a high level of irritating 
cleaning agents as well as oils and greases from surfaces. Indoor cleaning activities 
using blasting machines should be avoided   
 Cleaning using large brushes (attached to heavy hoses) particularly for prolonged 
periods must be avoided or delegated to other employees e.g. when cleaning larger 
trailers 
 Avoid lifting and carrying/moving large heavy tubs containing cleaning solution (e.g. 25 
litre containers)  
Work organisation 
 To review the cleaning schedule for each job and discuss with the client, to avoid the 
need for high intensity cleaning over a short period of time 
Personal protective equipment 
 A suitable respirator should be worn when supervising or inspecting indoor cleaning 
operations e.g. cleaning of warehouses which may involve the use of high pressure 
hoses and chemical cleaning agents.  
2 Bricklayer 8 
Job tasks/work methods/physical aspects of the job 
 Avoid dusty tasks e.g. putting cement into mixers, making up plaster, paper stripping 
and any occasional demolition work.  If these tasks cannot be avoided, then a suitable 
respirator (mask) should be used for the duration of the task   
 Where possible, avoid tasks which require regular bending or working below waist level 
e.g. when laying bricks below waist height.  Consider sitting on a stable stool when 
working at lower levels for prolonged periods and avoid storing materials at ground 
level  
 Avoid lifting heavy items e.g. bags of cements, carrying too many bricks/blocks at a 
time and ‘loading out’ i.e. carrying building material from storage to build area  
 Consider using mechanical lifting aids e.g. trolleys or telehandlers when moving large 
loads 
 Physical work should be delegated to other staff/contractors e.g. digging out footing in 
new builds 
Work environment 
 Where possible avoid outdoor work on damp /frosty days.  Consider re-scheduling 
work with client(s) to avoid working in cold conditions 
Work organisation 
 Schedule jobs which enable pacing of work to avoid continuous work e.g. working 
more than 2 hours without a break 
Personal protective equipment 
 Check and ensure that you have the right type of face mask (respirator) for the different 
tasks.  For example, masks recommended for dusty jobs are not likely to provide 
protection when painting, varnishing and using thinners  
3 HGV tank driver 2 
Occupational health services and education  
 It is important that all vehicle drivers who transport cement report any respiratory 
symptoms to the local occupational health department, who can advise on workplace 
adjustments, if needed  
 It is also important for employees to attend the annual appointments offered by the 









 To report to the line manager about the need for regular cleaning of the office and 
work surfaces, to avoid the build-up of dust 
Occupational health services and education  
 Need to report any respiratory symptoms at work to the local occupational health team, 
who can advise on workplace risk assessments and improvements to the work 
environment 
5 Senior care assistant 2 
Substances/materials 











irritation. You should avoid handling (making-up solutions and applying) strong 
cleaning agents and entering rooms whilst deep cleaning is being conducted by other 
staff particularly in areas which are not well ventilated  
Occupational health services and education  
 You should report any respiratory problems at work to the occupational health 
team/care home manager so that the care home can review its cleaning and manual 
handling practices particularly for carers with existing respiratory problems.   
 
 
6 Plumber 5 
Substances/materials  
 Soldering activities can generate fumes which can cause respiratory 
irritation/sensitisation.  The fume levels can be reduced by using: 
 Plastic instead of copper fitting  
 Use of solder ring joint or crimp fitting  
Job tasks/work methods/physical aspects of the job    
 Alternatives to the use of wire wool for cleaning copper pipes should be considered e.g. 
abrasive pads, particularly when cleaning for prolonged periods and very old pipes 
which may be coated with various metals, paints etc. Could also consider using 
mechanic pipe cleaning tools e.g. monument pipe cleaners 
 Wherever possible, physical work should be avoided e.g. carrying radiators and 
breaking up cast iron baths  
Work environment  
 Dusty work areas should be screened to avoid the spread of dust in to your work 
environment      
Personal protective equipment  
 Need to wear a dust respirator when conducting all cleaning activities after completion 
of job tasks (e.g. at end of each day) 
7 Cleaner 2 
Substances/ materials  
 Most cleaning chemicals are respiratory irritants which can worsen symptoms of those 
with existing respiratory problems. Where possible avoid using strong cleaning agents 
particularly in confined spaces or in poorly ventilated areas 
Occupational health services and education  
 It is important to inform management of respiratory symptoms at work so that: 
a) Work methods can be reviewed to minimise exposure to chemicals 
(cleaning agents and dusts) which may be due to: 
 the over use of cleaning agents by colleagues 
 cleaning being conducted in poorly ventilated areas  









Work environment  
 Individuals with existing respiratory problems may be affected by work processes 
conducted by others in their vicinity. It is therefore important to review the layout of 
tasks to ensure that those with respiratory symptoms are not working closely to tasks 
conducted by other colleagues who use substances which may cause respiratory 
irritation or sensitisation e.g.  painting and solvent cleaning operations 
Personal protective equipment  
 Workers with existing respiratory problems who are required to wear respirators may 
find the use of disposable mask impedes their breathing.  For these individuals, air-fed 
respirators should be provided.    
9 Museum attendant 2 
Job tasks/work methods/physical aspects of the job  
 Working in a museum requires daily walking, carrying and moving objects and climbing 
stairs (no lift) which may exacerbate respiratory symptoms of individuals with existing 
respiratory problems. Work should be regularly reviewed to minimise these activities, 
particularly climbing stairs and one off events (e.g. organising particular events), which 
require additional physical effort    
Occupational health services  
 Individuals with respiratory problems should contact occupational health services who 
can advise on the need for routine health surveillance, any workplace adjustments and 








 You currently choose to have your coffee/lunch break in your car which avoids the 
need to climb stairs to reach the canteen.  In winter months this may worsen your 
symptoms. Although your manager is happy for you to take your breaks at your 
workstation, this is not ideal.  You should ask your manager to create a separate area 
for breaks on the same floor, but away from your work station. It is important that 
official work breaks are away from the work desk/area which will help you to relax 
Occupational health services and education 
 A number of positive changes have been made recently by your manager which 
should reduce respiratory symptoms at work.  These changes include changes to your 











carrying and bending. It is important that you monitor and report the effects of these 
changes on tiredness and your respiratory symptoms to the company occupational 
health team 
 
11 Pupil guide 3 
Job tasks/work methods/physical aspects of the job  
 Children can misbehave which may cause you stress and anxiety and in-turn, may 
flare up your respiratory symptoms.  We understand that this situation only occurs 
occasionally. However, it is important that you monitor such episodes and inform your 
employer so that they can assess the group of children that you work with  
 Your job is not physically demanding but handling children’s bags and climbing stairs 
in the school can aggravate respiratory symptoms.  Although you are aware of this and 
take your time when conducting such activities, sometimes time pressure may require 
you move quickly.  We therefore suggest that you monitor and report any worsening of 
symptoms to your employer 
Occupational health services and education  
 You should make contact with your employer occupational health team so that they 
can monitor your respiratory symptoms at work, and provide advice on any changes 
which may be needed in the future 
12 Senior care assistant 3 
Job tasks/work methods/physical aspects of the job  
 Although your current role mainly involves assessment of potential service users in 
their homes, occasionally you may be required to help move service users. This 
should be avoided, particularly when working in a confined environment which is 
poorly ventilated 
Work organisation 
 Climbing stairs can also aggravate symptoms.  It is recommended that a pre-visit 
assessment is conducted to understand the layout of the house environment and 
rooms used by the service user 
Occupational health services and education  
 It is important that you report any flare-up of respiratory symptoms (when visiting the 









Job tasks/work methods/physical aspects of the job  
 Climbing stairs at work can aggravate respiratory symptoms. It would be helpful to 
organise work to avoid/minimise the use of stairs   
 Although your work is largely office based, you are occasionally required to lift/carry 
small objects e.g. alternators (weight 2-5Kg), which you stated does not cause you 
problems. However, you must ensure the carrying of objects is minimised by using the 
correct lifting aids. This will also reduce risk of injuries e.g. shelf trolley, keg truck, 
trolleys with suction cups  
Occupational health services and education  
 Given that you work in a small company with no access to occupational health 
services, it is important for you to monitor any work related activities which worsen 
your respiratory symptoms and report these to your GP   
14 Car mechanic 4 
Substances/ materials  
 Exposure to diesel fumes should be minimised by the following: 
a) Turning engine off when not required 
b) Installing air vents in walls and ceiling(s)  
c) Fitting tail pipe exhaust extraction systems or by attaching filters to tail 
pipes 
Job tasks/work methods/physical aspects of the job 
 Avoid blowing dust out of brake pads/clutch housing. Instead, use break cleaning 
equipment which prevents dust from escaping. 
 Manual handling of heavy car components should be avoided.  Although lifting hoists 
are used, removal and alignment of certain car parts will still require supporting heavy 
car components e.g. gear box.  
Work environment   
 The workshop should be heated, particularly in the winter months. A cold work 
environment can aggravate respiratory symptoms especially when working in enclosed 
spaces with diesel exhaust fumes 
15 Finance director 3 
Job tasks/work methods/physical aspects of the job 
 Lifting and carrying of boxes/parcels should be avoided particularly in confined spaces 
or when climbing stairs. Where possible mechanical aids should be used and work 
should be organised to minimise the carrying distances e.g. use of trolleys 
Work environment 
 Small offices (with limited ventilation) with a number of photocopiers and printers can 
generate a dry environment.  Some printers may produce irritant gases.  This 
environment can aggravate existing respiratory symptoms. It is recommend that the 
ventilation in such offices is improved, with the aim of improving the humidity and avoid 











 Offices should have sufficient ventilation. Where natural ventilation (opening of 
windows) is not sufficient, then mechanical ventilation should be installed to deliver the 
adequate volume of air. For this, the following should be taken into account: room size, 







 Working in small poorly ventilated offices (with computer and printers) can produce a 
dry hot environment as well as a build of chemical irritants, which can cause 
discomfort for those with existing breathing problems. The ventilation needs (fresh air 
requirements) should be reviewed, and account for: room size, number of occupants 
and office equipment (computers and printers). Mechanical ventilation may be needed 
when natural ventilation is insufficient 
Work organisation 
 Cleaning agents used by other staff may aggravate respiratory problems. This may 
occur when cleaning is being carried out near you or when you enter an area which 
has been recently cleaned. Wherever possible, work should be organised so that 
cleaning activities are not conducted around you and that areas being cleaned are well 









Occupational health services and education  
 Based on the consultation it appears that your current job task do not worsen your 
breathing problems. However, as COPD is a progressive condition, it is important that 
you inform your employer if and when your breathing symptoms become worse at 
work. High paced work as well as lifting and carrying of items can aggravate breathing 
problems    
18 Midwife 1 
Occupational health services and education  
 You should inform the occupational health team of your COPD diagnosis so that the 
team are able to consider the need for routine respiratory surveillance, monitor the 
effects of work on health and if required, make reasonable workplace adjustments. 
19 HGV driver 4 
Substances/ materials  
 Precautions should be taken to minimise the exposure to chemical substances at work 
including: wood dusts, diesel vapours and fumes  
 Equipment for cleaning the trailer should be selected to minimise the generation of 
dust.  The use of brushes should be avoided and instead, vacuum systems should be 
used (with appropriate filters)  
Job tasks/work methods/physical aspects of the job  
 Occasionally there is a need to manually load and unload vehicles. This can flare up 
breathing problems, particularly if this involves bending and carrying articles or when 
holding/supporting items above shoulder height. You should discuss the need for 
mechanical lifting aids in advance of deliveries with both the employer and the client 
(delivery site)   
Occupational health services and education  
 If work activities such as cleaning, lifting and handling timber cause any respiratory 
symptoms (e.g. cough, shortness of breath), then these should be reported to the 
company occupational health department or your GP 
20 Handyman 1 
Personal protective equipment 
 Some work tasks, such as cleaning in confined spaces (e.g. cabins) can generate dust 
and irritant cleaning chemicals which can aggravate breathing problems (e.g. cough, 
shortness of breath). We understand that cleaning is usually conducted without any 
ventilation extraction systems and respiratory masks. If the only control option is to use 
a respirator (mask) then you need to ensure that it fits well and does not cause any 
discomfort with your breathing.  Different types of mask are available, and this should 







Job tasks/work methods/physical aspects of the job 
 Manual handling tasks can aggravate respiratory symptoms and is a common cause of 
injuries to upper limbs and lower back. Manual handling of articles (lifting, lowering, 
carrying pushing or pulling) should be avoided and instead, lifting aids and trolleys 
should be used, particularly when delivering components to clients e.g. transporting 
metal articles from vehicle to client premises. 
Personal protective equipment 
 Although your exposure to chemicals (dusts and fumes) is infrequent e.g. when 
visiting/ supervising staff in the engineering work shop, short high exposures to 
chemicals given off from metal working and in metal cleaning processes can aggravate 
respiratory symptoms. It recommended that a breathing mask is used when attending 
the engineering workshop 
22 Cleaner 2 
Occupational health services and education  
 The cleaning chemicals that you use may contain substances which can irritate the 











worsening of breathing symptoms you must report this to the occupational health 
department, who can review the cleaning substance and cleaning methods to minimise 
the effects of chemicals on your respiratory health. The occupational health 
department can also advise you on the need to use a respirator (mask), type of 
respirator and when to use it 
 We recommend that you refer yourself to the company occupational health department 
and make them aware that you have been diagnosed with COPD. The occupational 
health department can advise you on the need for routine respiratory surveillance 
(respiratory questionnaires or lung function testing on site) and monitor any effects of 
work on your respiratory health. This will also help the company to meet its legal health 
and safety obligations.  
 
23 Caretaker (school) 5 
 
See highlighted for recommendation type 
 During summer months the cleaning, sanding varnishing of school floors generates 
airborne chemicals which can trigger breathing problems. The nature of the work 
(amount of material used, speed of work, physical nature of job) suggests that 
exposure to solvents and dust particles are likely to be high and the work physically 
demanding. You have experienced worsening of breathing problems when conducting 
these tasks which are likely to worsen further with repeated exposure. We recommend 
that these activities should only be conducted:  
a) In a well-ventilated area (work environment) 
b) With frequent breaks taken away from the work areas (work organisation) 
and, 
c) With suitable respirators, to protect against airborne dust and solvent 
vapours. Advice should be sought on the best type of respirator for the 
chemical substances which may be inhaled during cleaning and varnishing 
(personal protective equipment) 
Substances/materials 
 If your symptoms continue to worsen, despite following the above recommendations, 
then cleaning and polishing activities should be avoided.  
Occupational health services and education  
 You should inform your employer of any respiratory symptoms experienced whilst 
conducting any work related tasks. This is important so that they are able to monitor 
the effect of work on your lung health and make any necessary work place 
adjustments. This will also help your employer to meet their legal requirements e.g. 
under the Control of Substances Hazardous to Health Regulations 2002 (as 
amended).  
24 Plasterer 3 
Job tasks/work methods/physical aspects of the job  
 Majority of tasks related to the construction industry involve manual handling, lifting, 
carrying and working below waist which can all aggravate existing breathing problems. 
As it is technically difficult to use lifting aids in domestic buildings e.g. to transport bags 
of cement, plaster board, we recommend that you consider employing an assistant 
(apprentice) who can conduct such activities and to support you with the manual 
aspects of your work. This will also help to broaden the scope of the work (contracts) 
that you can take on as well as enable you to delegate the activities which can worsen 
your breathing problems and cause tiredness    
Work environment 
 Tasks such as removing and mixing plaster will generate dust and it is well known that 
dust (construction dust) can aggravate breathing problems such as COPD. Dust can 
be reduced by damping and working in a ventilated area. 
Personal protective equipment 
 However in enclosed spaces, these methods may not be sufficient to reduce the dust 
generated, and there will be a need to additionally use respiratory protection. A 
suitable respirator (dust mask) should be used when exposed to plaster dust. There 
are two types of dust masks:  
a) A disposable filter type  
b) A battery powered positive pressure respirator 
Type (b) does not impede breathing as it delivers filtered air over the face, whereas the 
disposable type mask can restrict breathing and which can become uncomfortable. We 
recommend that you trial the use of a positive pressure breathing mask and assess if this 








Job tasks/work methods/physical aspects of the job 
It is understood that you currently provide ‘level 3’ road side vehicle repair/recovery service 
which usually involves attending to vehicles that require: complex diagnostics, longer time to 
repair and are at greater likelihood of requiring vehicle recovery. Observations whilst waiting 
for vehicle recovery require additional safe practices e.g. assessing traffic conditions, 
lighting, road surface etc. which can be stressful. A number of tasks performed during such 











(tyre removal), working below waist level (lifting and moving tools and inspecting vehicles), 
excessive force (using a hammer to remove nut bolts without key) as well as exposure to 
diesel vapours and fume (which can irritate the lungs). There is also the possibility of 
exposure to chemicals released from deployment of vehicle air bags, as well as asbestos 
dust from the vehicle brakes 
 Please remember not to blow dust out of brake drums or clutch housing. Instead use 
the properly designed brake cleaning equipment 
 The exposure to pollutants, the amount of manual handling and anxiety could be 
reduced by conducting low level of repair work (level 1 or 2) which should be 
discussed with the occupational health department. This is particularly important if 
work related tasks are making breathing problems worse or causing tiredness 
 It is also important that the correct lifting equipment is used 
Personal protective equipment 
 It is important that a suitable breathing mask (respirator) is used when exposed to 
chemicals (asbestos, diesel fume, oil mists, leaks from air-conditioning systems), 







Job tasks/work methods/physical aspects of the job 
 The use of brushes/brooms to clean floors should be avoided; instead, vacuum 
cleaners (with suitable filters) should be used   
Occupational health services and education  
You mentioned that you have been diagnosed with asthma by your GP and that over the 
past 8 years you have visited the company occupational health department once to raise 
concerns with breathing problems. You found the consultation with OH nurse was not 
helpful, and have not visited the occupational health department since  
 It is important that you inform your local occupational health department of any 
breathing problems which you believe may be aggravated by your current daily work 
tasks and the work environment which may include cleaning operations (exposure to 
cleaning agents and dusts) as well as activities which involve manual handling e.g. 
furniture removal. The OH department can then assess whether any breathing 
problems experienced are work-related and the need for any workplace modifications 
 
27 Lollipop man 2 
Work organisation  
 If breathing symptoms worsen further during winter month we suggest changing work 
schedules to avoid working during cold spells. So for example, limiting work to 
evenings only during winter months, or refraining from work during colder spells.   
Occupational health services and education  
 It is important that the occupational health department are made aware of your COPD 
and any worsening of your symptoms so they can recommend any suitable workplace 
adjustments, if needed.   Any health matters discussed with occupational health should 





for tool hire 
company) 
4 
See highlighted for recommendation type 
 Sprays such as WD40 can irritate the lungs and worsen breathing.  Such sprays should 
be used in a well-ventilated area (substances/materials) and a mask should be worn 
particularly when spraying in confined spaces (personal protective equipment)   
 It is also important to discuss alternatives to WD40 or other cleaning agents with your 
employer, which are less likely to give off chemicals during the cleaning of metal 
components. Non-aerosol versions of WD40 are available, which may reduce the 
amount of airborne chemicals generated when applying the lubricant remover 
(substances/materials) 
Personal protective equipment 
 If you find using a disposable breathing mask uncomfortable, then a positive pressure 
air fed respirator should be used, particularly when working in areas with volatile 
chemicals or dusts, for example: during cleaning or tool maintenance activities  
Occupational health services and education  
 Manual handling e.g. lifting and moving of metal panels and equipment, can worsen 
breathing problems. When you experience breathing problems (e.g. breathlessness) 
after moving such objects, it is important that you inform your line manager and/or the 
occupational health department so that any workplace adjustments can be made. This 
may include scheduling of your work so to: 
a) avoid lifting of heavy goods or, 
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